This is a Validated Antibody Database (VAD) review about human CD3, based on 509 published articles (read how Labome selects the articles), using CD3 antibody in all methods. It is aimed to help Labome visitors find the most suited CD3 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
CD3 synonym: CD3-DELTA; IMD19; T3D

others
CD3 antibody (BioLegend, UCHT1) was used . PLoS Pathog (2018) ncbi
CD3 antibody (Biolegend, UCHT1) was used . Front Immunol (2018) ncbi
In order to investigate the effectiveness of a neoantigen vaccine against melanoma, CD3 antibody (Biolegend, UCHT1) was used . Nature (2017) ncbi
CD3 antibody (Biolegend, UCHT1) was used . Oncotarget (2017) ncbi
CD3 antibody (BioLegend, UCHT1) was used . elife (2017) ncbi
CD3 antibody (BioLegend, UCHT1) was used . J Exp Med (2017) ncbi
In order to determine the localization of FcgammaRI, FcgammaRII, and SIRPalpha in macrophages, CD3 antibody (BioLegend, UCHT1) was used . J Cell Biol (2017) ncbi
Invitrogen
mouse monoclonal (OKT3)
  • flow cytometry; human; 1:200
Invitrogen CD3 antibody (eBioscience, 48-0037-42) was used in flow cytometry on human samples at 1:200. Life Sci Alliance (2022) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry; mouse; loading ...
Invitrogen CD3 antibody (Thermo Fisher Scientific, RM-9107-S) was used in immunohistochemistry on mouse samples . Nat Commun (2022) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; mouse; 1:300; loading ...; fig 5d
Invitrogen CD3 antibody (Epredia Labvision, RM9107R7) was used in immunohistochemistry - paraffin section on mouse samples at 1:300 (fig 5d). Cell Mol Gastroenterol Hepatol (2022) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - frozen section; rat; 1:500; loading ...; fig 5c
Invitrogen CD3 antibody (Thermo Fisher, MA1-90582) was used in immunohistochemistry - frozen section on rat samples at 1:500 (fig 5c). Sci Rep (2022) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; fig 5d
Invitrogen CD3 antibody (Thermo Fisher, 45-0036-42) was used in flow cytometry on human samples (fig 5d). J Biol Chem (2022) ncbi
mouse monoclonal (UCHT1)
  • blocking or activating experiments; human; 1 ug/ml; loading ...; fig 7h
Invitrogen CD3 antibody (Thermo Fisher, 14-0038) was used in blocking or activating experiments on human samples at 1 ug/ml (fig 7h). J Exp Med (2022) ncbi
mouse monoclonal (OKT3)
  • blocking or activating experiments; human; 0.25 ug/ml; loading ...; fig 5d
Invitrogen CD3 antibody (eBioscience, OKT3) was used in blocking or activating experiments on human samples at 0.25 ug/ml (fig 5d). Oncoimmunology (2022) ncbi
mouse monoclonal (OKT3)
  • blocking or activating experiments; human; 2 ug/ml; loading ...; fig 4b
Invitrogen CD3 antibody (eBioscience, 16-0037) was used in blocking or activating experiments on human samples at 2 ug/ml (fig 4b). J Immunother Cancer (2022) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry; mouse; 1:500; loading ...; fig 3c
Invitrogen CD3 antibody (THERMOFISHER, MA5-14,524) was used in immunohistochemistry on mouse samples at 1:500 (fig 3c). Sci Rep (2021) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; mouse; 1:150; loading ...; fig 3b
Invitrogen CD3 antibody (ThermoScientific, MA5-14524) was used in immunohistochemistry - paraffin section on mouse samples at 1:150 (fig 3b). J Inflamm Res (2021) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human; 1:200; loading ...; fig s3a
Invitrogen CD3 antibody (Invitrogen, 47-0037-41) was used in flow cytometry on human samples at 1:200 (fig s3a). Nature (2021) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human; 1:40; loading ...
Invitrogen CD3 antibody (ThermoFisher Scientific, 45-0037-42) was used in flow cytometry on human samples at 1:40. elife (2021) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry; human; 1:100; loading ...; fig 1d
Invitrogen CD3 antibody (Thermo Fisher Scientific, SP7) was used in immunohistochemistry on human samples at 1:100 (fig 1d). Neuropathol Appl Neurobiol (2021) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; fig 5b
Invitrogen CD3 antibody (Thermo Fisher Scientific, UCHT1) was used in flow cytometry on human samples (fig 5b). ACS Synth Biol (2021) ncbi
mouse monoclonal (UCHT1)
  • other; human; loading ...; fig s4-1e
Invitrogen CD3 antibody (Thermo Fisher Scientific, 16-0038-85) was used in other on human samples (fig s4-1e). elife (2021) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig 1b
Invitrogen CD3 antibody (eBioscience, UCHT-1) was used in flow cytometry on human samples (fig 1b). Arthritis Res Ther (2021) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human; loading ...; fig s3
Invitrogen CD3 antibody (Invitrogen, 47-0037-41) was used in flow cytometry on human samples (fig s3). Nature (2021) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human; 1:200; fig e4a
Invitrogen CD3 antibody (Invitrogen, 47-0037-41) was used in flow cytometry on human samples at 1:200 (fig e4a). Nature (2021) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; 1:20; fig s11
Invitrogen CD3 antibody (Thermo Fisher Scientific, SK7) was used in flow cytometry on human samples at 1:20 (fig s11). Science (2021) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; mouse; 1:600; loading ...; fig e1j
Invitrogen CD3 antibody (Thermo Fischer, RM-9107-S1) was used in immunohistochemistry - paraffin section on mouse samples at 1:600 (fig e1j). EMBO Rep (2021) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human; fig 4
Invitrogen CD3 antibody (eBioscience, OKT4) was used in flow cytometry on human samples (fig 4). Aging Cell (2021) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig 6c
Invitrogen CD3 antibody (eBioscience, UCHT1) was used in flow cytometry on human samples (fig 6c). Cell Death Dis (2020) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; loading ...
Invitrogen CD3 antibody (Invitrogen, 11-0036-42) was used in flow cytometry on human samples . Cancer Sci (2021) ncbi
mouse monoclonal (UCHT1)
  • western blot; human; 1:50; loading ...; fig s8a
Invitrogen CD3 antibody (Thermo Fisher, 56-0038-42) was used in western blot on human samples at 1:50 (fig s8a). Science (2020) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human; 1:50; loading ...; fig 1s3b
Invitrogen CD3 antibody (Thermo Fisher Scientific, MHCD0304) was used in flow cytometry on human samples at 1:50 (fig 1s3b). elife (2020) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig 2a
Invitrogen CD3 antibody (eBiosciences, UCHT1) was used in flow cytometry on human samples (fig 2a). Science (2020) ncbi
mouse monoclonal (F7.2.38)
  • immunohistochemistry; mouse; fig 3e
Invitrogen CD3 antibody (ThermoFisher Scientific, F7.2.38) was used in immunohistochemistry on mouse samples (fig 3e). Nat Commun (2020) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human; loading ...; fig 7j
Invitrogen CD3 antibody (Invitrogen, 7D6) was used in flow cytometry on human samples (fig 7j). J Exp Med (2020) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig 3s1
Invitrogen CD3 antibody (eBioscience, 11-0038-42) was used in flow cytometry on human samples (fig 3s1). elife (2020) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; mouse; 1:100; loading ...; fig 5a
Invitrogen CD3 antibody (eBioscience, 15003842) was used in flow cytometry on mouse samples at 1:100 (fig 5a). Nat Commun (2019) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human; loading ...; fig s1c
Invitrogen CD3 antibody (eBioscience, 48-0037-41) was used in flow cytometry on human samples (fig s1c). Cell (2019) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; loading ...; fig s1a
Invitrogen CD3 antibody (eBioscience, 17-0036-42) was used in flow cytometry on human samples (fig s1a). BMC Cancer (2019) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; loading ...; fig 3f, 3g
Invitrogen CD3 antibody (Invitrogen, SK7) was used in flow cytometry on human samples (fig 3f, 3g). Brain Pathol (2020) ncbi
mouse monoclonal (OKT3)
  • blocking or activating experiments; human; 2 ug/ml; loading ...; fig 4a
Invitrogen CD3 antibody (eBioscience, 16-0037-85) was used in blocking or activating experiments on human samples at 2 ug/ml (fig 4a). Diagn Pathol (2019) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; rhesus macaque; 1:200; loading ...; fig 3g
Invitrogen CD3 antibody (Invitrogen, 47-0037-41) was used in flow cytometry on rhesus macaque samples at 1:200 (fig 3g). Nature (2019) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human; 1:200; loading ...; fig 2s1b
Invitrogen CD3 antibody (eBioscience, 45-0037-71) was used in flow cytometry on human samples at 1:200 (fig 2s1b). elife (2019) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; mouse; 1:100; loading ...; fig 3b
Invitrogen CD3 antibody (Themo, SP7) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 3b). elife (2019) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; loading ...; fig 1a
Invitrogen CD3 antibody (eBioscience, SK7) was used in flow cytometry on human samples (fig 1a). Arthritis Res Ther (2019) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; human; 1:150; loading ...; fig s4a
Invitrogen CD3 antibody (Thermofisher, MA1-90582) was used in immunohistochemistry - paraffin section on human samples at 1:150 (fig s4a). Cancer Cell (2019) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human; loading ...; fig 1a
Invitrogen CD3 antibody (eBioscience, OKT3) was used in flow cytometry on human samples (fig 1a). Immunol Cell Biol (2019) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; loading ...; fig 1a
Invitrogen CD3 antibody (eBioscience, 45-0036) was used in flow cytometry on human samples (fig 1a). Cell (2019) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig s2a
Invitrogen CD3 antibody (Life Technologies, UCHT1) was used in flow cytometry on human samples (fig s2a). Nat Med (2019) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; loading ...; fig s18b
Invitrogen CD3 antibody (eBioscience, SK7) was used in flow cytometry on human samples (fig s18b). Science (2018) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry; mouse; 1:20; loading ...; fig 2m
Invitrogen CD3 antibody (Thermo Fisher, SP7) was used in immunohistochemistry on mouse samples at 1:20 (fig 2m). J Exp Med (2018) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human; loading ...; fig s3i
Invitrogen CD3 antibody (eBiosciences, 13-0037-82) was used in flow cytometry on human samples (fig s3i). Cell (2018) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig s4a
Invitrogen CD3 antibody (eBiosciences, UCHT1) was used in flow cytometry on human samples (fig s4a). Sci Immunol (2018) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; human; loading ...; fig 3b
Invitrogen CD3 antibody (Thermo Fisher Scientific, Sp7) was used in immunohistochemistry - paraffin section on human samples (fig 3b). J Clin Invest (2018) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human; loading ...; fig 1b
Invitrogen CD3 antibody (eBioscience, OKT3) was used in flow cytometry on human samples (fig 1b). J Clin Invest (2018) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 2b
Invitrogen CD3 antibody (ThermoFisher, SP7) was used in immunohistochemistry - paraffin section on mouse samples (fig 2b). Cell (2017) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human; fig 2c
In order to study the involvement of RANKL in decidual M2 macrophage polarization, Invitrogen CD3 antibody (ebioscience, 16-0037) was used in flow cytometry on human samples (fig 2c). Cell Death Dis (2017) ncbi
mouse monoclonal (7D6)
  • flow cytometry; mouse; loading ...; fig 3b
Invitrogen CD3 antibody (Life Technologies, MHCD0301) was used in flow cytometry on mouse samples (fig 3b). Cell Stem Cell (2017) ncbi
mouse monoclonal (S4.1)
  • flow cytometry; human; loading ...; fig s1
Invitrogen CD3 antibody (Invitrogen, S4.1) was used in flow cytometry on human samples (fig s1). Eur J Immunol (2018) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; tbl s1
In order to investigate the effect of Shigella infection on human lymphocytes, Invitrogen CD3 antibody (eBioscience, 13-0038-82) was used in flow cytometry on human samples (tbl s1). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human; loading ...; tbl s1
In order to investigate the effect of Shigella infection on human lymphocytes, Invitrogen CD3 antibody (eBioscience, 11-0037-42) was used in flow cytometry on human samples (tbl s1). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (OKT3)
  • blocking or activating experiments; human; 1 ug/ml; loading ...; fig 6d
Invitrogen CD3 antibody (ebioscience, OKT3) was used in blocking or activating experiments on human samples at 1 ug/ml (fig 6d). PLoS ONE (2017) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; 1:200; loading ...; fig 4a
In order to study the interaction between CD100 and CD72 and its role in T cell proliferation, Invitrogen CD3 antibody (eBiosciences, UCHT1) was used in flow cytometry on human samples at 1:200 (fig 4a). Front Immunol (2017) ncbi
mouse monoclonal (S4.1 (7D6))
  • flow cytometry; human; loading ...; fig 1e
Invitrogen CD3 antibody (Invitrogen, MHCD0331) was used in flow cytometry on human samples (fig 1e). J Clin Invest (2017) ncbi
mouse monoclonal (OKT3)
  • blocking or activating experiments; human; loading ...; tbl 1
In order to investigate infiltrating T cells in liver cancer through single-cell sequencing, Invitrogen CD3 antibody (eBioscience, 16-0037-85) was used in blocking or activating experiments on human samples (tbl 1). Cell (2017) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; fig 3a
In order to generate T cells from cord blood hematopoietic progenitor cells transduced to express an antigen receptor as assess their ability to limit malignant cells and graft versus host disease, Invitrogen CD3 antibody (eBioscience, 48-0038-42) was used in flow cytometry on human samples (fig 3a). Oncoimmunology (2017) ncbi
mouse monoclonal (OKT3)
  • blocking or activating experiments; human; loading ...; fig s9
In order to find neoantigens in human mantle-cell lymphomas using samples from human patients, Invitrogen CD3 antibody (eBioscience, OKT3) was used in blocking or activating experiments on human samples (fig s9). Nature (2017) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig 3e
In order to investigate origin of tumor-infiltrating T regulatory cells in breast cancer samples, Invitrogen CD3 antibody (Thermo Fisher Scientific, 48-0038) was used in flow cytometry on human samples (fig 3e). Cell Res (2017) ncbi
mouse monoclonal (HIT3a)
  • flow cytometry; human; loading ...; fig 3a
In order to investigate origin of tumor-infiltrating T regulatory cells in breast cancer samples, Invitrogen CD3 antibody (Thermo Fisher Scientific, 11-0039) was used in flow cytometry on human samples (fig 3a). Cell Res (2017) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig 4b
In order to study the differentiation of innate lymphoid cells, Invitrogen CD3 antibody (eBioscience, 11-0038) was used in flow cytometry on human samples (fig 4b). Cell (2017) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human; loading ...; fig 3a
Invitrogen CD3 antibody (eBioscience, OKT3) was used in flow cytometry on human samples (fig 3a). J Immunol (2017) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human; loading ...; fig 2a
Invitrogen CD3 antibody (eBioscience, OKT-3) was used in flow cytometry on human samples (fig 2a). Oncoimmunology (2017) ncbi
rat monoclonal (CD3-12)
  • immunohistochemistry - frozen section; rhesus macaque; loading ...; fig 2a
In order to study CXCR5+ CD8 T cells in SIV-infected animals, Invitrogen CD3 antibody (Thermo Fischer, CD3-12) was used in immunohistochemistry - frozen section on rhesus macaque samples (fig 2a). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; loading ...; fig 1a
In order to characterize the periferal blood lymphocytes phenotype in tacrolimus-treated liver transplanted patients., Invitrogen CD3 antibody (eBioscience, SK7) was used in flow cytometry on human samples (fig 1a). Med Princ Pract (2017) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; mouse; 1:150; loading ...; fig 5
In order to employ ChIP-seq to analyze PAX8-PPARG fusion protein binding sites in a PAX8-PPARG fusion protein follicular thyroid carcinoma mouse model, Invitrogen CD3 antibody (Thermo Fischer Scientific, MA5-14524) was used in immunohistochemistry - paraffin section on mouse samples at 1:150 (fig 5). Oncotarget (2017) ncbi
mouse monoclonal (7D6)
  • flow cytometry; mouse; loading ...; fig s4
In order to study the impact of modulating IFN-I signaling during suppressive combined antiretroviral therapy, Invitrogen CD3 antibody (Invitrogen, 7D6) was used in flow cytometry on mouse samples (fig s4). J Clin Invest (2017) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human; loading ...; fig 1
In order to study the restoration of immune function in chronic HIV infection, Invitrogen CD3 antibody (eBioscience, OKT3) was used in flow cytometry on human samples (fig 1). J Clin Invest (2017) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry; mouse; loading ...; fig s1b
In order to use transgenic mice to assess the effects of progressively disrupting Hras and Nras genes on urethane lung tumorigenesis, Invitrogen CD3 antibody (ThermoFisher, RM9107) was used in immunohistochemistry on mouse samples (fig s1b). PLoS ONE (2016) ncbi
mouse monoclonal (HIT3a)
  • flow cytometry; human; loading ...
In order to characterize gammadelta T cell subsets from healthy humans, Invitrogen CD3 antibody (ebioscience, HIT3a) was used in flow cytometry on human samples . Proc Natl Acad Sci U S A (2016) ncbi
mouse monoclonal (OKT3)
  • immunocytochemistry; human; tbl 1
In order to discuss methods to visualize gangliosides involved in CD4 positive T cell activation, Invitrogen CD3 antibody (eBioscience, 16-0037-81) was used in immunocytochemistry on human samples (tbl 1). J Vis Exp (2016) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human; loading ...; fig 2c
Invitrogen CD3 antibody (eBiosciences, OKT3) was used in flow cytometry on human samples (fig 2c). PLoS Pathog (2016) ncbi
mouse monoclonal (UCHT1, HIB19)
In order to identify a role for CK2 in healthy human thymocytes in the selection of the gamma delta T-cell lineage, Invitrogen CD3 antibody (eBioscience, UCHT1) was used . Leukemia (2017) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human; loading ...; fig 1c
In order to profile the infiltration levels of immune cell populations in 19 cancer types, Invitrogen CD3 antibody (Invitrogen, MHCD0317) was used in flow cytometry on human samples (fig 1c). Genome Biol (2016) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; loading ...; fig 1b
In order to investigate the role of Eomes in the retention of liver natural killer cells, Invitrogen CD3 antibody (eBiosciences, SK7) was used in flow cytometry on human samples (fig 1b). J Immunol (2016) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; human; loading ...; fig 1e
In order to look for C3d+ microglial clusters in patients with multiple sclerosis, Invitrogen CD3 antibody (Thermo Scientific, SP7) was used in immunohistochemistry - paraffin section on human samples (fig 1e). Glia (2017) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - frozen section; human; 1:150; loading ...; fig 2b
In order to use MALDI-TOF-MS imaging to study immune cells in colon cancer samples, Invitrogen CD3 antibody (Thermo-Fisher, SP7) was used in immunohistochemistry - frozen section on human samples at 1:150 (fig 2b). J Proteome Res (2017) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 2a
In order to clarify the B cell-intrinsic functions of c-REL and RELA, Invitrogen CD3 antibody (Thermo Fisher Scientific, SP7) was used in immunohistochemistry - paraffin section on mouse samples (fig 2a). Immunol Cell Biol (2017) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human; loading ...
In order to identify RLTPR in patients and determine the effects of these mutations on CD4 positive T cells, Invitrogen CD3 antibody (Invitrogen, 7D6) was used in flow cytometry on human samples . J Exp Med (2016) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig s1a
In order to study immune cells infiltration and renal injury in CCL5 KO mice., Invitrogen CD3 antibody (Laboratory Vision, SP7) was used in immunohistochemistry - paraffin section on mouse samples (fig s1a). Am J Pathol (2016) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; human; 1:50; loading ...
In order to analyze small-cell lung cancer samples for CD274 mutations, Invitrogen CD3 antibody (Thermo Scientific, SP7) was used in immunohistochemistry - paraffin section on human samples at 1:50. Clin Cancer Res (2017) ncbi
mouse monoclonal (UCHT1, HIB19)
In order to investigate how differences in B cell populations may contribute to HIV susceptibility, Invitrogen CD3 antibody (Invitrogen, UCHT1) was used . AIDS Res Hum Retroviruses (2016) ncbi
mouse monoclonal (OKT3)
  • blocking or activating experiments; human; 2.5 ug/ml; loading ...; fig 7d
In order to find that internal membrane reservoirs in T lymphocytes are recruited, likely through exocytosis, to induce large active deformations, Invitrogen CD3 antibody (eBioscience, 16-0037-85) was used in blocking or activating experiments on human samples at 2.5 ug/ml (fig 7d). Mol Biol Cell (2016) ncbi
mouse monoclonal (OKT3)
  • blocking or activating experiments; human; fig 6a
In order to develop a method to quantify both the spatial distribution of a protein and its colocalization status, Invitrogen CD3 antibody (eBiosciences, 16-0037) was used in blocking or activating experiments on human samples (fig 6a). Mol Biol Cell (2016) ncbi
mouse monoclonal (OKT3)
  • blocking or activating experiments; human; fig 1
Invitrogen CD3 antibody (eBioscience, 16-0037) was used in blocking or activating experiments on human samples (fig 1). Proc Natl Acad Sci U S A (2016) ncbi
mouse monoclonal (S4.1 (7D6))
  • flow cytometry; human; loading ...
In order to elucidate the mechanisms by which DRibbles induce T-cell activation, Invitrogen CD3 antibody (Invitrogen, MHCD0331) was used in flow cytometry on human samples . Cell Death Dis (2016) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human; loading ...
In order to study the cytolytic effector capacity of HIV-specific CD8+ T cells, Invitrogen CD3 antibody (Invitrogen, S4.1) was used in flow cytometry on human samples . PLoS Pathog (2016) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human
Invitrogen CD3 antibody (eBioscience, OKT3) was used in flow cytometry on human samples . elife (2016) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; human; fig 1
In order to determine the density and distribution of tumor-infiltrating lymphocytes and tertiary lymphoid structures in pulmonary metastases from primary colorectal cancer and correlate them with clinicopathological variables, Invitrogen CD3 antibody (Thermo Fisher, RM9107-S1) was used in immunohistochemistry - paraffin section on human samples (fig 1). Clin Exp Metastasis (2016) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; fig 1a
In order to assess the effects of platelet-derived ectosomes on natural killer cells, Invitrogen CD3 antibody (eBiosciences, SK7) was used in flow cytometry on human samples (fig 1a). J Immunol (2016) ncbi
mouse monoclonal (UCHT1)
  • blocking or activating experiments; human; 1 ug/ml; loading ...; fig s3a
In order to use knockout mice to determine the role of cereblon in T cells, Invitrogen CD3 antibody (eBiosciences, UCHT1) was used in blocking or activating experiments on human samples at 1 ug/ml (fig s3a). Proc Natl Acad Sci U S A (2016) ncbi
mouse monoclonal (UCHT1, HIB19)
In order to characterize B cells and antibody repertoires from injection drug users, Invitrogen CD3 antibody (Invitrogen, UCHT1) was used . PLoS ONE (2016) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; mouse; fig 6
In order to study the reversal of renal injury and high blood pressure by renal rescue of dopamine D2 receptor function, Invitrogen CD3 antibody (Thermo Scientific, MA5-14524) was used in immunohistochemistry - paraffin section on mouse samples (fig 6). JCI Insight (2016) ncbi
mouse monoclonal (UCHT1)
  • immunohistochemistry; human; 1:200; loading ...; fig 5d
In order to develop methods to study aberrant crypt foci, Invitrogen CD3 antibody (eBioscience, UCHT1) was used in immunohistochemistry on human samples at 1:200 (fig 5d). Mol Cancer Res (2016) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human; fig 2
In order to study activation of myeloid dendritic cells, regulatory T cells and effector cells in lichen planus, Invitrogen CD3 antibody (Invitrogen, S4.1) was used in flow cytometry on human samples (fig 2). J Transl Med (2016) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; fig s1c
In order to report that human CD11c positive cells are the main VEGF-A-producing cell population in reactive secondary lymphoid organs, Invitrogen CD3 antibody (Thermo Scientific, SP7) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig s1c). Oncotarget (2016) ncbi
mouse monoclonal (OKT3)
  • blocking or activating experiments; human; fig 1
Invitrogen CD3 antibody (eBioscience, OKT3) was used in blocking or activating experiments on human samples (fig 1). Oncotarget (2016) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; fig S1
In order to study chronic hepatitis C virus infections and the functional dichotomy of V-delta2 gamma-delta T cells and their role in cytotoxicity and not IFN-gamma production, Invitrogen CD3 antibody (eBioscience, SK7) was used in flow cytometry on human samples (fig S1). Sci Rep (2016) ncbi
mouse monoclonal (UCHT1)
  • mass cytometry; human; loading ...; tbl 1, 2
In order to use elemental metal isotopes conjugated to monoclonal antibodies and study intracellular functional markers and surface phenotypic markers on natural killer cells, Invitrogen CD3 antibody (Life Technologies, UCHT1) was used in mass cytometry on human samples (tbl 1, 2). Methods Mol Biol (2016) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...
In order to test if the two hematopoietic systems in patients with mixed chimerism remain functional and study immunological differences, Invitrogen CD3 antibody (Invitrogen, UCHT1) was used in flow cytometry on human samples . PLoS ONE (2016) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human; loading ...; fig s3
Invitrogen CD3 antibody (eBioscience, OKT3) was used in flow cytometry on human samples (fig s3). PLoS ONE (2016) ncbi
mouse monoclonal (OKT3)
  • blocking or activating experiments; human; loading ...; fig s2a
  • immunohistochemistry - paraffin section; human; fig 4b
In order to investigate if ectopic expression of CX3CR1 enhances the homing of adoptively transferred T cells towards CX3CL1-producing tumors, resulting in increased T cell infiltration in tumor tissues, Invitrogen CD3 antibody (eBioscience, EB16-0037-85) was used in blocking or activating experiments on human samples (fig s2a) and in immunohistochemistry - paraffin section on human samples (fig 4b). J Immunother Cancer (2016) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...
In order to characterize B and T cells from patients with thrombocytopenia, Invitrogen CD3 antibody (Invitrogen, CD0330) was used in flow cytometry on human samples . Haematologica (2016) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; mouse; 1:500; loading ...; fig s2b
In order to assess the impact of phospholipase C gamma 2 mutations to the development of gastric mucosa-associated lymphoid tissue lymphomas, Invitrogen CD3 antibody (Thermo Fisher Scientific, SP7) was used in immunohistochemistry - paraffin section on mouse samples at 1:500 (fig s2b). PLoS ONE (2016) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human
Invitrogen CD3 antibody (eBioscience, 48-0038-42) was used in flow cytometry on human samples . Oncoimmunology (2016) ncbi
domestic rabbit monoclonal (SP7)
  • flow cytometry; mouse; 1:150; loading ...; fig 4
In order to test whether heat-killed Staphyloccocus aureus inhibits the development of atherosclerosis, Invitrogen CD3 antibody (Thermo Fischer Scientific, SP7) was used in flow cytometry on mouse samples at 1:150 (fig 4). J Intern Med (2016) ncbi
mouse monoclonal (OKT3)
  • blocking or activating experiments; human; fig 8
Invitrogen CD3 antibody (eBioscience, 16-0037-85) was used in blocking or activating experiments on human samples (fig 8). J Exp Med (2016) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; mouse; fig 5
In order to determine the role of fibroblast growth factor 21 (FGF21) in protecting from iselt hyperplasia and high fat diet induced inflammation in the pancreas, Invitrogen CD3 antibody (Thermo Scientific, MA1-90582) was used in immunohistochemistry - paraffin section on mouse samples (fig 5). PLoS ONE (2016) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry; mouse; 1:200; fig 4
In order to study murine experimental autoimmune encephalomyelitisto find a method for the histopathological study of the multifocal nature of spinal cord lesions, Invitrogen CD3 antibody (Neomarkers, RM-9107-5) was used in immunohistochemistry on mouse samples at 1:200 (fig 4). Peerj (2016) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; mouse; 1:50; fig 4b
In order to discuss models of squamous lung tumors to test therapeutic regimens, Invitrogen CD3 antibody (Thermo Fisher, SP7) was used in immunohistochemistry - paraffin section on mouse samples at 1:50 (fig 4b). J Thorac Oncol (2016) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human; fig 4
Invitrogen CD3 antibody (eBioscience, OKT-3) was used in flow cytometry on human samples (fig 4). Sci Rep (2016) ncbi
domestic rabbit monoclonal (SP7)
  • western blot; rat; 1:100; fig 13
In order to investigate the molecular mechanisms that regulate cardiomyocyte necroptosis, Invitrogen CD3 antibody (Thermo Scientific, RM9107) was used in western blot on rat samples at 1:100 (fig 13). Nat Med (2016) ncbi
mouse monoclonal (UCHT1, HIB19)
In order to characterize the gut-associated lymphoid tissue of HIV-controllers, Invitrogen CD3 antibody (eBioscience, UCHT1) was used . Immunol Res (2016) ncbi
mouse monoclonal (OKT3)
  • blocking or activating experiments; human; fig 2
In order to investigate the control of LAT recruitment to the immune synapse and T-cell activation in vivo by IFT20, Invitrogen CD3 antibody (eBioscence, 16-0037-85) was used in blocking or activating experiments on human samples (fig 2). Proc Natl Acad Sci U S A (2016) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; human; 1:500; fig 1
In order to study nontuberculous mycobacterial infection with mutual IgG4-related lymphadenopathy, Invitrogen CD3 antibody (Thermo Fisher, SP7) was used in immunohistochemistry - paraffin section on human samples at 1:500 (fig 1). APMIS (2016) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; fig 5
Invitrogen CD3 antibody (eBioscience, UCHT1) was used in flow cytometry on human samples (fig 5). PLoS Pathog (2015) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; human; 1:2000; fig 1
In order to compare multiple sclerosis to autoimmune encephalitis in humans, Invitrogen CD3 antibody (Neomarkers, RM-9107-S) was used in immunohistochemistry - paraffin section on human samples at 1:2000 (fig 1). Acta Neuropathol Commun (2015) ncbi
mouse monoclonal (OKT3)
  • blocking or activating experiments; human; loading ...
In order to demonstrate that TGF-beta induces the differentiation of human CXCL13-producing CD4 positive T cells from naive CD4 positive T cells, Invitrogen CD3 antibody (eBioscience, OKT3) was used in blocking or activating experiments on human samples . Eur J Immunol (2016) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human; fig 1
In order to study factors that specify the Treg lineage, Invitrogen CD3 antibody (Invitrogen, MHCD0317) was used in flow cytometry on human samples (fig 1). elife (2015) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; human; fig 1c
In order to study the localization and function of CXCR2 in hepatocellular carcinoma, Invitrogen CD3 antibody (Thermo Scientific, SP7) was used in immunohistochemistry - paraffin section on human samples (fig 1c). J Exp Clin Cancer Res (2015) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; fig 3
Invitrogen CD3 antibody (Tonbo, 25-0038) was used in flow cytometry on human samples (fig 3). Nat Commun (2015) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; human; fig 1c
Invitrogen CD3 antibody (Labvision, SP7) was used in immunohistochemistry - paraffin section on human samples (fig 1c). Nat Med (2015) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; fig 7
Invitrogen CD3 antibody (eBioscience, UCHT1) was used in flow cytometry on human samples (fig 7). Eur J Immunol (2016) ncbi
mouse monoclonal (HIT3a)
  • ELISA; human; fig 2
In order to characterize a bispecific scFv antibody targeting of human melanoma made in transgenic cattle called r28M, Invitrogen CD3 antibody (eBioscience, 16?C0039) was used in ELISA on human samples (fig 2). PLoS ONE (2015) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human; loading ...; fig s1a
In order to study age-related changes in human immunity during a primary virus infection experimentally induced by immunization with live-attenuated yellow fever vaccine, Invitrogen CD3 antibody (eBioscience, OKT3) was used in flow cytometry on human samples (fig s1a). J Immunol (2015) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; mouse; loading ...
In order to assess the effects of allosteric inhibitors on different mutant forms of isocitrate dehydrogenase 1 in leukemia, Invitrogen CD3 antibody (eBioscience, UCHT1) was used in flow cytometry on mouse samples . Nat Chem Biol (2015) ncbi
mouse monoclonal (HIT3a)
  • flow cytometry; human; loading ...; fig e3d
In order to discuss the importance of IL-5 positive Th2 cells to allergies, Invitrogen CD3 antibody (eBioscience, (HIT3A) was used in flow cytometry on human samples (fig e3d). J Allergy Clin Immunol (2016) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig e3d
In order to discuss the importance of IL-5 positive Th2 cells to allergies, Invitrogen CD3 antibody (Invitrogen, UCHT1) was used in flow cytometry on human samples (fig e3d). J Allergy Clin Immunol (2016) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; human; 1:250; tbl 1
In order to elucidate the prognosis of gastric cancer by tumor-infiltrating immune cells, Invitrogen CD3 antibody (Thermo Scientific, SP7) was used in immunohistochemistry - paraffin section on human samples at 1:250 (tbl 1). Medicine (Baltimore) (2015) ncbi
mouse monoclonal (OKT3)
  • blocking or activating experiments; human; fig 1
Invitrogen CD3 antibody (eBioscience, 16-0037-85) was used in blocking or activating experiments on human samples (fig 1). MAbs (2016) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human
In order to determine the proportions, phenotype, survival, and apoptotic susceptibility of Tregs in sarcoidosis, Invitrogen CD3 antibody (eBiosciences, SK7) was used in flow cytometry on human samples . Respir Res (2015) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; human; loading ...; fig 6a
In order to determine the effects of PD-0360324, a fully human immunoglobulin G2 monoclonal antibody against macrophage colony-stimulating factor, in patients with cutaneous lupus erythematosus, Invitrogen CD3 antibody (Thermo, SP7) was used in immunohistochemistry - paraffin section on human samples (fig 6a). Clin Exp Immunol (2016) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig 3a
In order to assess the efficacy of a single vaccination of the Yellow Fever vaccine, Invitrogen CD3 antibody (Invitrogen, Q10054) was used in flow cytometry on human samples (fig 3a). Hum Vaccin Immunother (2016) ncbi
mouse monoclonal (OKT3)
  • blocking or activating experiments; human; 1 ug/ml; fig 6c
Invitrogen CD3 antibody (eBioscience, OKT3) was used in blocking or activating experiments on human samples at 1 ug/ml (fig 6c). Nat Immunol (2015) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human; fig 1
Invitrogen CD3 antibody (eBioscience, OKT3) was used in flow cytometry on human samples (fig 1). Cancer Immunol Immunother (2015) ncbi
mouse monoclonal (OKT3)
  • blocking or activating experiments; human; fig s5
In order to study how conformational changes control T cell receptor association and activity of Zap70, Invitrogen CD3 antibody (eBiosciences, 16-0037) was used in blocking or activating experiments on human samples (fig s5). Nat Immunol (2015) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig 2a
In order to examine the effects of immunosuppressive agents on Polyomavirus BKV-specific T cells, Invitrogen CD3 antibody (eBioscience, UCHT1) was used in flow cytometry on human samples (fig 2a). Kidney Int (2015) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; fig 4
In order to discuss the role of T cells in Rasmussen encephalitis, Invitrogen CD3 antibody (eBioscience, UCHT1) was used in flow cytometry on human samples (fig 4). J Neuroinflammation (2015) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; human; loading ...; fig s1
In order to determine the periluminal distribution of CD4+ HIV target cells, Invitrogen CD3 antibody (Thermo, SP7) was used in immunohistochemistry - paraffin section on human samples (fig s1). PLoS ONE (2015) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry; human; fig 4a
In order to determine the expression and function of HLA-G, HLA-G-regulatory microRNAs and the immune cell infiltration in renal cell carcinoma samples, Invitrogen CD3 antibody (Thermo Scientific, MA1?C90582) was used in immunohistochemistry on human samples (fig 4a). Oncoimmunology (2015) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human; fig 1b
Invitrogen CD3 antibody (eBioscience, OKT3) was used in flow cytometry on human samples (fig 1b). Proc Natl Acad Sci U S A (2015) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human; fig s3
In order to determine the competitive advantage for human hematopoietic stem cells in vivo provided by CCND1-CDK4-mediated cell cycle progression, Invitrogen CD3 antibody (eBioscience, OKT3) was used in flow cytometry on human samples (fig s3). J Exp Med (2015) ncbi
mouse monoclonal (HIT3a)
  • flow cytometry; human; fig s3
In order to determine the competitive advantage for human hematopoietic stem cells in vivo provided by CCND1-CDK4-mediated cell cycle progression, Invitrogen CD3 antibody (eBioscience, HIT3A) was used in flow cytometry on human samples (fig s3). J Exp Med (2015) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human; fig 4
In order to investigate the role of VAMP8 in exocytosis, Invitrogen CD3 antibody (Invitrogen, S4.1) was used in flow cytometry on human samples (fig 4). J Cell Biol (2015) ncbi
mouse monoclonal (MEM-57)
  • immunohistochemistry; human; 1:200
In order to characterize placental gastrokine 2 expression in the placenta, Invitrogen CD3 antibody (Thermo Scientific, MA1-19454) was used in immunohistochemistry on human samples at 1:200. Histochem Cell Biol (2015) ncbi
domestic rabbit polyclonal
In order to describe the pathophysiology of canine diabetes, Invitrogen CD3 antibody (Life Technologies, PA1-37282) was used . PLoS ONE (2015) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry; human
Invitrogen CD3 antibody (Thermo Fisher Scientific, SP7) was used in immunohistochemistry on human samples . World J Urol (2016) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human
Invitrogen CD3 antibody (eBioscience, 48-0037-42) was used in flow cytometry on human samples . Blood Cancer J (2015) ncbi
mouse monoclonal (OKT3)
  • blocking or activating experiments; human; 0.01 ug/ml; fig 1
In order to discuss how to use induced-pluripotent stem cells to generate neuron-like cells, Invitrogen CD3 antibody (eBioscience, OKT3) was used in blocking or activating experiments on human samples at 0.01 ug/ml (fig 1). J Chin Med Assoc (2015) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; fig 1
In order to examine the antibody repertoire of patients with acute systemic lupus erythematosus, Invitrogen CD3 antibody (Invitrogen, UCHT1) was used in flow cytometry on human samples (fig 1). Nat Immunol (2015) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; rhesus macaque; 1:100
Invitrogen CD3 antibody (Lab Vision/NeoMarkers, SP7) was used in immunohistochemistry - paraffin section on rhesus macaque samples at 1:100. PLoS ONE (2015) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human
Invitrogen CD3 antibody (eBioscience, UCHT1) was used in flow cytometry on human samples . J Immunol (2015) ncbi
mouse monoclonal (S4.1)
  • flow cytometry; human; fig 6
In order to report the phase I trial results of CDX-301, Invitrogen CD3 antibody (Invitrogen, S4.1) was used in flow cytometry on human samples (fig 6). Bone Marrow Transplant (2015) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; mouse; 7.5 ug/ml; loading ...; fig 6a
In order to develop an image analysis workflow to assess mouse colon cancer, Invitrogen CD3 antibody (Thermo Scientific, RM-9107-S) was used in immunohistochemistry - paraffin section on mouse samples at 7.5 ug/ml (fig 6a). Vet Pathol (2016) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry; human; fig 4h
In order to identify a MCF2L variant linked to cardiovascular disease, Invitrogen CD3 antibody (ThermoFischer, SP7) was used in immunohistochemistry on human samples (fig 4h). Eur J Hum Genet (2016) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; mouse; 1:300; fig 1
In order to study the inhibition of extracellular CyPA in a mouse model of troponin I-induced autoimmune myocarditis, Invitrogen CD3 antibody (Thermo Fisher Scientific, SP-7) was used in immunohistochemistry - paraffin section on mouse samples at 1:300 (fig 1). PLoS ONE (2015) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig 1b
In order to assess intrahepatic delivery of anti-CEA chimeric antigen receptor-modified T cells through percutaneous hepatic artery infusions, Invitrogen CD3 antibody (Invitrogen, UCHT1) was used in flow cytometry on human samples (fig 1b). Clin Cancer Res (2015) ncbi
mouse monoclonal (OKT3)
  • blocking or activating experiments; human; 5 ug/ml
In order to study dysregulation of CD62L expression during HIV infection, Invitrogen CD3 antibody (eBioscience, OKT3) was used in blocking or activating experiments on human samples at 5 ug/ml. J Virol (2015) ncbi
domestic rabbit monoclonal (SP7)
  • immunoprecipitation; mouse
  • immunohistochemistry; human
Invitrogen CD3 antibody (Thermo Scientific, SP7) was used in immunoprecipitation on mouse samples and in immunohistochemistry on human samples . Dig Dis Sci (2015) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry; human; 1:100
Invitrogen CD3 antibody (Lab Vision, SP7) was used in immunohistochemistry on human samples at 1:100. PLoS ONE (2015) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry; mouse; fig 3
In order to analyze the effects of tumor growth and spread in two murine models with monocolonal antibodies to oncofetal antigen- an immature laminin receptor protein, Invitrogen CD3 antibody (Thermo Scientific, RM9107-s) was used in immunohistochemistry on mouse samples (fig 3). Cancer Biol Ther (2015) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human
In order to measure the memory CD4(+) T-cell responses to each varicella zoster virus protein at baseline and after zoster vaccination, Invitrogen CD3 antibody (Invitrogen, S4.1) was used in flow cytometry on human samples . J Infect Dis (2015) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human
In order to study the role of melanoma cell surface-associated calreticulin in melphalan-induced antitumor immunity, Invitrogen CD3 antibody (eBioscience, 48-0038) was used in flow cytometry on human samples . Cancer Res (2015) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry; mouse; 1:100; loading ...; fig s3a
In order to study the role of STAT3 in KRAS mutant lung adenocarcinoma., Invitrogen CD3 antibody (Neomarkers, RM9107) was used in immunohistochemistry on mouse samples at 1:100 (fig s3a). Nat Commun (2015) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; tbl 1
Invitrogen CD3 antibody (eBioscience, SK7) was used in flow cytometry on human samples (tbl 1). J Immunol (2015) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; tbl 1
Invitrogen CD3 antibody (eBioscience, UCHT1) was used in flow cytometry on human samples (tbl 1). J Immunol (2015) ncbi
mouse monoclonal (S4.1)
  • flow cytometry; human; tbl s1
In order to examine the early impact of viral replicative capacity on HIV-1 immunopathogenesis, Invitrogen CD3 antibody (Invitrogen, S4.1) was used in flow cytometry on human samples (tbl s1). Proc Natl Acad Sci U S A (2015) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human; tbl s1
In order to examine the early impact of viral replicative capacity on HIV-1 immunopathogenesis, Invitrogen CD3 antibody (Invitrogen, S4.1) was used in flow cytometry on human samples (tbl s1). Proc Natl Acad Sci U S A (2015) ncbi
mouse monoclonal (OKT3)
  • blocking or activating experiments; human; fig 3
In order to describe the phenotype and functional potential of metastatic differentiated thyroid cancer-associated PD-1 positive T cells, Invitrogen CD3 antibody (eBioscience, OKT3) was used in blocking or activating experiments on human samples (fig 3). Cancer Immunol Res (2015) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human
In order to show that intermediate DNA methylation is a conserved signature of gene regulation and exon usage, Invitrogen CD3 antibody (Invitrogen, MHCD0306) was used in flow cytometry on human samples . Nat Commun (2015) ncbi
mouse monoclonal (OKT3)
  • blocking or activating experiments; human; loading ...
In order to demonstrate a role for the actin network in regulating LFA-1 activity in T cells, Invitrogen CD3 antibody (eBioscience, OKT3) was used in blocking or activating experiments on human samples . J Cell Biol (2015) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry; human; 1:25; loading ...; fig 2d
In order to study the effect of topical tenofovir gel in the rectal mucosa and primary vaginal cells., Invitrogen CD3 antibody (Thermo Fisher Scientific, RM9107S) was used in immunohistochemistry on human samples at 1:25 (fig 2d). elife (2015) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; mouse; tbl 1
In order to characterize histomorphometric tumors by induction of colorectal cancer in mice, Invitrogen CD3 antibody (NeoMarkers, RM 9107) was used in immunohistochemistry - paraffin section on mouse samples (tbl 1). Methods Mol Biol (2015) ncbi
mouse monoclonal (OKT3)
  • blocking or activating experiments; human; 0.5 ug/ml
Invitrogen CD3 antibody (eBIoscience, OKT3) was used in blocking or activating experiments on human samples at 0.5 ug/ml. J Biol Chem (2015) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - free floating section; human
Invitrogen CD3 antibody (Lab Vision, SP7) was used in immunohistochemistry - free floating section on human samples . Arthritis Rheumatol (2015) ncbi
mouse monoclonal (S4.1)
  • flow cytometry; mouse; 1:2000
In order to test if mesenchymal stromal cells support the growth and survival of leukemic stem cells in vitro, Invitrogen CD3 antibody (Invitrogen, S4.1PB) was used in flow cytometry on mouse samples at 1:2000. Stem Cell Res (2015) ncbi
mouse monoclonal (OKT3)
  • blocking or activating experiments; human
Invitrogen CD3 antibody (eBioscience, OKT3) was used in blocking or activating experiments on human samples . J Autoimmun (2015) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human
Invitrogen CD3 antibody (eBioscience, SK7) was used in flow cytometry on human samples . J Allergy Clin Immunol (2015) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; human; 1:150
Invitrogen CD3 antibody (Thermo Scientific Labvision, SP7) was used in immunohistochemistry - paraffin section on human samples at 1:150. J Am Acad Dermatol (2015) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; fig 6g
In order to test if flow cytometry can be used to find mantle cell lymphoma, Invitrogen CD3 antibody (eBioscience, UCHT1) was used in flow cytometry on human samples (fig 6g). Cytometry B Clin Cytom (2014) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human
Invitrogen CD3 antibody (e-Bioscience, SK7) was used in flow cytometry on human samples . Nat Commun (2014) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human
Invitrogen CD3 antibody (eBioscience, OKT3) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human
Invitrogen CD3 antibody (eBioscience, OKT3) was used in flow cytometry on human samples . J Immunol (2014) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; tbl 1
Invitrogen CD3 antibody (eBiosciences, UCHT1) was used in flow cytometry on human samples (tbl 1). J Gen Virol (2015) ncbi
mouse monoclonal (OKT3)
  • blocking or activating experiments; human; 2 ug/ml
Invitrogen CD3 antibody (eBioscience, OKT3) was used in blocking or activating experiments on human samples at 2 ug/ml. PLoS Negl Trop Dis (2014) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; human
Invitrogen CD3 antibody (Thermo Scientific, SP7) was used in immunohistochemistry - paraffin section on human samples . Cancer Immunol Immunother (2015) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human
Invitrogen CD3 antibody (eBioscience, SK7) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry; human; 1:150
Invitrogen CD3 antibody (THERMO SC., SP7) was used in immunohistochemistry on human samples at 1:150. BMC Clin Pathol (2014) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; mouse; fig 4
In order to analyze deubiquitinization Usp9X and its regulation of proximal T cell receptor signaling and tolerance induction, Invitrogen CD3 antibody (Thermo Fisher Scientific, SP7) was used in immunohistochemistry - paraffin section on mouse samples (fig 4). J Exp Med (2014) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human
Invitrogen CD3 antibody (eBioscience, UCHT1) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human; 0.05 ug/ml
Invitrogen CD3 antibody (eBioscience, OKT3) was used in flow cytometry on human samples at 0.05 ug/ml. J Leukoc Biol (2014) ncbi
mouse monoclonal (OKT3)
  • blocking or activating experiments; human
In order to study the role of CD93 molecule in mature dendritic cells and T cells, Invitrogen CD3 antibody (eBioscience, OKT3) was used in blocking or activating experiments on human samples . Immunobiology (2015) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human
Invitrogen CD3 antibody (eBioscience, SK7) was used in flow cytometry on human samples . Clin Cancer Res (2014) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human
Invitrogen CD3 antibody (eBioscience, UCHT1) was used in flow cytometry on human samples . Med Microbiol Immunol (2014) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human
Invitrogen CD3 antibody (eBioscience, UCHT1) was used in flow cytometry on human samples . J Exp Med (2014) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human
In order to study the cell mediated immune response to JCV T-Ag in patients with colorectal adenomatous polyps or cancers, Invitrogen CD3 antibody (eBioscience, 45-0037-42) was used in flow cytometry on human samples . Gut Microbes (2014) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; human; 1:2000
In order to study the relations between neurodegeneration, demyelination, inflammation, and iron in regards to multiple sclerosis, Invitrogen CD3 antibody (Neomarkers, RM-9107-S) was used in immunohistochemistry - paraffin section on human samples at 1:2000. J Neurol Neurosurg Psychiatry (2014) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human
In order to study the role of gammadeltaT cells during human ischemic stroke, Invitrogen CD3 antibody (Invitrogen, MHCD0317) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human
Invitrogen CD3 antibody (eBioscience, UCHT1) was used in flow cytometry on human samples . J Infect Dis (2014) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human
Invitrogen CD3 antibody (eBiosciences, OKT3) was used in flow cytometry on human samples . J Clin Immunol (2014) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; mouse; 1:200
In order to explore the protective mechanism by which the oxysterol receptors suppress inflammatory bowel disease, Invitrogen CD3 antibody (Labvision, RM-9107-S0) was used in immunohistochemistry - paraffin section on mouse samples at 1:200. Mucosal Immunol (2014) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; human
In order to characterize stroma cells and ductal epithelium comparing chronic pancreatitis and pancreatic ductal adenocarcinoma, Invitrogen CD3 antibody (Fisher/Thermo Scientific, SP7) was used in immunohistochemistry - paraffin section on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human
In order to investigate the anti-influenza responses of T cell subsets, Invitrogen CD3 antibody (Invitrogen, UCHT1) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human
Invitrogen CD3 antibody (e-Biosciences, OKT-3) was used in flow cytometry on human samples . J Clin Immunol (2014) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human
Invitrogen CD3 antibody (eBioscience, OKT3) was used in flow cytometry on human samples . J Immunol Res (2014) ncbi
mouse monoclonal (S4.1 (7D6))
  • flow cytometry; human
In order to study virus-specific human memory T-cell activation in response to Dribble-mediated cross-presentation of viral antigens, Invitrogen CD3 antibody (Invitrogen, MHCD0331) was used in flow cytometry on human samples . J Transl Med (2014) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human
Invitrogen CD3 antibody (eBioscience, SK7) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human
Invitrogen CD3 antibody (eBioscience, UCHT1) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (UCHT1, HIB19)
In order to investigate the effects of lymphopenia and chronic exposure to IFN on T cell homeostasis, Invitrogen CD3 antibody (Invitrogen, UCHT1) was used . PLoS Pathog (2014) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; tbl 1
In order to study the effect of innate lymphoid cells on B cells, Invitrogen CD3 antibody (eBioscience, UCHT1) was used in flow cytometry on human samples (tbl 1). Nat Immunol (2014) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human
In order to examine human differentiated effector CD4(+) T cells that are defined by low levels of IL-2 and IL-7 receptors, Invitrogen CD3 antibody (Invitrogen, S4.1) was used in flow cytometry on human samples . Cancer Res (2014) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; human
Invitrogen CD3 antibody (Thermo Fisher Scientific, SP7) was used in immunohistochemistry - paraffin section on human samples . Circ Arrhythm Electrophysiol (2014) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human
Invitrogen CD3 antibody (eBioscience, 14-0037-82) was used in flow cytometry on human samples . Clin Cancer Res (2014) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry; human; 1:100
Invitrogen CD3 antibody (Labvision/Thermo Scientific, SP7) was used in immunohistochemistry on human samples at 1:100. PLoS Pathog (2014) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human
Invitrogen CD3 antibody (eBioscience, UCHT1) was used in flow cytometry on human samples . PLoS Pathog (2014) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig 1
In order to discuss the importance of assessing immune competence in cancer patients, Invitrogen CD3 antibody (Invitrogen, UCHT1) was used in flow cytometry on human samples (fig 1). Cancer Immunol Immunother (2014) ncbi
domestic rabbit monoclonal (SP7)
  • immunocytochemistry; human; 1:100
Invitrogen CD3 antibody (Thermo Scientific, SP7) was used in immunocytochemistry on human samples at 1:100. J Crohns Colitis (2014) ncbi
mouse monoclonal (OKT3)
  • blocking or activating experiments; human; 3 ug/ml
Invitrogen CD3 antibody (eBioscience, OKT3) was used in blocking or activating experiments on human samples at 3 ug/ml. J Immunol (2014) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; fig 1
In order to study CD161 high CD8+ T cells in an HIV and Mycobacterium tuberculosis endemic African setting., Invitrogen CD3 antibody (Invitrogen, UCHT1) was used in flow cytometry on human samples (fig 1). PLoS ONE (2013) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human
In order to examine the effect on cellular iron uptake upon expression of the accessory protein Nef from different lentiviral strains, Invitrogen CD3 antibody (Caltag, UCHT1) was used in flow cytometry on human samples . Retrovirology (2014) ncbi
mouse monoclonal (UCHT1)
  • blocking or activating experiments; human
In order to test the effect of different Mycobacterium tuberculosis molecules on HIV-1 replication, Invitrogen CD3 antibody (Ebioscience, UCHT1) was used in blocking or activating experiments on human samples . PLoS ONE (2013) ncbi
mouse monoclonal (HIT3a)
  • blocking or activating experiments; human; 0.5 ug/ml; fig 1
Invitrogen CD3 antibody (eBioscience, HIT3a) was used in blocking or activating experiments on human samples at 0.5 ug/ml (fig 1). Ann Rheum Dis (2015) ncbi
mouse monoclonal (OKT3)
  • blocking or activating experiments; human
Invitrogen CD3 antibody (eBioscience, OKT3) was used in blocking or activating experiments on human samples . Clin Exp Immunol (2014) ncbi
mouse monoclonal (UCHT1, HIB19)
In order to correlate biomarkers associated with coagulation, monocyte activation, and inflammation in elite controllers of HIV infection, Invitrogen CD3 antibody (eBioscience, UCHT1) was used . J Infect Dis (2014) ncbi
mouse monoclonal (S4.1)
  • flow cytometry; human
In order to use zinc-finger nucleases to simultaneous modify ccr5 and cxcr4 in primary human CD4(+) T cells and introduce these cells into a humanized mouse model of HIV-1 infection, Invitrogen CD3 antibody (Invitrogen, S4.1) was used in flow cytometry on human samples . Blood (2014) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; human; 1:500; fig 1
In order to test if the epileptogenic mechanisms underlying Rasmussen encephalitis are related to changes in ADK expression, Invitrogen CD3 antibody (Lab Vision, SP7) was used in immunohistochemistry - paraffin section on human samples at 1:500 (fig 1). J Neuropathol Exp Neurol (2013) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; fig 1
In order to study iNKT cells and A2ARs in sickle cell disease, Invitrogen CD3 antibody (Invitrogen, UCHT1) was used in flow cytometry on human samples (fig 1). PLoS ONE (2013) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; 1:10; fig 4
In order to investigate the cytotoxicity of acyl glucuronide, Invitrogen CD3 antibody (Invitrogen, UCHT1) was used in flow cytometry on human samples at 1:10 (fig 4). Drug Metab Dispos (2014) ncbi
mouse monoclonal (7D6)
  • blocking or activating experiments; human
  • western blot; human; fig 5
In order to explore how EBV infection influences CMV-driven immune differentiation, Invitrogen CD3 antibody (Invitrogen, S4.1) was used in blocking or activating experiments on human samples and in western blot on human samples (fig 5). J Virol (2013) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human
Invitrogen CD3 antibody (eBioscience, SK7) was used in flow cytometry on human samples . J Hepatol (2014) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human
Invitrogen CD3 antibody (eBioscience, UCHT1) was used in flow cytometry on human samples . Ann Rheum Dis (2014) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; fig 1
In order to characterize T cells after MVA85A vaccination, Invitrogen CD3 antibody (Invitrogen, UCHT1) was used in flow cytometry on human samples (fig 1). Eur J Immunol (2013) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; human; 1:2000; fig 1
In order to investigate the mechanisms that lead to demyelination and neurodegeneration, Invitrogen CD3 antibody (Neomarkers, RM-9107-S) was used in immunohistochemistry - paraffin section on human samples at 1:2000 (fig 1). Brain (2013) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human
In order to identify the cause of an autosomal recessive syndrome, Invitrogen CD3 antibody (Invitrogen, S4.1) was used in flow cytometry on human samples . J Med Genet (2013) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; fig 1
In order to determine cytokine profiles of CD4(+) T-helper (h) cells in adults and young children vaccinated with the antigens PspA, PcpA, PhtD, PhtE, Ply, LytB of Streptococcus pneumonia and protein D and OMP26 of non-typeable Haemophilus influenza, Invitrogen CD3 antibody (Invitrogen, clone UCHT1) was used in flow cytometry on human samples (fig 1). Vaccine (2013) ncbi
mouse monoclonal (S4.1)
  • flow cytometry; human
In order to study facilitation of HIV-1 transmission to cervico-vaginal tissue ex vivo by interleukin-7, Invitrogen CD3 antibody (Invitrogen, noca) was used in flow cytometry on human samples . PLoS Pathog (2013) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human; fig 3
In order to test if impaired human neonatal CD4(+) T cell immunity is due to reduced signaling by naive CD4(+) T cells following engagement of the alphabeta-TCR/CD3 complex and CD28, Invitrogen CD3 antibody (Invitrogen, clone S4.1) was used in flow cytometry on human samples (fig 3). J Immunol (2013) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human; fig 4
In order to assess the effects of trichosanthin treatment, Invitrogen CD3 antibody (Invitrogen, S4.1) was used in flow cytometry on human samples (fig 4). J Investig Allergol Clin Immunol (2012) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; fig 1
In order to report results from a phase 1 trial testing the A2AR agonist regadenoson in adults with sickle cell disease, Invitrogen CD3 antibody (Invitrogen, UCHT1) was used in flow cytometry on human samples (fig 1). Blood (2013) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human
In order to study assembly of the T cell antigen receptor, Invitrogen CD3 antibody (Caltag, S4.1) was used in flow cytometry on human samples . BMC Immunol (2013) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; human; 1:150; tbl 2
In order to discuss how Epstein-Barr virus contributes to the development of small B-cell neoplasms, Invitrogen CD3 antibody (Labvision, SP7) was used in immunohistochemistry - paraffin section on human samples at 1:150 (tbl 2). PLoS ONE (2012) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human; fig 1
In order to identify integrin alpha2 as a novel stem cell marker, Invitrogen CD3 antibody (Invitrogen, S4.1) was used in flow cytometry on human samples (fig 1). Stem Cells (2013) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human; fig 2
In order to study the roles of the decidua-derived CCL2 in the Th2 predominance found at the maternal-fetal interface, Invitrogen CD3 antibody (CALTAG, MHCD0305) was used in flow cytometry on human samples (fig 2). Clin Immunol (2012) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - frozen section; mouse; 1:50; fig s3
In order to report that TNFR1-independent prion accumulation in lymph nodes depends on LTbetaR signaling, Invitrogen CD3 antibody (Thermoscientific, RM-9107-S1) was used in immunohistochemistry - frozen section on mouse samples at 1:50 (fig s3). PLoS Pathog (2012) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human
In order to determine the function and phenotypes of antigen-specific CD4(+) T cells in adults compared to infants upon acellular pertussis vaccine administration, Invitrogen CD3 antibody (Invitrogen, UCHT1) was used in flow cytometry on human samples . Clin Exp Immunol (2012) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human
In order to analyze the regulation of Amphiregulin expression in human T cell subsets, Invitrogen CD3 antibody (Invitrogen, UCHT1) was used in flow cytometry on human samples . PLoS ONE (2012) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; fig 2
In order to study influenza-specific CD4 T cells respond to vaccination using Ki67 as a marker, Invitrogen CD3 antibody (Invitrogen, clone UCHT1) was used in flow cytometry on human samples (fig 2). Vaccine (2012) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human; fig 4
In order to identify surrogates of anti-tumor immune responsiveness after DC vaccination, Invitrogen CD3 antibody (Invitrogen, MHCD0317) was used in flow cytometry on human samples (fig 4). PLoS ONE (2012) ncbi
mouse monoclonal (S4.1)
  • flow cytometry; human; fig 5
In order to analyze the proliferation and functional profile of circulating double positive T cells from acutely HIV-infected individuals and chronically HIV-infected viral controllers, Invitrogen CD3 antibody (Invitrogen, S4.1) was used in flow cytometry on human samples (fig 5). J Immunol (2012) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry; human; 1:100; fig 1
In order to test if damage to the lymphoid tissue fibroblastic reticular cell network contributes to naive T cell loss during HIV-1 infection, Invitrogen CD3 antibody (Thermo Scientific, RM-9107-S1) was used in immunohistochemistry on human samples at 1:100 (fig 1). PLoS Pathog (2012) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry; mouse
In order to characterize mammary cancers in multiparous Stat1 knockout mice, Invitrogen CD3 antibody (Neomarkers, RM9107) was used in immunohistochemistry on mouse samples . Oncotarget (2011) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry; human; 1:150; fig 2
In order to evaluate the prognostic value of tumor-infiltrating lymphocytes in the anthracycline-based chemotherapy, Invitrogen CD3 antibody (Lab Vision, RM-9107) was used in immunohistochemistry on human samples at 1:150 (fig 2). Breast Cancer Res (2011) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...
In order to characterize two pathogenic, noncoding aberrations of UNC13D in patients with familial hemophagocytic lymphohistiocytosis, Invitrogen CD3 antibody (eBiosciences, UHCT1) was used in flow cytometry on human samples . Blood (2011) ncbi
mouse monoclonal (OKT3)
  • blocking or activating experiments; human; 2.5 ug/ml
Invitrogen CD3 antibody (eBioscience, OKT3) was used in blocking or activating experiments on human samples at 2.5 ug/ml. PLoS ONE (2011) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; human; loading ...
  • immunohistochemistry; human
In order to study three clinical cases of follicular dendritic cell sarcoma, Invitrogen CD3 antibody (Thermo Scientific, SP7) was used in immunohistochemistry - paraffin section on human samples and in immunohistochemistry on human samples . Hum Pathol (2012) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human; fig S2
In order to examine tumor and nonadjacent normal breast tissue from women with breast cancer, who either had or had not received neoadjuvant chemotherapy before surgery, Invitrogen CD3 antibody (eBioscience, 46-0037-42) was used in flow cytometry on human samples (fig S2). Proc Natl Acad Sci U S A (2012) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry; human; 1:150; fig 5C
In order to examine tumor and nonadjacent normal breast tissue from women with breast cancer, who either had or had not received neoadjuvant chemotherapy before surgery, Invitrogen CD3 antibody (Thermo Scientific, RM-9107-S1) was used in immunohistochemistry on human samples at 1:150 (fig 5C). Proc Natl Acad Sci U S A (2012) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human; fig 5
In order to assess the immune responses of peripheral blood to chlamydial antigens, Invitrogen CD3 antibody (Invitrogen, S4.1) was used in flow cytometry on human samples (fig 5). Front Microbiol (2011) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; human; 1:150; tbl 2
In order to identify biomarkers to distinguish between true recurrence and new primary cases of ipsilateral breast tumor recurrence, Invitrogen CD3 antibody (Lab vision, RM-9107) was used in immunohistochemistry - paraffin section on human samples at 1:150 (tbl 2). Breast Cancer (Auckl) (2011) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; human
  • immunohistochemistry; human
In order to investigate the clinical and pathological features in a girl with common variable immunodeficiency, Invitrogen CD3 antibody (Thermo, SP7) was used in immunohistochemistry - paraffin section on human samples and in immunohistochemistry on human samples . Int J Surg Pathol (2014) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; fig s2
In order to track T cells after transplantation, Invitrogen CD3 antibody (Invitrogen, UCHT1) was used in flow cytometry on human samples (fig s2). EMBO Mol Med (2011) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human; fig 2
In order to describe methods to mimic peripheral lymphoid organs in vitro, Invitrogen CD3 antibody (Caltag, MHCD0318) was used in flow cytometry on human samples (fig 2). Biotechnol Bioeng (2011) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human
In order to investigate the regulation of the CD4 and CD8 T cell pools during HIV infection, Invitrogen CD3 antibody (Invitrogen, clone UHCT1) was used in flow cytometry on human samples . J Immunol (2011) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human; fig 1
In order to identify immunological/virological biomarkers associated with sleep quality in patients with chronic hepatitis C, Invitrogen CD3 antibody (Caltag, MHCD0306) was used in flow cytometry on human samples (fig 1). Scand J Immunol (2011) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; tbl 3
In order to examine human cross-reactive T cells against a pandemic virus, Invitrogen CD3 antibody (Invitrogen, clone UCHT1) was used in flow cytometry on human samples (tbl 3). Vaccine (2011) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; human; fig 3
  • immunohistochemistry; human
In order to investigate the localization of the prolactin receptor in atherosclerotic plaques, Invitrogen CD3 antibody (Thermo Fisher, SP7) was used in immunohistochemistry - paraffin section on human samples (fig 3) and in immunohistochemistry on human samples . J Endocrinol (2011) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human; fig 2
In order to investigate IL-15-driven NK receptor induction in CD8+ T cells, Invitrogen CD3 antibody (eBioscience, OKT3) was used in flow cytometry on human samples (fig 2). Immunobiology (2011) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human; fig 1
In order to study the molecular mechanisms that regulate the "recall" NK cell response after rabies vaccination, Invitrogen CD3 antibody (Caltag/Invitrogen, S4.1) was used in flow cytometry on human samples (fig 1). J Immunol (2010) ncbi
mouse monoclonal (S4.1)
  • flow cytometry; mouse; fig 3
In order to compare the therapeutic efficacy of CD19-specific human primary T cells that constitutively express gamma(c)-cytokines, Invitrogen CD3 antibody (Caltag, S4.1) was used in flow cytometry on mouse samples (fig 3). Blood (2010) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; fig 1
In order to study T regulatory cells in inflamed human liver samples, Invitrogen CD3 antibody (eBioscience, UCHT-1) was used in flow cytometry on human samples (fig 1). J Immunol (2010) ncbi
mouse monoclonal (7D6)
  • other; human; fig 2
In order to develop a procedure for the disaggregation of colorectal cancers and normal intestinal mucosal tissues to produce single cell suspensions and assess surface antigens, Invitrogen CD3 antibody (Invitrogen, S4.1) was used in other on human samples (fig 2). J Immunol Methods (2010) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human
In order to identify biomarkers in the first synovial fluid aspirate obtained from children with oligoarticular juvenile idiopathic arthritis, Invitrogen CD3 antibody (Caltag, S4.1) was used in flow cytometry on human samples . Arthritis Rheum (2010) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human; fig 1
In order to study IL-7 receptor expression and IL-7 signaling in human thymocytes, Invitrogen CD3 antibody (Invitrogen, S4.1) was used in flow cytometry on human samples (fig 1). Hum Immunol (2010) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human
In order to assess the safety and efficacy of bone marrow-derived mesenchymal stem cells in two systemic lupus erythematosus patients, Invitrogen CD3 antibody (Caltag, MHCD0304) was used in flow cytometry on human samples . Lupus (2010) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human; 1:20; fig 3
In order to investigate targeting CEACAM6 for treatment of pancreatic adenocarcinomas, Invitrogen CD3 antibody (CalTag, clone MHCD0304) was used in flow cytometry on human samples at 1:20 (fig 3). J Pathol (2009) ncbi
mouse monoclonal (S4.1)
  • flow cytometry; human
In order to study the improvement of simultaneous phenotype-specific telomere length measurement by FISH-flow cytometry by quantum dots thermal stability, Invitrogen CD3 antibody (Invitrogen, noca) was used in flow cytometry on human samples . J Immunol Methods (2009) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human
In order to develop a xenotransplantation system using human hematopoietic stem cells and mice, Invitrogen CD3 antibody (Caltag/Invitrogen, S4.1) was used in flow cytometry on human samples . Nat Protoc (2008) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; tbl 1
In order to characterize lymphocyte subgroups in peripheral blood of advanced stage lung cancer patients, Invitrogen CD3 antibody (eBioscience, 15-0038) was used in flow cytometry on human samples (tbl 1). Med Oncol (2010) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry; human; 1:150; fig 1
In order to study autoantibodies and tumor-infiltrating T cells in epithelial ovarian cancer, Invitrogen CD3 antibody (Lab Vision, RM-9107) was used in immunohistochemistry on human samples at 1:150 (fig 1). PLoS ONE (2008) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; rhesus macaque; fig 4
  • flow cytometry; human; fig 4
Invitrogen CD3 antibody (eBioscience, OKT3) was used in flow cytometry on rhesus macaque samples (fig 4) and in flow cytometry on human samples (fig 4). J Virol (2008) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human
In order to correlate Notch receptor expression and the severity of systemic lupus erythematosus disease, Invitrogen CD3 antibody (Caltag, S4.1) was used in flow cytometry on human samples . Lupus (2008) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human; fig 2
In order to study the effect of EBV load in patients with rheumatoid arthritis, Invitrogen CD3 antibody (Invitrogen, S4.1) was used in flow cytometry on human samples (fig 2). J Immunol (2008) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human
In order to develop a 6-color assay to identify dendritic cells, Invitrogen CD3 antibody (Caltag, S4.1) was used in flow cytometry on human samples . Cytometry B Clin Cytom (2008) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human
In order to study the use of DEC-205 targeting in vaccination against Epstein-Barr virus, Invitrogen CD3 antibody (Invitrogen, S4.1) was used in flow cytometry on human samples . Blood (2008) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human; loading ...; fig 2a
In order to demonstrate that aerosolized interferon-gamma results in the transient conversion of sputum smears in multidrug-resistant pulmonary tuberculosis, Invitrogen CD3 antibody (Invitrogen, S4.1) was used in flow cytometry on human samples (fig 2a). Int J Tuberc Lung Dis (2008) ncbi
mouse monoclonal (7D6)
  • blocking or activating experiments; human
In order to determine the relationship between organophosphate pesticide exposure and biomarkers of oxidative stress and DNA damage, Invitrogen CD3 antibody (Invitrogen, S4.1) was used in blocking or activating experiments on human samples . Toxicol Appl Pharmacol (2008) ncbi
mouse monoclonal (7D6)
  • blocking or activating experiments; human; 0.1 ug/ml; fig 3c
In order to generate a selectable lentiviral vector with a proliferative advantage to study transgene immunogenicity in gene-modified T cells, Invitrogen CD3 antibody (Caltag/Invitrogen, S4.1) was used in blocking or activating experiments on human samples at 0.1 ug/ml (fig 3c). Gene Ther (2007) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human
In order to characterize human Th17 cells, Invitrogen CD3 antibody (CalTag, MHCD0306) was used in flow cytometry on human samples . Nat Immunol (2007) ncbi
mouse monoclonal (OKT3)
  • blocking or activating experiments; human
In order to develop a system for the decoration of enveloped viruses with functionally active cytokines, Invitrogen CD3 antibody (eBioscience, OKT3) was used in blocking or activating experiments on human samples . J Virol (2007) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human; fig 3
In order to identify and characterize the receptor encoded by KIR2DL5, Invitrogen CD3 antibody (Caltag, S4.1) was used in flow cytometry on human samples (fig 3). J Immunol (2007) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human
In order to characterize CD34+ cells from bone marrow of untreated patients with chronic myelogenous leukemia in chronic phase, Invitrogen CD3 antibody (Caltag, S4.1) was used in flow cytometry on human samples . Leukemia (2007) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human
In order to study GATA-3 and T-box expression in human T cells, Invitrogen CD3 antibody (Caltag, S4.1) was used in flow cytometry on human samples . Blood (2007) ncbi
mouse monoclonal (OKT3)
  • blocking or activating experiments; human; 0.5 ug/ml
In order to measure T cell responses to a tumor-associated antigen and test if T regulatory cells affect those anti-tumor immune responses in patients with colorectal cancer, Invitrogen CD3 antibody (eBioscience, OKT3) was used in blocking or activating experiments on human samples at 0.5 ug/ml. PLoS ONE (2006) ncbi
mouse monoclonal (HIT3a)
  • flow cytometry; human; fig 4
Invitrogen CD3 antibody (eBioscience, HIT3a) was used in flow cytometry on human samples (fig 4). J Virol (2006) ncbi
mouse monoclonal (OKT3)
  • blocking or activating experiments; human
In order to assess the T cell-stimulatory capacity of mature dendritic cells and macrophages using a model of allogeneic MLR, Invitrogen CD3 antibody (eBioscience, OKT-3) was used in blocking or activating experiments on human samples . J Immunol (2006) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human
Invitrogen CD3 antibody (eBioscience, OKT3) was used in flow cytometry on human samples . J Immunol (2006) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human
In order to detect the JAK2 V617F mutation in hematopoietic stem cells and their progeny in patients with polycythemia vera, Invitrogen CD3 antibody (Caltag, S4.1) was used in flow cytometry on human samples . Proc Natl Acad Sci U S A (2006) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human
In order to develop methods to establish long-term, antigen-specific T-cell lines and clones, Invitrogen CD3 antibody (Caltag, S4.1) was used in flow cytometry on human samples . Immunol Lett (2006) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human; fig s1
In order to test if delta-1 affects the formation of human plasmacytoid dendritic cells, Invitrogen CD3 antibody (Caltag, S4.1) was used in flow cytometry on human samples (fig s1). Blood (2006) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human
In order to investigate the role of ORF66 kinase of varicella-zoster virus using T cells, Invitrogen CD3 antibody (Caltag, S4.1) was used in flow cytometry on human samples . J Virol (2005) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human; tbl 2
In order to use flow cytometry to study granzyme A, B, and K expression in human peripheral blood lymphocytes, Invitrogen CD3 antibody (Caltag, S4.1) was used in flow cytometry on human samples (tbl 2). Eur J Immunol (2005) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human
In order to study how macrophages and serum factors contribute to the development of systemic lupus erythematosus, Invitrogen CD3 antibody (Caltag, S4.1) was used in flow cytometry on human samples . Ann Rheum Dis (2006) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human
In order to characterize natural killer cells in the decidua of sporadic miscarriages and induced abortions, Invitrogen CD3 antibody (Caltag, S4.1) was used in flow cytometry on human samples . Mol Hum Reprod (2005) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human
In order to discuss methods to distinguish natural killer cells from natural killer T cells, Invitrogen CD3 antibody (Caltag, S4.1) was used in flow cytometry on human samples . Cytometry A (2005) ncbi
mouse monoclonal (7D6)
  • flow cytometry; African green monkey; fig 1
In order to discuss available reagents for studying the neotropical primate squirrel monkey, Invitrogen CD3 antibody (Caltag Laboratories, S4.1) was used in flow cytometry on African green monkey samples (fig 1). J Immunol Methods (2005) ncbi
mouse monoclonal (SPV-T3b)
  • flow cytometry; human; fig 2
In order to elucidate how interleukin-4 promotes the development of T helper type 2 cells, Invitrogen CD3 antibody (Zymed, SPV-T3b) was used in flow cytometry on human samples (fig 2). Eur J Immunol (2005) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human; fig 2
In order to assess the effects of a TransFix-based stabilization technique on leukocyte scatter characteristics, immunophenotyping, membrane permeability, absolute cell counting and morphology, Invitrogen CD3 antibody (Caltag Laboratories, S4.1) was used in flow cytometry on human samples (fig 2). J Immunol Methods (2004) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human; fig 3
In order to elucidate how the monoclonal antibody, 11C9, reduces dendritic cell-induced T cell activation, Invitrogen CD3 antibody (Caltag, S4.1) was used in flow cytometry on human samples (fig 3). J Immunol (2004) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human
In order to investigate T cell-mediated transfer of varicella-zoster virus to skin, Invitrogen CD3 antibody (Caltag, S4.1) was used in flow cytometry on human samples . J Exp Med (2004) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human
In order to characterize human CD133+ HPCs, Invitrogen CD3 antibody (Caltag, S4.1) was used in flow cytometry on human samples . Transfusion (2004) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human
In order to study the life-cycle events of HIV-1 in primary cultures of human uterine epithelial cells and stromal fibroblasts, Invitrogen CD3 antibody (Caltag, MHCD0301) was used in flow cytometry on human samples . J Infect Dis (2004) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human; tbl 1
In order to characterize natural killer cells in women with recurrent spontaneous abortion of unexplained etiology, Invitrogen CD3 antibody (CALTAG, S4.1) was used in flow cytometry on human samples (tbl 1). Am J Reprod Immunol (2004) ncbi
mouse monoclonal (SPV-T3b)
  • blocking or activating experiments; human; 1 ug/ml
In order to investigate the role of LIR-2 in dendritic cells, Invitrogen CD3 antibody (Zymed, SPV-T3b) was used in blocking or activating experiments on human samples at 1 ug/ml. Eur J Immunol (2004) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human
In order to test if CD103 has a regulatory role in the microenvironment of the epithelial cell layer, Invitrogen CD3 antibody (Caltag, S4.1) was used in flow cytometry on human samples . Cytometry B Clin Cytom (2003) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human
In order to ask if flow cytometry can be used for the detection of bone marrow involvement in the different types of B-cell malignant neoplasms, Invitrogen CD3 antibody (Zymed, S4.1) was used in flow cytometry on human samples . Cytometry B Clin Cytom (2003) ncbi
mouse monoclonal (7D6)
  • immunohistochemistry - frozen section; human; fig 1
In order to study the effect of leukemia inhibitor factor on HIV replication, Invitrogen CD3 antibody (Caltag Laboratories, clone S4.1) was used in immunohistochemistry - frozen section on human samples (fig 1). AIDS (2003) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human
In order to examine adhesion molecules in patients with restenosis, Invitrogen CD3 antibody (Caltag, S4.1) was used in flow cytometry on human samples . Cytometry B Clin Cytom (2003) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human; tbl 2
In order to assess the ability of a modified cell separator system to isolate monocytes by elutriation, Invitrogen CD3 antibody (Caltag, S4.1) was used in flow cytometry on human samples (tbl 2). Transfusion (2003) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human; fig 1
In order to study the effect of lacking ICOS in patients with common variable immunodeficiency, Invitrogen CD3 antibody (Caltag, S4.1) was used in flow cytometry on human samples (fig 1). Nat Immunol (2003) ncbi
mouse monoclonal (SPV-T3b)
  • immunohistochemistry - paraffin section; human; fig 4
In order to identify a timeframe in human and pig kidney organogenesis that may be optimal for transplantation, Invitrogen CD3 antibody (Zymed, 070303) was used in immunohistochemistry - paraffin section on human samples (fig 4). Nat Med (2003) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human; fig 1
In order to identify and characterize immature CD2(-/low) T cells in peripheral blood, Invitrogen CD3 antibody (Caltag, S4.1) was used in flow cytometry on human samples (fig 1). J Immunol (2002) ncbi
mouse monoclonal (OKT3)
  • flow cytometry; human; fig 1
In order to identify and characterize immature CD2(-/low) T cells in peripheral blood, Invitrogen CD3 antibody (Caltag, OKT3) was used in flow cytometry on human samples (fig 1). J Immunol (2002) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human
In order to report how to isolate highly purified hematopoietic intermediates, Invitrogen CD3 antibody (Caltag, S4.1) was used in flow cytometry on human samples . Proc Natl Acad Sci U S A (2002) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human; 4 ug/ml
In order to characterize human splenic dendritic cells, Invitrogen CD3 antibody (Caltag, S4.1) was used in flow cytometry on human samples at 4 ug/ml. Blood (2001) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human; fig 1
In order to elucidate the mechanisms that promote recruitment and survival of T cells within the pediatric inflamed joint, Invitrogen CD3 antibody (Caltag, S4.1) was used in flow cytometry on human samples (fig 1). J Immunol (2001) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human; fig 3
In order to assess cryptomonad-derived phycobiliproteins for their applicability to flow cytometry, Invitrogen CD3 antibody (Caltag Laboratories, clone S4.1) was used in flow cytometry on human samples (fig 3). Cytometry (2001) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human; fig 4
In order to compare the immune responses of T cells isolated from human secondary lymphoid organs and peripheral blood, Invitrogen CD3 antibody (Caltag, S4.1) was used in flow cytometry on human samples (fig 4). Int Immunol (2001) ncbi
mouse monoclonal (SPV-T3b)
  • other; bovine
In order to study how extracellular matrix-embedded cytokines regulate thyroid cell surface molecules, Invitrogen CD3 antibody (Zymed, SPV-T3b) was used in other on bovine samples . Thyroid (2000) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human
In order to discuss studying rhesus macaques infected with simian immunodeficiency viruses or simian-human immunodeficiency viruses, Invitrogen CD3 antibody (Caltag, S4.1) was used in flow cytometry on human samples . Cytometry (2000) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human; tbl 2
In order to optimize B- and T-lymphoid lineage detection in acute leukemias by intracellular staining for myeloperoxidase, CD79a, and CD3, Invitrogen CD3 antibody (Caltag, clone S4.1) was used in flow cytometry on human samples (tbl 2). J Immunol Methods (2000) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human
In order to identify factors that down regulate CD4 on cultured monocytes, Invitrogen CD3 antibody (Caltag, S4.1) was used in flow cytometry on human samples . Clin Diagn Lab Immunol (2000) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human; tbl 5
In order to discuss methods of CD34+ cell selection from blood, Invitrogen CD3 antibody (Caltag, S4.1) was used in flow cytometry on human samples (tbl 5). Transfusion (2000) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human
In order to characterize the cells present in the cutaneous blister fluid patients with toxic epidermal necrolysis, Invitrogen CD3 antibody (Caltag, S4-1) was used in flow cytometry on human samples . Clin Exp Immunol (2000) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human
In order to study perturbations in eosinophil homeostasis following treatment of lymphatic filariasis, Invitrogen CD3 antibody (Caltag, S4.1) was used in flow cytometry on human samples . Infect Immun (2000) ncbi
mouse monoclonal (7D6)
  • flow cytometry; mouse
In order to elucidate role of SOD-1 overexpression in thymocyte biology, Invitrogen CD3 antibody (Caltag, S4.1) was used in flow cytometry on mouse samples . J Immunol (1999) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human
In order to study selective expression of cytokines by T cells, Invitrogen CD3 antibody (Caltag, S4.1) was used in flow cytometry on human samples . J Immunol (1999) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human; fig 4
In order to determine the functional properties of CK beta-11/MIP-3 beta/ELC, Invitrogen CD3 antibody (Caltag, S4.1) was used in flow cytometry on human samples (fig 4). J Immunol (1998) ncbi
mouse monoclonal (7D6)
  • flow cytometry; human; fig 5
In order to report an in vitro assay for thymic T-cell development, Invitrogen CD3 antibody (Caltag, S4.1) was used in flow cytometry on human samples (fig 5). Blood (1998) ncbi
mouse monoclonal (7D6)
  • immunocytochemistry; human; fig 3
In order to report that human hematopoietic cells survive and proliferate in severe combined immunodeficient mice treated with busulfan and cyclophosphamide, Invitrogen CD3 antibody (Caltag, S4.1) was used in immunocytochemistry on human samples (fig 3). Stem Cells (1997) ncbi
mouse monoclonal (7D6)
  • immunocytochemistry; human; fig 2
In order to describe the cellular composition and organization of lymphoid aggregates in the stratum basalis of uterine endometrium, Invitrogen CD3 antibody (Caltag, S4.1) was used in immunocytochemistry on human samples (fig 2). J Leukoc Biol (1997) ncbi
mouse monoclonal (S4.1 (7D6))
  • immunoprecipitation; human; fig 3
In order to characterize antigens associated with the T3 complex, Invitrogen CD3 antibody (noco, noca) was used in immunoprecipitation on human samples (fig 3). J Biol Chem (1983) ncbi
mouse monoclonal (7D6)
  • immunoprecipitation; human; fig 3
In order to characterize antigens associated with the T3 complex, Invitrogen CD3 antibody (noco, noca) was used in immunoprecipitation on human samples (fig 3). J Biol Chem (1983) ncbi
mouse monoclonal (S4.1)
  • immunoprecipitation; human; fig 3
In order to characterize antigens associated with the T3 complex, Invitrogen CD3 antibody (noco, noca) was used in immunoprecipitation on human samples (fig 3). J Biol Chem (1983) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human
In order to review TCR alpha/beta-T3 complex expression and formation, Invitrogen CD3 antibody (noco, UCHT1) was used in flow cytometry on human samples . Cell (1986) ncbi
mouse monoclonal (S4.1)
  • western blot; human
In order to clone the human 20K non-glycosylated T3-epsilon, Invitrogen CD3 antibody (noco, noca) was used in western blot on human samples . Nature (1986) ncbi
mouse monoclonal (7D6)
  • western blot; human
In order to clone the human 20K non-glycosylated T3-epsilon, Invitrogen CD3 antibody (noco, noca) was used in western blot on human samples . Nature (1986) ncbi
mouse monoclonal (S4.1 (7D6))
  • western blot; human
In order to clone the human 20K non-glycosylated T3-epsilon, Invitrogen CD3 antibody (noco, noca) was used in western blot on human samples . Nature (1986) ncbi
Abcam
domestic rabbit monoclonal (SP7)
  • immunohistochemistry; mouse; 1:200; loading ...; fig 3g
Abcam CD3 antibody (Abcam, ab21703) was used in immunohistochemistry on mouse samples at 1:200 (fig 3g). elife (2022) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; mouse; 1:200; fig s8a
  • immunohistochemistry - paraffin section; human; loading ...; fig s3a, 2a
Abcam CD3 antibody (Abcam, ab16669) was used in immunohistochemistry - paraffin section on mouse samples at 1:200 (fig s8a) and in immunohistochemistry - paraffin section on human samples (fig s3a, 2a). Theranostics (2022) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 2g
Abcam CD3 antibody (Abcam, ab16669) was used in immunohistochemistry - paraffin section on mouse samples (fig 2g). Cell Rep (2022) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - frozen section; rat; 1:200; loading ...; fig 4a
Abcam CD3 antibody (Abcam, ab16669) was used in immunohistochemistry - frozen section on rat samples at 1:200 (fig 4a). Front Pharmacol (2022) ncbi
domestic rabbit monoclonal (SP162)
  • immunohistochemistry - paraffin section; mouse; 1:250; fig 3f
Abcam CD3 antibody (Abcam, ab135372) was used in immunohistochemistry - paraffin section on mouse samples at 1:250 (fig 3f). Cell Rep (2022) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; fig 1e
  • immunohistochemistry - paraffin section; mouse; 1:100; fig 5e, s6
Abcam CD3 antibody (Abcam, ab16669) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 1e) and in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 5e, s6). Proc Natl Acad Sci U S A (2022) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 3b
Abcam CD3 antibody (Abcam, ab16669) was used in immunohistochemistry - paraffin section on mouse samples (fig 3b). Cell Rep (2022) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - frozen section; mouse; 1:100; loading ...; fig 3f
Abcam CD3 antibody (Abcam, ab16669) was used in immunohistochemistry - frozen section on mouse samples at 1:100 (fig 3f). J Neuroinflammation (2022) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; rat; 1:300; loading ...; fig 4c
Abcam CD3 antibody (Abcam, ab16669) was used in immunohistochemistry - paraffin section on rat samples at 1:300 (fig 4c). Int J Mol Sci (2021) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry; human; 1:100; fig 2a
Abcam CD3 antibody (Abcam, ab16669) was used in immunohistochemistry on human samples at 1:100 (fig 2a). Front Immunol (2021) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; mouse; 1:100; loading ...; fig 7a
Abcam CD3 antibody (Abcam, ab16669) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 7a). Sci Rep (2021) ncbi
domestic rabbit monoclonal (SP162)
  • immunohistochemistry; human; 1:50; fig 2e
Abcam CD3 antibody (Abcam, ab135372) was used in immunohistochemistry on human samples at 1:50 (fig 2e). Front Immunol (2021) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry; mouse; 1:200; loading ...; fig 5e
Abcam CD3 antibody (Abcam, ab16669) was used in immunohistochemistry on mouse samples at 1:200 (fig 5e). Int J Mol Sci (2021) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; human; 1:200; loading ...; fig s5c
Abcam CD3 antibody (Abcam, ab16669) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig s5c). Bone Res (2021) ncbi
domestic rabbit monoclonal (SP162)
  • immunohistochemistry; mouse; 1:500; fig 5a
Abcam CD3 antibody (Abcam, ab135372) was used in immunohistochemistry on mouse samples at 1:500 (fig 5a). Vaccines (Basel) (2021) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; human; loading ...; fig 1f
  • immunohistochemistry - frozen section; mouse; loading ...; fig 6c
Abcam CD3 antibody (Abcam, ab16669) was used in immunohistochemistry - paraffin section on human samples (fig 1f) and in immunohistochemistry - frozen section on mouse samples (fig 6c). Circulation (2021) ncbi
domestic rabbit monoclonal (SP162)
  • immunohistochemistry - paraffin section; human; 1:150; loading ...; fig s1a
Abcam CD3 antibody (Abcam, ab135372) was used in immunohistochemistry - paraffin section on human samples at 1:150 (fig s1a). Front Cell Dev Biol (2021) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry; mouse; 1:100; loading ...; fig 4a
Abcam CD3 antibody (Abcam, ab16669) was used in immunohistochemistry on mouse samples at 1:100 (fig 4a). Am J Cancer Res (2021) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 3f
Abcam CD3 antibody (Abcam, ab16669) was used in immunohistochemistry - paraffin section on mouse samples (fig 3f). Mol Cancer (2021) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 1h
Abcam CD3 antibody (Abcam, ab16669) was used in immunohistochemistry - paraffin section on mouse samples (fig 1h). Adv Sci (Weinh) (2021) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry; human; 1:400; loading ...; fig 4b
Abcam CD3 antibody (abcam, ab16669) was used in immunohistochemistry on human samples at 1:400 (fig 4b). Nat Commun (2021) ncbi
domestic rabbit monoclonal (SP7)
  • western blot; human; 1:100; loading ...
Abcam CD3 antibody (Abcam, ab16669) was used in western blot on human samples at 1:100. Cell Death Dis (2021) ncbi
domestic rabbit monoclonal (SP162)
  • immunohistochemistry - paraffin section; mouse; 1:200; loading ...; fig 4b
Abcam CD3 antibody (Abcam, ab135372) was used in immunohistochemistry - paraffin section on mouse samples at 1:200 (fig 4b). FEBS Open Bio (2021) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 3a
Abcam CD3 antibody (Abcam, SP7) was used in immunohistochemistry - paraffin section on mouse samples (fig 3a). J Clin Invest (2021) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry; mouse; 1:100; loading ...; fig 2e
Abcam CD3 antibody (Abcam, ab16669) was used in immunohistochemistry on mouse samples at 1:100 (fig 2e). elife (2020) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; mouse; 1:100; loading ...; fig 1d
Abcam CD3 antibody (Abcam, ab16669) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 1d). J Am Soc Nephrol (2020) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; mouse; 1:100; loading ...; fig 1d
Abcam CD3 antibody (Abcam, ab16669) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 1d). Cell Death Dis (2020) ncbi
domestic rabbit monoclonal (EP4426)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...
Abcam CD3 antibody (Abcam, ab208514) was used in immunohistochemistry - paraffin section on human samples at 1:100. Nat Cell Biol (2020) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry; human; 1:200; loading ...; fig 1a
Abcam CD3 antibody (Abcam, Ab16669) was used in immunohistochemistry on human samples at 1:200 (fig 1a). Nat Commun (2020) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; human; 1:200; loading ...; fig s1a
Abcam CD3 antibody (Abcam, ab16669) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig s1a). Sci Rep (2019) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 4h
Abcam CD3 antibody (Abcam, ab16669) was used in immunohistochemistry - paraffin section on mouse samples (fig 4h). Cell (2019) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; mouse; fig 3g
Abcam CD3 antibody (Abcam, ab16669) was used in immunohistochemistry - paraffin section on mouse samples (fig 3g). J Clin Invest (2019) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 2d
Abcam CD3 antibody (Abcam, ab16669) was used in immunohistochemistry - paraffin section on mouse samples (fig 2d). J Clin Invest (2019) ncbi
domestic rabbit monoclonal (EP4426)
  • immunohistochemistry - paraffin section; human; 1:150; loading ...; fig 7
Abcam CD3 antibody (Abcam, ab109531) was used in immunohistochemistry - paraffin section on human samples at 1:150 (fig 7). Breast Cancer Res (2019) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry; mouse; 1:100; loading ...; fig 5h
Abcam CD3 antibody (Abcam, ab16669) was used in immunohistochemistry on mouse samples at 1:100 (fig 5h). Nat Commun (2019) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; mouse; 1:100; loading ...
Abcam CD3 antibody (abcam, ab16669) was used in immunohistochemistry - paraffin section on mouse samples at 1:100. Nature (2018) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry; mouse; 1:100; loading ...; fig 2b
Abcam CD3 antibody (Abcam, SP7) was used in immunohistochemistry on mouse samples at 1:100 (fig 2b). Front Immunol (2018) ncbi
domestic rabbit monoclonal (EP4426)
  • western blot; human; loading ...; fig 2c
Abcam CD3 antibody (Abcam, EP4426) was used in western blot on human samples (fig 2c). J Immunol (2018) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - frozen section; mouse; 1:100; loading ...; fig 4g, 5f
Abcam CD3 antibody (Abcam, ab16669) was used in immunohistochemistry - frozen section on mouse samples at 1:100 (fig 4g, 5f). J Neurovirol (2018) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; mouse; 1:100; loading ...; fig s13a
Abcam CD3 antibody (Abcam, ab16669) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig s13a). Nat Commun (2018) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - frozen section; mouse; loading ...; fig s3h
Abcam CD3 antibody (Abcam, SP7) was used in immunohistochemistry - frozen section on mouse samples (fig s3h). J Clin Invest (2018) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; mouse; 1:100; loading ...; fig 2
Abcam CD3 antibody (Abcam, SP7) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 2). J Immunol (2018) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 2a
Abcam CD3 antibody (Abcam, ab16669) was used in immunohistochemistry - paraffin section on mouse samples (fig 2a). Am J Transl Res (2017) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; human; loading ...; tbl 1
In order to investigate infiltrating T cells in liver cancer through single-cell sequencing, Abcam CD3 antibody (Abcam, ab16669) was used in immunohistochemistry - paraffin section on human samples (tbl 1). Cell (2017) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; mouse; 1:200; loading ...; fig 5d
Abcam CD3 antibody (Abcam, ab16669) was used in immunohistochemistry - paraffin section on mouse samples at 1:200 (fig 5d). Genes Dev (2017) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry; human; loading ...; fig 5a
Abcam CD3 antibody (Abcam, SP7) was used in immunohistochemistry on human samples (fig 5a). Oncoimmunology (2017) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - frozen section; mouse; 1:100
  • immunohistochemistry - paraffin section; mouse; 1:100
  • immunohistochemistry; mouse; loading ...; fig 37
  • immunohistochemistry - frozen section; rat; 1:100
  • immunohistochemistry - paraffin section; rat; 1:100
  • immunohistochemistry - paraffin section; African green monkey; 1:200
  • immunohistochemistry - frozen section; cat; 1:100
  • immunohistochemistry - paraffin section; cat; 1:100
  • immunohistochemistry - paraffin section; pigs ; 1:200
In order to outline the protocols for antibodies used for immunohistochemical studies, Abcam CD3 antibody (Abcam, ab16669) was used in immunohistochemistry - frozen section on mouse samples at 1:100, in immunohistochemistry - paraffin section on mouse samples at 1:100, in immunohistochemistry on mouse samples (fig 37), in immunohistochemistry - frozen section on rat samples at 1:100, in immunohistochemistry - paraffin section on rat samples at 1:100, in immunohistochemistry - paraffin section on African green monkey samples at 1:200, in immunohistochemistry - frozen section on cat samples at 1:100, in immunohistochemistry - paraffin section on cat samples at 1:100 and in immunohistochemistry - paraffin section on pigs samples at 1:200. J Toxicol Pathol (2017) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; mouse; 1:200; loading ...; fig 6a
In order to show a role for Hippo signaling in the epicardium in recruiting T regulatory cells post infarct, Abcam CD3 antibody (Abcam, 16669) was used in immunohistochemistry - paraffin section on mouse samples at 1:200 (fig 6a). J Clin Invest (2017) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - frozen section; human; 1:100; loading ...
In order to characterize activated T cells in joint tissue from patients with rheumatoid arthritis, Abcam CD3 antibody (Abcam, SP7) was used in immunohistochemistry - frozen section on human samples at 1:100. Nature (2017) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - frozen section; mouse; 1:50; loading ...; fig s3e
In order to determine that cardiac abundance of the transcription factor GATA4 is high at P1, but becomes strongly reduced at P7 in parallel with loss of regenerative capacity, Abcam CD3 antibody (Abcam, ab16669) was used in immunohistochemistry - frozen section on mouse samples at 1:50 (fig s3e). EMBO Mol Med (2017) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; mouse; 1:100; loading ...; fig 6b
Abcam CD3 antibody (Abcam, ab16669) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 6b). Nat Commun (2017) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; mouse; 1:100; loading ...; fig 6G-I
In order to investigate the effects of a CDK4/6 inhibitor on the senescence-associated secretory phenotype, Abcam CD3 antibody (Abcam, ab-16669) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 6G-I). Mol Cancer Res (2017) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - frozen section; mouse; loading ...; fig 4a
In order to investigate the role of Toll-like receptor 9 in in cardiac remodeling after myocardial infarction, Abcam CD3 antibody (Abcam, ab16669) was used in immunohistochemistry - frozen section on mouse samples (fig 4a). Am J Physiol Heart Circ Physiol (2016) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry; mouse; 1:100; loading ...; tbl 1
In order to test if the respiratory deficits in West Nile virus-infected rodents are neurological, Abcam CD3 antibody (Abcam, ab16669) was used in immunohistochemistry on mouse samples at 1:100 (tbl 1). J Neurovirol (2017) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 6d
In order to determine the function of thymosin in the kidneys, Abcam CD3 antibody (Abcam, ab16669) was used in immunohistochemistry - paraffin section on mouse samples (fig 6d). Kidney Int (2016) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; human; loading ...; fig 9a
Abcam CD3 antibody (Abcam, ab16669) was used in immunohistochemistry - paraffin section on human samples (fig 9a). Oncotarget (2016) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; human; loading ...; fig 1c
Abcam CD3 antibody (Abcam, SP7) was used in immunohistochemistry - paraffin section on human samples (fig 1c). Science (2016) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; mouse; fig 4
In order to study attenuation of bleomycin-induced skin scelerosis in mice through knockout of endothelin type B receptor signaling, Abcam CD3 antibody (Abcam, ab16669) was used in immunohistochemistry - paraffin section on mouse samples (fig 4). Arthritis Res Ther (2016) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; pigs ; 1:200; fig 7
Abcam CD3 antibody (Abcam, ab16669) was used in immunohistochemistry - paraffin section on pigs samples at 1:200 (fig 7). PLoS ONE (2016) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; mouse; 1:100; loading ...; fig 10a
In order to report the course of Rickettsia typhi infection in RAG1 knockout mice, Abcam CD3 antibody (Abcam, SP7) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 10a). Infect Immun (2016) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; mouse; fig 7
In order to elucidate miR-21 that induces fibrosis in an acute cardiac allograft transplantation model, Abcam CD3 antibody (Abcam, 16669) was used in immunohistochemistry - paraffin section on mouse samples (fig 7). Cardiovasc Res (2016) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; pigs ; fig 9
Abcam CD3 antibody (Abcam, ab16669) was used in immunohistochemistry - paraffin section on pigs samples (fig 9). J Am Heart Assoc (2016) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; mouse
In order to study cessation of colorectal cancer colonization of the liver by acting on the hepatic microenvironment by IFN-alpha gene/cell therapy, Abcam CD3 antibody (AbCam, SP7) was used in immunohistochemistry - paraffin section on mouse samples . EMBO Mol Med (2016) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; human; 1:200; loading ...; fig 1b
In order to correlate the pathological profile of facet joints and clinical features of patients With thoracolumbar kyphosis secondary to ankylosing spondylitis, Abcam CD3 antibody (abcam, SP7) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 1b). Spine (Phila Pa 1976) (2016) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry; mouse; 1:60
Abcam CD3 antibody (Abcam, ab16669) was used in immunohistochemistry on mouse samples at 1:60. Endocrinology (2015) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 3c
In order to use personalized immunotherapy to target individual tumor-specific mutations in patients, Abcam CD3 antibody (Abcam, SP7) was used in immunohistochemistry - paraffin section on mouse samples (fig 3c). Nature (2015) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry; human; 1:100
Abcam CD3 antibody (Abcam, ab16669) was used in immunohistochemistry on human samples at 1:100. Breast Cancer Res (2015) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; rat
Abcam CD3 antibody (abcam, SP7) was used in immunohistochemistry - paraffin section on rat samples . PLoS ONE (2015) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; mouse; 1:500; fig s4
In order to study juxtacrine signaling from macrophages and monocytes and a breast cancer stem cell niche, Abcam CD3 antibody (Abcam, ab16669) was used in immunohistochemistry - paraffin section on mouse samples at 1:500 (fig s4). Nat Cell Biol (2014) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry; pigs
Abcam CD3 antibody (Abcam, ab16669) was used in immunohistochemistry on pigs samples . Acta Vet Scand (2014) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; mouse; fig 4
Abcam CD3 antibody (Abcam, SP7) was used in immunohistochemistry - paraffin section on mouse samples (fig 4). PLoS ONE (2014) ncbi
BioLegend
mouse monoclonal (UCHT1)
  • flow cytometry; human; 1:100; loading ...; fig 6a
BioLegend CD3 antibody (Biolegend, UCHT1) was used in flow cytometry on human samples at 1:100 (fig 6a). J Neuroinflammation (2022) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; 1:100; loading ...; fig 1a
BioLegend CD3 antibody (Biolegend, UCHT1) was used in flow cytometry on human samples at 1:100 (fig 1a). Signal Transduct Target Ther (2022) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human
BioLegend CD3 antibody (BioLegend, UCHT1) was used in flow cytometry on human samples . Front Immunol (2021) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...
BioLegend CD3 antibody (Biolegend, UCHT1) was used in flow cytometry on human samples . Front Immunol (2021) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; fig 5
BioLegend CD3 antibody (BioLegend, UCHT1) was used in flow cytometry on human samples (fig 5). Arthritis Res Ther (2021) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig 3b
BioLegend CD3 antibody (Biolegend, UCHT1) was used in flow cytometry on human samples (fig 3b). Acta Neuropathol (2021) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human
BioLegend CD3 antibody (Biolegend, UCHT1) was used in flow cytometry on human samples . Immunity (2021) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig 1
BioLegend CD3 antibody (BioLegend, UCHT1) was used in flow cytometry on human samples (fig 1). Am J Trop Med Hyg (2018) ncbi
Miltenyi Biotec
mouse monoclonal (OKT3)
  • blocking or activating experiments; human; 1 ug/ml; loading ...; fig 2b
Miltenyi Biotec CD3 antibody (Miltenyi Biotec, 130-093-387) was used in blocking or activating experiments on human samples at 1 ug/ml (fig 2b). PLoS ONE (2022) ncbi
Santa Cruz Biotechnology
mouse monoclonal (F-1)
  • western blot; mouse; 1:100; loading ...; fig 2b
Santa Cruz Biotechnology CD3 antibody (Santa Cruz, sc-137137) was used in western blot on mouse samples at 1:100 (fig 2b). Nat Commun (2019) ncbi
mouse monoclonal (F-1)
  • western blot; human; 1:500; loading ...; fig 5c
Santa Cruz Biotechnology CD3 antibody (SantaCruz, SC-137137) was used in western blot on human samples at 1:500 (fig 5c). Nat Commun (2016) ncbi
Beckman Coulter
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig 5a
Beckman Coulter CD3 antibody (Beckman Coulter, UCHT1) was used in flow cytometry on human samples (fig 5a). Front Immunol (2021) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...
Beckman Coulter CD3 antibody (Beckman Coulter, IM2705U) was used in flow cytometry on human samples . J Clin Invest (2020) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig s2
Beckman Coulter CD3 antibody (Beckman Coulter, UCHT1) was used in flow cytometry on human samples (fig s2). EBioMedicine (2020) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig s4a, s8a
Beckman Coulter CD3 antibody (Beckman Coulter, UCHT1) was used in flow cytometry on human samples (fig s4a, s8a). Nat Commun (2020) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig 3b
Beckman Coulter CD3 antibody (Beckman Coulter, UCHT1) was used in flow cytometry on human samples (fig 3b). Front Immunol (2019) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig 1a
Beckman Coulter CD3 antibody (Beckman Coulter, A93687) was used in flow cytometry on human samples (fig 1a). Sci Rep (2019) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig 1a
Beckman Coulter CD3 antibody (Beckman Coulter, UCHT1) was used in flow cytometry on human samples (fig 1a). J Infect Dis (2019) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig 5a
Beckman Coulter CD3 antibody (Beckman Coulter, UCHT-1) was used in flow cytometry on human samples (fig 5a). Proc Natl Acad Sci U S A (2018) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig 3d
Beckman Coulter CD3 antibody (Beckman Coulter, UCHT1) was used in flow cytometry on human samples (fig 3d). Ann Rheum Dis (2018) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; tbl s1
In order to investigate the effect of Shigella infection on human lymphocytes, Beckman Coulter CD3 antibody (Beckman, IOTest IM2467) was used in flow cytometry on human samples (tbl s1). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig 1a
In order to study the expression of CCR10 and CXCR3 in circulating CD8 T cells specific for human herpes simplex virus, Beckman Coulter CD3 antibody (Beckman Coulter, UCHT1) was used in flow cytometry on human samples (fig 1a). J Virol (2017) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig 1
Beckman Coulter CD3 antibody (Beckman Coulter, IM2705U) was used in flow cytometry on human samples (fig 1). Exp Ther Med (2017) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig 2d
Beckman Coulter CD3 antibody (Beckman Coulter, A66329) was used in flow cytometry on human samples (fig 2d). Oncoimmunology (2016) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; 1:100; loading ...; fig s2
Beckman Coulter CD3 antibody (Beckman Coulter, UCHT1) was used in flow cytometry on human samples at 1:100 (fig s2). JCI Insight (2017) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; 1:25; loading ...; fig 1b
In order to explore the role of thrombopoietin signaling in the human primitive hematopoietic stem cell compartment, Beckman Coulter CD3 antibody (Beckman Coulter, UCHT1) was used in flow cytometry on human samples at 1:25 (fig 1b). Cell Transplant (2017) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...
In order to assess the role of C1q in downregulating allergic inflammation, Beckman Coulter CD3 antibody (Beckmann Coulter, UCHT1) was used in flow cytometry on human samples . Mucosal Immunol (2017) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig s1a
Beckman Coulter CD3 antibody (Beckman-Coulter, UCHT1) was used in flow cytometry on human samples (fig s1a). J Immunol (2016) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human
In order to study disruption of the cereblon-CD147-MCT1 axis to exert antitumor activity and teratogenicity due to immunomodulatory drugs, Beckman Coulter CD3 antibody (Beckman Coulter, UCHT1) was used in flow cytometry on human samples . Nat Med (2016) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig s1
In order to characterize the immune responses of children immunized with Plasmodium falciparum apical membrane antigen 1, Beckman Coulter CD3 antibody (Beckman Coulter, UCHT1) was used in flow cytometry on human samples (fig s1). Vaccine (2016) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig 3c
Beckman Coulter CD3 antibody (Beckman, UCHT1) was used in flow cytometry on human samples (fig 3c). Clin Cancer Res (2016) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; fig 6a
In order to develop and characterize a mouse anti-human CD275 monoclonal antibody, Beckman Coulter CD3 antibody (Immunotech, UCHT1) was used in flow cytometry on human samples (fig 6a). Monoclon Antib Immunodiagn Immunother (2016) ncbi
mouse monoclonal (UCHT1)
  • immunohistochemistry; human; loading ...; fig 2d
In order to report that local inhibition of TNF-alpha is sufficient to suppress psoriasis in human patients, Beckman Coulter CD3 antibody (Beckman Coulter, UCHT1) was used in immunohistochemistry on human samples (fig 2d). Exp Dermatol (2016) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human
Beckman Coulter CD3 antibody (Beckman-Coulter, UCHT1) was used in flow cytometry on human samples . Clin Cancer Res (2016) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; fig 3
Beckman Coulter CD3 antibody (Beckman Coulter, IM2705U) was used in flow cytometry on human samples (fig 3). Leukemia (2016) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human
Beckman Coulter CD3 antibody (Beckman Coulter, Clone UCHT1) was used in flow cytometry on human samples . Int J Infect Dis (2015) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human
Beckman Coulter CD3 antibody (Beckman Coulter, 6607100) was used in flow cytometry on human samples . Curr Protoc Cytom (2015) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human
Beckman Coulter CD3 antibody (Beckman-Coulter, UCHT1) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human
In order to study l immune markers in H1N1pdm2009 virus-infected pregnant women, pregnant women with an influenza-like illness, healthy pregnant women, and healthy non-pregnant women, Beckman Coulter CD3 antibody (Immunotech, IM2635) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human
Beckman Coulter CD3 antibody (Beckman Coulter, UCHT1) was used in flow cytometry on human samples . J Exp Med (2014) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; fig 7
In order to characterize VLA-4 blockade and promotion of differential routes into human CNS involving MCAM-adhesion of TH17 cells and PSGL-1 rolling of T cells, Beckman Coulter CD3 antibody (Beckman Coulter, UCHT1) was used in flow cytometry on human samples (fig 7). J Exp Med (2014) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human
Beckman Coulter CD3 antibody (Beckman Coulter, UCHT1) was used in flow cytometry on human samples . J Immunol Res (2014) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; loading ...; tbl 1
Beckman Coulter CD3 antibody (Beckman Coulter, UCHT1) was used in flow cytometry on human samples (tbl 1). Am J Transplant (2014) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; fig 1
In order to assess how invariant natural killer T cells distribute, differentiate, and function in fetal peripheral lymphoid and non-lymphoid organs, Beckman Coulter CD3 antibody (Beckman Coulter, UCHT1) was used in flow cytometry on human samples (fig 1). Mucosal Immunol (2014) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human
Beckman Coulter CD3 antibody (Beckman Coulter, UCHT1) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human; fig 1
In order to study mucosal associated invariant T cells and B cell interactions, Beckman Coulter CD3 antibody (Beckman-Coulter, clone UCHT1) was used in flow cytometry on human samples (fig 1). Front Immunol (2014) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human
Beckman Coulter CD3 antibody (Beckman, UCHT1) was used in flow cytometry on human samples . Clin Cancer Res (2013) ncbi
mouse monoclonal (UCHT1)
  • flow cytometry; human
Beckman Coulter CD3 antibody (Beckman Coletr, UCHT1) was used in flow cytometry on human samples . Cell Stress Chaperones (2012) ncbi
Dako
mouse monoclonal (F7.2.38)
  • immunohistochemistry - paraffin section; mouse; 1:400; fig 5a
Dako CD3 antibody (DAKO/Agilent, F.7.2.38) was used in immunohistochemistry - paraffin section on mouse samples at 1:400 (fig 5a). J Immunother Cancer (2021) ncbi
mouse monoclonal (F7.2.38)
  • immunohistochemistry - paraffin section; human; 1:50; loading ...; fig 2c
Dako CD3 antibody (Dako, M7254) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 2c). J Pers Med (2021) ncbi
mouse monoclonal (F7.2.38)
  • flow cytometry; mouse; loading ...
Dako CD3 antibody (Dako, F7.2.38) was used in flow cytometry on mouse samples . J Virol (2020) ncbi
mouse monoclonal (F7.2.38)
  • immunohistochemistry; human; 1:50; loading ...; fig 3a
Dako CD3 antibody (DAKO, F7.2.38) was used in immunohistochemistry on human samples at 1:50 (fig 3a). Nat Immunol (2019) ncbi
mouse monoclonal (F7.2.38)
  • immunohistochemistry - paraffin section; hamsters; 1:100; loading ...; fig s3
Dako CD3 antibody (Dako, 7254) was used in immunohistochemistry - paraffin section on hamsters samples at 1:100 (fig s3). J Infect Dis (2018) ncbi
mouse monoclonal (F7.2.38)
  • immunocytochemistry; African green monkey; loading ...; fig 1c
Dako CD3 antibody (Dako, M725401) was used in immunocytochemistry on African green monkey samples (fig 1c). J Clin Invest (2018) ncbi
mouse monoclonal (F7.2.38)
  • immunohistochemistry; human; 1:100; loading ...; fig 2a
In order to investigate origin of tumor-infiltrating T regulatory cells in breast cancer samples, Dako CD3 antibody (Dako, M7254) was used in immunohistochemistry on human samples at 1:100 (fig 2a). Cell Res (2017) ncbi
mouse monoclonal (F7.2.38)
  • immunohistochemistry - paraffin section; bovine; fig st3
  • immunohistochemistry - paraffin section; dogs; 1:10; loading ...; fig st3
  • immunohistochemistry - paraffin section; rat; 1:500; loading ...; fig st3
  • immunohistochemistry - paraffin section; human; 2.5 ug/ml; loading ...; fig st3
In order to outline the protocols for antibodies used for immunohistochemical studies, Dako CD3 antibody (Dako, M7254) was used in immunohistochemistry - paraffin section on bovine samples (fig st3), in immunohistochemistry - paraffin section on dogs samples at 1:10 (fig st3), in immunohistochemistry - paraffin section on rat samples at 1:500 (fig st3) and in immunohistochemistry - paraffin section on human samples at 2.5 ug/ml (fig st3). J Toxicol Pathol (2017) ncbi
mouse monoclonal (F7.2.38)
  • immunohistochemistry - frozen section; human; 1:100; loading ...; fig 6i
In order to clarify the role of T cell aging in rheumatoid arthritis, Dako CD3 antibody (Dako, F7.2.38) was used in immunohistochemistry - frozen section on human samples at 1:100 (fig 6i). Immunity (2016) ncbi
mouse monoclonal (F7.2.38)
  • immunohistochemistry - paraffin section; human; 1:20; tbl 2
In order to compare leukemic non-nodal mantle cell lymphoma with classical mantle cell lymphoma and aggressive mantle cell lymphoma, Dako CD3 antibody (Dako, F7.2.38) was used in immunohistochemistry - paraffin section on human samples at 1:20 (tbl 2). Virchows Arch (2016) ncbi
mouse monoclonal (F7.2.38)
  • immunohistochemistry - paraffin section; human; loading ...; fig s3a
Dako CD3 antibody (Dako, F7.2.38) was used in immunohistochemistry - paraffin section on human samples (fig s3a). J Immunol (2016) ncbi
mouse monoclonal (F7.2.38)
  • immunohistochemistry - paraffin section; mouse; 1:300; loading ...; fig 3c
In order to investigate the role of general control non-derepressible 2 in resolving autoimmune neuroinflammation, Dako CD3 antibody (Dako, F7.2.38) was used in immunohistochemistry - paraffin section on mouse samples at 1:300 (fig 3c). J Neuroimmunol (2016) ncbi
mouse monoclonal (F7.2.38)
  • immunohistochemistry; African green monkey; loading ...
In order to perform an enhanced embryo-fetal development investigation using pateclizumab in cynomolgus monkeys, Dako CD3 antibody (Dako, M7254) was used in immunohistochemistry on African green monkey samples . Reprod Toxicol (2016) ncbi
mouse monoclonal (F7.2.38)
  • immunohistochemistry; pigs ; 1:1000; tbl 2
In order to assess the impact of different porcine reproductive and respiratory syndrome virus strains to induce thymocyte loss, Dako CD3 antibody (Dako, F7.2.38) was used in immunohistochemistry on pigs samples at 1:1000 (tbl 2). Vet Microbiol (2016) ncbi
mouse monoclonal (F7.2.38)
  • immunohistochemistry; human; 1:25; fig 4
Dako CD3 antibody (Dako, F7.2.38) was used in immunohistochemistry on human samples at 1:25 (fig 4). Sci Rep (2016) ncbi
mouse monoclonal (F7.2.38)
  • immunohistochemistry - paraffin section; human; 1:200; fig 1
In order to evaluate the promotion of B cell activation and CXCR4 downregulation by CD161 and LLT1 expression in human germinal centers, Dako CD3 antibody (Dako, F7.2.38) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 1). J Immunol (2016) ncbi
mouse monoclonal (F7.2.38)
  • immunohistochemistry - paraffin section; human; 1:100; fig 6a
In order to assess the role of TLR3 in enterocytic CCL20 signaling, Dako CD3 antibody (Dako, M7254) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 6a). PLoS ONE (2015) ncbi
mouse monoclonal (F7.2.38)
  • immunohistochemistry - paraffin section; human; 1:400; fig 2
In order to characterize human lung cancer stroma for inflammatory and immune cell composition, Dako CD3 antibody (Dako, F.2.38) was used in immunohistochemistry - paraffin section on human samples at 1:400 (fig 2). PLoS ONE (2015) ncbi
mouse monoclonal (F7.2.38)
  • immunohistochemistry - paraffin section; human; 1:25
Dako CD3 antibody (Dako, clone F7.2.38) was used in immunohistochemistry - paraffin section on human samples at 1:25. PLoS ONE (2015) ncbi
mouse monoclonal (F7.2.38)
  • immunohistochemistry - paraffin section; human
In order to describe the clinicopathological features of 15 patients with Epstein-Barr virus-positive nodal T/NK-cell lymphoma, Dako CD3 antibody (Dako, F7.2.38) was used in immunohistochemistry - paraffin section on human samples . Hum Pathol (2015) ncbi
mouse monoclonal (F7.2.38)
  • immunohistochemistry; human; 1:75
Dako CD3 antibody (Dako, F7.2.38) was used in immunohistochemistry on human samples at 1:75. Scand J Immunol (2015) ncbi
mouse monoclonal (F7.2.38)
  • immunohistochemistry - paraffin section; human
Dako CD3 antibody (Dako, F7.2.38) was used in immunohistochemistry - paraffin section on human samples . Ann Neurol (2015) ncbi
mouse monoclonal (F7.2.38)
  • immunohistochemistry; human; 1:60
Dako CD3 antibody (DAKO, M7254 (F7.2.38)) was used in immunohistochemistry on human samples at 1:60. Muscle Nerve (2015) ncbi
mouse monoclonal (F7.2.38)
  • immunohistochemistry - paraffin section; human
Dako CD3 antibody (Dako, F7.2.38) was used in immunohistochemistry - paraffin section on human samples . J Cutan Pathol (2015) ncbi
mouse monoclonal (F7.2.38)
  • immunohistochemistry; human; 5 ug/ml; fig 1f
Dako CD3 antibody (Dako, M7254) was used in immunohistochemistry on human samples at 5 ug/ml (fig 1f). J Allergy Clin Immunol (2015) ncbi
mouse monoclonal (F7.2.38)
  • immunohistochemistry - paraffin section; human
Dako CD3 antibody (Dako, F7.2.38) was used in immunohistochemistry - paraffin section on human samples . J Hepatol (2015) ncbi
mouse monoclonal (F7.2.38)
  • immunocytochemistry; mouse
Dako CD3 antibody (DAKO, F7.2.38) was used in immunocytochemistry on mouse samples . J Autoimmun (2015) ncbi
mouse monoclonal (F7.2.38)
  • immunohistochemistry; mouse
In order to study the mechanism for the effect of HMGB1 on myeloid-derived suppressor cells, Dako CD3 antibody (Dako, F7.2.38) was used in immunohistochemistry on mouse samples . Cancer Res (2014) ncbi
mouse monoclonal (F7.2.38)
  • immunohistochemistry; human
Dako CD3 antibody (Dako, F7.2.38) was used in immunohistochemistry on human samples . Exp Mol Pathol (2014) ncbi
mouse monoclonal (F7.2.38)
  • immunohistochemistry - paraffin section; human; 1:50
Dako CD3 antibody (Dako A/S, F7.2.38) was used in immunohistochemistry - paraffin section on human samples at 1:50. Clin Exp Allergy (2014) ncbi
mouse monoclonal (F7.2.38)
  • immunohistochemistry - paraffin section; human; 1:50; fig 4
In order to characterize two patients with multinodular and vacuolating neuronal tumors, Dako CD3 antibody (Dako, M7254) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 4). Acta Neuropathol Commun (2014) ncbi
mouse monoclonal (F7.2.38)
  • immunohistochemistry; domestic rabbit
Dako CD3 antibody (DAKO, F7.2.38) was used in immunohistochemistry on domestic rabbit samples . Neuropathology (2014) ncbi
mouse monoclonal (F7.2.38)
  • immunohistochemistry - paraffin section; human; fig 4
Dako CD3 antibody (Dakocytomation, M7254) was used in immunohistochemistry - paraffin section on human samples (fig 4). J Med Primatol (2014) ncbi
mouse monoclonal (F7.2.38)
  • immunohistochemistry - frozen section; human; 1:100
Dako CD3 antibody (Dako, M7254) was used in immunohistochemistry - frozen section on human samples at 1:100. Herpesviridae (2013) ncbi
mouse monoclonal (F7.2.38)
  • immunohistochemistry - paraffin section; human; 1:800
Dako CD3 antibody (Dako, F7.2.38) was used in immunohistochemistry - paraffin section on human samples at 1:800. Clin Cancer Res (2014) ncbi
mouse monoclonal (F7.2.38)
  • immunohistochemistry - paraffin section; dogs; 1:50
In order to assess the effect of chemotherapy on canine indolent and aggressive lymphoma, Dako CD3 antibody (Dako, F7.2.38) was used in immunohistochemistry - paraffin section on dogs samples at 1:50. Vet Comp Oncol (2015) ncbi
mouse monoclonal (F7.2.38)
  • immunohistochemistry - paraffin section; human; 1:200
In order to study the role of TORC1 in the fetal brain lesions observed in tuberous sclerosis complex, Dako CD3 antibody (DAKO, F7.2.38) was used in immunohistochemistry - paraffin section on human samples at 1:200. Brain Pathol (2013) ncbi
BD Biosciences
rat monoclonal (17A2)
  • flow cytometry; mouse; fig 5a
BD Biosciences CD3 antibody (BD, 555274) was used in flow cytometry on mouse samples (fig 5a). Theranostics (2022) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; 1:100; loading ...; fig s6d, s4e
BD Biosciences CD3 antibody (BD, 17A2) was used in flow cytometry on mouse samples at 1:100 (fig s6d, s4e). Nat Commun (2021) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; 1:100; loading ...
BD Biosciences CD3 antibody (BD Biosciences, 555274) was used in flow cytometry on mouse samples at 1:100. elife (2020) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; loading ...; fig 3e
BD Biosciences CD3 antibody (BD Pharmingen, 555274) was used in flow cytometry on mouse samples (fig 3e). elife (2019) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; loading ...; fig s7b
BD Biosciences CD3 antibody (BD, 345765) was used in flow cytometry on human samples (fig s7b). J Clin Invest (2019) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; loading ...; fig 2c
BD Biosciences CD3 antibody (BD Biosciences, 555274) was used in flow cytometry on mouse samples (fig 2c). Nat Immunol (2018) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; loading ...; fig s2e
BD Biosciences CD3 antibody (BD, SK7) was used in flow cytometry on human samples (fig s2e). Nature (2017) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; fig 4b
In order to propose that decidual stromal cells are a cellular source of BAFF for B cells present in decidua during pregnancy, BD Biosciences CD3 antibody (BD Bioscience, 345763) was used in flow cytometry on human samples (fig 4b). Sci Rep (2017) ncbi
mouse monoclonal (SK7)
  • flow cytometry; human; 1:40; loading ...; fig 7b
In order to use flow cytometry and barcoded peptide-major histocompatibility complex multimers to screen for T cell specificities, BD Biosciences CD3 antibody (BD, 345763) was used in flow cytometry on human samples at 1:40 (fig 7b). Nat Biotechnol (2016) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; fig 1
BD Biosciences CD3 antibody (BD Biosciences, 555274) was used in flow cytometry on mouse samples (fig 1). Nat Commun (2016) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; loading ...; fig 2a
BD Biosciences CD3 antibody (Becton Dickinson, 17A2) was used in flow cytometry on mouse samples (fig 2a). Vaccines (Basel) (2016) ncbi
rat monoclonal (17A2)
  • immunohistochemistry - paraffin section; domestic rabbit; 5 ug/ml; fig 13
BD Biosciences CD3 antibody (BD Biosciences, 55274) was used in immunohistochemistry - paraffin section on domestic rabbit samples at 5 ug/ml (fig 13). PLoS ONE (2015) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; 1:100
BD Biosciences CD3 antibody (BD Biosciences, 555274) was used in flow cytometry on mouse samples at 1:100. Nat Commun (2015) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse
BD Biosciences CD3 antibody (BD Biosciences, 555274) was used in flow cytometry on mouse samples . Cardiovasc Res (2015) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse
BD Biosciences CD3 antibody (BD Biosciences, 17A2) was used in flow cytometry on mouse samples . PLoS Genet (2014) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse
In order to elucidate the immunological pathways that lead to obesity-associated asthma, BD Biosciences CD3 antibody (BD, 555274) was used in flow cytometry on mouse samples . Nat Med (2014) ncbi
ATCC
mouse monoclonal
  • flow cytometry; human; 1 ug/ml; fig 1
ATCC CD3 antibody (ATCC, CRL-8001) was used in flow cytometry on human samples at 1 ug/ml (fig 1). Oncoimmunology (2016) ncbi
Articles Reviewed
  1. Tran N, Ferreira L, Alvarez Moya B, Buttiglione V, Ferrini B, Zordan P, et al. Continuous sensing of IFNα by hepatic endothelial cells shapes a vascular antimetastatic barrier. elife. 2022;11: pubmed publisher
  2. Kemper K, Gielen E, Boross P, Houtkamp M, Plantinga T, de Poot S, et al. Mechanistic and pharmacodynamic studies of DuoBody-CD3x5T4 in preclinical tumor models. Life Sci Alliance. 2022;5: pubmed publisher
  3. Selle J, Dinger K, Jentgen V, Zanetti D, Will J, Georgomanolis T, et al. Maternal and perinatal obesity induce bronchial obstruction and pulmonary hypertension via IL-6-FoxO1-axis in later life. Nat Commun. 2022;13:4352 pubmed publisher
  4. Ma Z, Zhang W, Dong B, Xin Z, Ji Y, Su R, et al. Docetaxel remodels prostate cancer immune microenvironment and enhances checkpoint inhibitor-based immunotherapy. Theranostics. 2022;12:4965-4979 pubmed publisher
  5. Pi xf1 eros A, Kulkarni A, Gao H, Orr K, Glenn L, Huang F, et al. Proinflammatory signaling in islet β cells propagates invasion of pathogenic immune cells in autoimmune diabetes. Cell Rep. 2022;39:111011 pubmed publisher
  6. Hannawi Y, Ewees M, Moore J, Zweier J. Characterizing CD38 Expression and Enzymatic Activity in the Brain of Spontaneously Hypertensive Stroke-Prone Rats. Front Pharmacol. 2022;13:881708 pubmed publisher
  7. Tosti E, Almeida A, Tran T, Barbachan E Silva M, Broin P, Dubin R, et al. Loss of MMR and TGFBR2 Increases the Susceptibility to Microbiota-Dependent Inflammation-Associated Colon Cancer. Cell Mol Gastroenterol Hepatol. 2022;14:693-717 pubmed publisher
  8. Deal B, Reynolds L, PATTERSON C, Janjic J, Pollock J. Behavioral and inflammatory sex differences revealed by celecoxib nanotherapeutic treatment of peripheral neuroinflammation. Sci Rep. 2022;12:8472 pubmed publisher
  9. Taniguchi H, Caeser R, Chavan S, Zhan Y, Chow A, Manoj P, et al. WEE1 inhibition enhances the antitumor immune response to PD-L1 blockade by the concomitant activation of STING and STAT1 pathways in SCLC. Cell Rep. 2022;39:110814 pubmed publisher
  10. Hickman T, Choi E, Whiteman K, Muralidharan S, Pai T, Johnson T, et al. BOXR1030, an anti-GPC3 CAR with exogenous GOT2 expression, shows enhanced T cell metabolism and improved anti-cell line derived tumor xenograft activity. PLoS ONE. 2022;17:e0266980 pubmed publisher
  11. Benkhoucha M, Tran N, Breville G, Senoner I, Bradfield P, Papayannopoulou T, et al. CD4+c-Met+Itgα4+ T cell subset promotes murine neuroinflammation. J Neuroinflammation. 2022;19:103 pubmed publisher
  12. Ozmadenci D, Shankara Narayanan J, Andrew J, Ojalill M, Barrie A, Jiang S, et al. Tumor FAK orchestrates immunosuppression in ovarian cancer via the CD155/TIGIT axis. Proc Natl Acad Sci U S A. 2022;119:e2117065119 pubmed publisher
  13. Cortes J, Filip I, Albero R, Patiño Galindo J, Quinn S, Lin W, et al. Oncogenic Vav1-Myo1f induces therapeutically targetable macrophage-rich tumor microenvironment in peripheral T cell lymphoma. Cell Rep. 2022;39:110695 pubmed publisher
  14. Cha J, Chan L, Wang Y, Chu Y, Wang C, Lee H, et al. Ephrin receptor A10 monoclonal antibodies and the derived chimeric antigen receptor T cells exert an antitumor response in mouse models of triple-negative breast cancer. J Biol Chem. 2022;298:101817 pubmed publisher
  15. Shen X, Geng R, Li Q, Chen Y, Li S, Wang Q, et al. ACE2-independent infection of T lymphocytes by SARS-CoV-2. Signal Transduct Target Ther. 2022;7:83 pubmed publisher
  16. Liu M, Wu C, Luo S, Hua Q, Chen H, Weng Y, et al. PERK reprograms hematopoietic progenitor cells to direct tumor-promoting myelopoiesis in the spleen. J Exp Med. 2022;219: pubmed publisher
  17. Cui H, Liu F, Fang Y, Wang T, Yuan B, Ma C. Neuronal FcεRIα directly mediates ocular itch via IgE-immune complex in a mouse model of allergic conjunctivitis. J Neuroinflammation. 2022;19:55 pubmed publisher
  18. Pinkert J, Boehm H, Trautwein M, Doecke W, Wessel F, Ge Y, et al. T cell-mediated elimination of cancer cells by blocking CEACAM6-CEACAM1 interaction. Oncoimmunology. 2022;11:2008110 pubmed publisher
  19. Thakkar D, Paliwal S, Dharmadhikari B, Guan S, Liu L, Kar S, et al. Rationally targeted anti-VISTA antibody that blockades the C-C' loop region can reverse VISTA immune suppression and remodel the immune microenvironment to potently inhibit tumor growth in an Fc independent manner. J Immunother Cancer. 2022;10: pubmed publisher
  20. Muraro E, De Zorzi M, Miolo G, Lombardi D, Scalone S, Spazzapan S, et al. KIR-HLA Functional Repertoire Influences Trastuzumab Efficiency in Patients With HER2-Positive Breast Cancer. Front Immunol. 2021;12:791958 pubmed publisher
  21. Castoldi G, Carletti R, Ippolito S, Stella A, Zerbini G, Pelucchi S, et al. Angiotensin Type 2 and Mas Receptor Activation Prevents Myocardial Fibrosis and Hypertrophy through the Reduction of Inflammatory Cell Infiltration and Local Sympathetic Activity in Angiotensin II-Dependent Hypertension. Int J Mol Sci. 2021;22: pubmed publisher
  22. Fahy N, Palomares Cabeza V, Lolli A, Witte Bouma J, Merino A, Ridwan Y, et al. Chondrogenically Primed Human Mesenchymal Stem Cells Persist and Undergo Early Stages of Endochondral Ossification in an Immunocompetent Xenogeneic Model. Front Immunol. 2021;12:715267 pubmed publisher
  23. Naruse H, Itoh S, Itoh Y, Kagioka T, Abe M, Hayashi M. The Wnt/β-catenin signaling pathway has a healing ability for periapical periodontitis. Sci Rep. 2021;11:19673 pubmed publisher
  24. Ming S, Yin H, Li X, Gong S, Zhang G, Wu Y. GITR Promotes the Polarization of TFH-Like Cells in Helicobacter pylori-Positive Gastritis. Front Immunol. 2021;12:736269 pubmed publisher
  25. Qian S, Huang Q, Chen R, Mo J, Zhou L, Zhao Y, et al. Single-Cell RNA Sequencing Identifies New Inflammation-Promoting Cell Subsets in Asian Patients With Chronic Periodontitis. Front Immunol. 2021;12:711337 pubmed publisher
  26. Bruno K, Macomb L, Morales Lara A, Mathews J, Frisancho J, Yang A, et al. Sex-Specific Effects of Plastic Caging in Murine Viral Myocarditis. Int J Mol Sci. 2021;22: pubmed publisher
  27. Gan Y, He J, Zhu J, Xu Z, Wang Z, Yan J, et al. Spatially defined single-cell transcriptional profiling characterizes diverse chondrocyte subtypes and nucleus pulposus progenitors in human intervertebral discs. Bone Res. 2021;9:37 pubmed publisher
  28. Guo L, Xie H, Zhang Z, Wang Z, Peng S, Niu Y, et al. Fusion Protein Vaccine Based on Ag85B and STEAP1 Induces a Protective Immune Response against Prostate Cancer. Vaccines (Basel). 2021;9: pubmed publisher
  29. Liot S, El Kholti N, Balas J, Genestier L, Verrier B, Valcourt U, et al. Development of thymic tumor in [LSL:KrasG12D; Pdx1-CRE] mice, an adverse effect associated with accelerated pancreatic carcinogenesis. Sci Rep. 2021;11:15075 pubmed publisher
  30. Dalla Pietà A, Cappuzzello E, Palmerini P, Ventura A, Visentin A, Astori G, et al. Innovative therapeutic strategy for B-cell malignancies that combines obinutuzumab and cytokine-induced killer cells. J Immunother Cancer. 2021;9: pubmed publisher
  31. Yue X, Petersen F, Shu Y, Kasper B, Magatsin J, Ahmadi M, et al. Transfer of PBMC From SSc Patients Induces Autoantibodies and Systemic Inflammation in Rag2-/-/IL2rg-/- Mice. Front Immunol. 2021;12:677970 pubmed publisher
  32. Al Ani M, Elemam N, Hachim I, Raju T, Muhammad J, Hachim M, et al. Molecular Examination of Differentially Expressed Genes in the Brains of Experimental Autoimmune Encephalomyelitis Mice Post Herceptin Treatment. J Inflamm Res. 2021;14:2601-2617 pubmed publisher
  33. Wang Z, Muecksch F, Schaefer Babajew D, Finkin S, Viant C, Gaebler C, et al. Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection. Nature. 2021;595:426-431 pubmed publisher
  34. Ramos M, Tian L, de Ruiter E, Song C, Paucarmayta A, Singh A, et al. Cancer immunotherapy by NC410, a LAIR-2 Fc protein blocking human LAIR-collagen interaction. elife. 2021;10: pubmed publisher
  35. Ostriker A, Xie Y, Chakraborty R, Sizer A, Bai Y, Ding M, et al. TET2 Protects Against Vascular Smooth Muscle Cell Apoptosis and Intimal Thickening in Transplant Vasculopathy. Circulation. 2021;144:455-470 pubmed publisher
  36. Zhang J, Qi J, Wei H, Lei Y, Yu H, Liu N, et al. TGFβ1 in Cancer-Associated Fibroblasts Is Associated With Progression and Radiosensitivity in Small-Cell Lung Cancer. Front Cell Dev Biol. 2021;9:667645 pubmed publisher
  37. Wang J, Zhang Y, Xiao Y, Yuan X, Li P, Wang X, et al. Boosting immune surveillance by low-dose PI3K inhibitor facilitates early intervention of breast cancer. Am J Cancer Res. 2021;11:2005-2024 pubmed
  38. Yan C, Saleh N, Yang J, Nebhan C, Vilgelm A, Reddy E, et al. Novel induction of CD40 expression by tumor cells with RAS/RAF/PI3K pathway inhibition augments response to checkpoint blockade. Mol Cancer. 2021;20:85 pubmed publisher
  39. Zhang H, Xia Y, Wang F, Luo M, Yang K, Liang S, et al. Aldehyde Dehydrogenase 2 Mediates Alcohol-Induced Colorectal Cancer Immune Escape through Stabilizing PD-L1 Expression. Adv Sci (Weinh). 2021;8:2003404 pubmed publisher
  40. Hawerkamp H, Domdey A, Radau L, Sewerin P, Oláh P, Homey B, et al. Tofacitinib downregulates antiviral immune defence in keratinocytes and reduces T cell activation. Arthritis Res Ther. 2021;23:144 pubmed publisher
  41. Zimmer T, Broekaart D, Luinenburg M, Mijnsbergen C, Anink J, Sim N, et al. Balloon cells promote immune system activation in focal cortical dysplasia type 2b. Neuropathol Appl Neurobiol. 2021;47:826-839 pubmed publisher
  42. Ercolano G, Gomez Cadena A, Dumauthioz N, Vanoni G, Kreutzfeldt M, Wyss T, et al. PPARɣ drives IL-33-dependent ILC2 pro-tumoral functions. Nat Commun. 2021;12:2538 pubmed publisher
  43. Laurent E, Sieber A, Salzer B, Wachernig A, Seigner J, Lehner M, et al. Directed Evolution of Stabilized Monomeric CD19 for Monovalent CAR Interaction Studies and Monitoring of CAR-T Cell Patients. ACS Synth Biol. 2021;10:1184-1198 pubmed publisher
  44. Ingelfinger F, Krishnarajah S, Kramer M, Utz S, Galli E, Lutz M, et al. Single-cell profiling of myasthenia gravis identifies a pathogenic T cell signature. Acta Neuropathol. 2021;141:901-915 pubmed publisher
  45. Vemulapalli V, Chylek L, Erickson A, Pfeiffer A, Gabriel K, LaRochelle J, et al. Time-resolved phosphoproteomics reveals scaffolding and catalysis-responsive patterns of SHP2-dependent signaling. elife. 2021;10: pubmed publisher
  46. Jeong J, Choi S, Ahn S, Oh J, Kim Y, Lee C, et al. Neutrophil extracellular trap clearance by synovial macrophages in gout. Arthritis Res Ther. 2021;23:88 pubmed publisher
  47. Chiou S, Tseng D, Reuben A, Mallajosyula V, Molina I, Conley S, et al. Global analysis of shared T cell specificities in human non-small cell lung cancer enables HLA inference and antigen discovery. Immunity. 2021;54:586-602.e8 pubmed publisher
  48. Yin H, Zhang X, Yang P, Zhang X, Peng Y, Li D, et al. RNA m6A methylation orchestrates cancer growth and metastasis via macrophage reprogramming. Nat Commun. 2021;12:1394 pubmed publisher
  49. Jaworek C, Verel Yilmaz Y, Driesch S, Ostgathe S, Cook L, Wagner S, et al. Cohort Analysis of ADAM8 Expression in the PDAC Tumor Stroma. J Pers Med. 2021;11: pubmed publisher
  50. Wang Z, Schmidt F, Weisblum Y, Muecksch F, Barnes C, Finkin S, et al. mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants. Nature. 2021;592:616-622 pubmed publisher
  51. Klemke L, De Oliveira T, Witt D, Winkler N, Bohnenberger H, Bucala R, et al. Hsp90-stabilized MIF supports tumor progression via macrophage recruitment and angiogenesis in colorectal cancer. Cell Death Dis. 2021;12:155 pubmed publisher
  52. Gaebler C, Wang Z, Lorenzi J, Muecksch F, Finkin S, Tokuyama M, et al. Evolution of antibody immunity to SARS-CoV-2. Nature. 2021;591:639-644 pubmed publisher
  53. Zhang H, Liu P, Zhang Y, Han L, Hu Z, Cai Z, et al. Inhibition of galectin-3 augments the antitumor efficacy of PD-L1 blockade in non-small-cell lung cancer. FEBS Open Bio. 2021;11:911-920 pubmed publisher
  54. Break T, Oikonomou V, Dutzan N, Desai J, Swidergall M, Freiwald T, et al. Aberrant type 1 immunity drives susceptibility to mucosal fungal infections. Science. 2021;371: pubmed publisher
  55. Aslam M, Alemdehy M, Kwesi Maliepaard E, Muhaimin F, Caganova M, Pardieck I, et al. Histone methyltransferase DOT1L controls state-specific identity during B cell differentiation. EMBO Rep. 2021;22:e51184 pubmed publisher
  56. Webb L, Fra Bido S, Innocentin S, Matheson L, Attaf N, Bignon A, et al. Ageing promotes early T follicular helper cell differentiation by modulating expression of RBPJ. Aging Cell. 2021;20:e13295 pubmed publisher
  57. Harro C, Perez Sanz J, Costich T, Payne K, Anadon C, Chaurio R, et al. Methyltransferase inhibitors restore SATB1 protective activity against cutaneous T cell lymphoma in mice. J Clin Invest. 2021;131: pubmed publisher
  58. Luo B, Zhan Y, Luo M, Dong H, Liu J, Lin Y, et al. Engineering of α-PD-1 antibody-expressing long-lived plasma cells by CRISPR/Cas9-mediated targeted gene integration. Cell Death Dis. 2020;11:973 pubmed publisher
  59. Wang C, Weng M, Xia S, Zhang M, Chen C, Tang J, et al. Distinct roles of programmed death ligand 1 alternative splicing isoforms in colorectal cancer. Cancer Sci. 2021;112:178-193 pubmed publisher
  60. Lauver M, Goetschius D, Netherby Winslow C, Ayers K, Jin G, Haas D, et al. Antibody escape by polyomavirus capsid mutation facilitates neurovirulence. elife. 2020;9: pubmed publisher
  61. Mateus J, Grifoni A, Tarke A, Sidney J, Ramirez S, Dan J, et al. Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans. Science. 2020;370:89-94 pubmed publisher
  62. Tan E, Hopkins R, Lim C, Jamuar S, Ong C, Thoon K, et al. Dominant-negative NFKBIA mutation promotes IL-1β production causing hepatic disease with severe immunodeficiency. J Clin Invest. 2020;130:5817-5832 pubmed publisher
  63. Malacco N, Souza J, Martins F, Rachid M, Simplicio J, Tirapelli C, et al. Chronic ethanol consumption compromises neutrophil function in acute pulmonary Aspergillus fumigatus infection. elife. 2020;9: pubmed publisher
  64. Bennstein S, Weinhold S, Manser A, Scherenschlich N, Noll A, Raba K, et al. Umbilical cord blood-derived ILC1-like cells constitute a novel precursor for mature KIR+NKG2A- NK cells. elife. 2020;9: pubmed publisher
  65. Camu W, Mickunas M, Veyrune J, Payan C, Garlanda C, Locati M, et al. Repeated 5-day cycles of low dose aldesleukin in amyotrophic lateral sclerosis (IMODALS): A phase 2a randomised, double-blind, placebo-controlled trial. EBioMedicine. 2020;59:102844 pubmed publisher
  66. Brouwer P, Caniels T, van der Straten K, Snitselaar J, Aldon Y, Bangaru S, et al. Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability. Science. 2020;369:643-650 pubmed publisher
  67. Liu X, Kong W, Peterson C, McGrail D, Hoang A, Zhang X, et al. PBRM1 loss defines a nonimmunogenic tumor phenotype associated with checkpoint inhibitor resistance in renal carcinoma. Nat Commun. 2020;11:2135 pubmed publisher
  68. Viau A, Baaziz M, Aka A, Mazloum M, Nguyen C, Kuehn E, et al. Tubular STAT3 Limits Renal Inflammation in Autosomal Dominant Polycystic Kidney Disease. J Am Soc Nephrol. 2020;31:1035-1049 pubmed publisher
  69. Beziat V, Tavernier S, Chen Y, Ma C, Materna M, Laurence A, et al. Dominant-negative mutations in human IL6ST underlie hyper-IgE syndrome. J Exp Med. 2020;217: pubmed publisher
  70. Lindner P, Paul S, Eckstein M, Hampel C, Muenzner J, Erlenbach Wuensch K, et al. EMT transcription factor ZEB1 alters the epigenetic landscape of colorectal cancer cells. Cell Death Dis. 2020;11:147 pubmed publisher
  71. Minervina A, Pogorelyy M, Komech E, Karnaukhov V, Bacher P, Rosati E, et al. Primary and secondary anti-viral response captured by the dynamics and phenotype of individual T cell clones. elife. 2020;9: pubmed publisher
  72. Gaglia G, Rashid R, Yapp C, Joshi G, Li C, Lindquist S, et al. HSF1 phase transition mediates stress adaptation and cell fate decisions. Nat Cell Biol. 2020;22:151-158 pubmed publisher
  73. Yu M, Guo G, Huang L, Deng L, Chang C, Achyut B, et al. CD73 on cancer-associated fibroblasts enhanced by the A2B-mediated feedforward circuit enforces an immune checkpoint. Nat Commun. 2020;11:515 pubmed publisher
  74. Schafflick D, Xu C, Hartlehnert M, Cole M, Schulte Mecklenbeck A, Lautwein T, et al. Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis. Nat Commun. 2020;11:247 pubmed publisher
  75. Wang B, Saito Y, Nishimura M, Ren Z, Tjan L, Refaat A, et al. An Animal Model That Mimics Human Herpesvirus 6B Pathogenesis. J Virol. 2020;94: pubmed publisher
  76. Shi L, Wang J, Ding N, Zhang Y, Zhu Y, Dong S, et al. Inflammation induced by incomplete radiofrequency ablation accelerates tumor progression and hinders PD-1 immunotherapy. Nat Commun. 2019;10:5421 pubmed publisher
  77. Zhang Q, He Y, Luo N, Patel S, Han Y, Gao R, et al. Landscape and Dynamics of Single Immune Cells in Hepatocellular Carcinoma. Cell. 2019;179:829-845.e20 pubmed publisher
  78. Liberatore R, Mastrocola E, Cassella E, Schmidt F, Willen J, Voronin D, et al. Rhabdo-immunodeficiency virus, a murine model of acute HIV-1 infection. elife. 2019;8: pubmed publisher
  79. Haque A, Moriyama M, Kubota K, Ishiguro N, Sakamoto M, Chinju A, et al. CD206+ tumor-associated macrophages promote proliferation and invasion in oral squamous cell carcinoma via EGF production. Sci Rep. 2019;9:14611 pubmed publisher
  80. Wolf Y, Bartok O, Patkar S, Eli G, Cohen S, Litchfield K, et al. UVB-Induced Tumor Heterogeneity Diminishes Immune Response in Melanoma. Cell. 2019;179:219-235.e21 pubmed publisher
  81. Choi J, Lee E, Kim S, Park S, Oh S, Kang J, et al. Cytotoxic effects of ex vivo-expanded natural killer cell-enriched lymphocytes (MYJ1633) against liver cancer. BMC Cancer. 2019;19:817 pubmed publisher
  82. Fransen N, Crusius J, Smolders J, Mizee M, Van Eden C, Luchetti S, et al. Post-mortem multiple sclerosis lesion pathology is influenced by single nucleotide polymorphisms. Brain Pathol. 2020;30:106-119 pubmed publisher
  83. Han L, Hu J, Ma B, Wen D, Zhang T, Lu Z, et al. IL-17A increases MHC class I expression and promotes T cell activation in papillary thyroid cancer patients with coexistent Hashimoto's thyroiditis. Diagn Pathol. 2019;14:52 pubmed publisher
  84. Escolano A, Gristick H, Abernathy M, Merkenschlager J, Gautam R, Oliveira T, et al. Immunization expands B cells specific to HIV-1 V3 glycan in mice and macaques. Nature. 2019;: pubmed publisher
  85. Ingegnere T, Mariotti F, Pelosi A, Quintarelli C, De Angelis B, Tumino N, et al. Human CAR NK Cells: A New Non-viral Method Allowing High Efficient Transfection and Strong Tumor Cell Killing. Front Immunol. 2019;10:957 pubmed publisher
  86. Sivaram N, McLaughlin P, Han H, Petrenko O, Jiang Y, Ballou L, et al. Tumor-intrinsic PIK3CA represses tumor immunogenecity in a model of pancreatic cancer. J Clin Invest. 2019;130: pubmed publisher
  87. Zumaquero E, Stone S, Scharer C, Jenks S, Nellore A, Mousseau B, et al. IFNγ induces epigenetic programming of human T-bethi B cells and promotes TLR7/8 and IL-21 induced differentiation. elife. 2019;8: pubmed publisher
  88. Baeuerle P, Ding J, Patel E, Thorausch N, Horton H, Gierut J, et al. Synthetic TRuC receptors engaging the complete T cell receptor for potent anti-tumor response. Nat Commun. 2019;10:2087 pubmed publisher
  89. Kellish P, Shabashvili D, Rahman M, Nawab A, Guijarro M, Zhang M, et al. Oncolytic virotherapy for small-cell lung cancer induces immune infiltration and prolongs survival. J Clin Invest. 2019;129:2279-2292 pubmed publisher
  90. Walens A, DiMarco A, Lupo R, Kroger B, Damrauer J, Alvarez J. CCL5 promotes breast cancer recurrence through macrophage recruitment in residual tumors. elife. 2019;8: pubmed publisher
  91. Ye Y, Liu M, Tang L, Du F, Liu Y, Hao P, et al. Iguratimod represses B cell terminal differentiation linked with the inhibition of PKC/EGR1 axis. Arthritis Res Ther. 2019;21:92 pubmed publisher
  92. Cassetta L, Fragkogianni S, Sims A, Swierczak A, Forrester L, Zhang H, et al. Human Tumor-Associated Macrophage and Monocyte Transcriptional Landscapes Reveal Cancer-Specific Reprogramming, Biomarkers, and Therapeutic Targets. Cancer Cell. 2019;35:588-602.e10 pubmed publisher
  93. Santucci Pereira J, Zeleniuch Jacquotte A, Afanasyeva Y, Zhong H, Slifker M, Peri S, et al. Genomic signature of parity in the breast of premenopausal women. Breast Cancer Res. 2019;21:46 pubmed publisher
  94. de Jonge K, Ebering A, Nassiri S, Maby El Hajjami H, Ouertatani Sakouhi H, Baumgaertner P, et al. Circulating CD56bright NK cells inversely correlate with survival of melanoma patients. Sci Rep. 2019;9:4487 pubmed publisher
  95. Crippa S, Rossella V, Aprile A, Silvestri L, Rivis S, Scaramuzza S, et al. Bone marrow stromal cells from β-thalassemia patients have impaired hematopoietic supportive capacity. J Clin Invest. 2019;129:1566-1580 pubmed publisher
  96. Wen Z, Jin K, Shen Y, Yang Z, Li Y, Wu B, et al. N-myristoyltransferase deficiency impairs activation of kinase AMPK and promotes synovial tissue inflammation. Nat Immunol. 2019;20:313-325 pubmed publisher
  97. Banki Z, Krabbendam L, Klaver D, Leng T, Kruis S, Mehta H, et al. Antibody opsonization enhances MAIT cell responsiveness to bacteria via a TNF-dependent mechanism. Immunol Cell Biol. 2019;97:538-551 pubmed publisher
  98. Fan J, Liu L, Liu Q, Cui Y, Yao B, Zhang M, et al. CKIP-1 limits foam cell formation and inhibits atherosclerosis by promoting degradation of Oct-1 by REGγ. Nat Commun. 2019;10:425 pubmed publisher
  99. Collins P, Cella M, Porter S, Li S, Gurewitz G, Hong H, et al. Gene Regulatory Programs Conferring Phenotypic Identities to Human NK Cells. Cell. 2019;176:348-360.e12 pubmed publisher
  100. Scheper W, Kelderman S, Fanchi L, Linnemann C, Bendle G, de Rooij M, et al. Low and variable tumor reactivity of the intratumoral TCR repertoire in human cancers. Nat Med. 2019;25:89-94 pubmed publisher
  101. Deng M, Gui X, Kim J, Xie L, Chen W, Li Z, et al. LILRB4 signalling in leukaemia cells mediates T cell suppression and tumour infiltration. Nature. 2018;562:605-609 pubmed publisher
  102. Ye W, Chew M, Hou J, Lai F, Leopold S, Loo H, et al. Microvesicles from malaria-infected red blood cells activate natural killer cells via MDA5 pathway. PLoS Pathog. 2018;14:e1007298 pubmed publisher
  103. van Erp E, Feyaerts D, Duijst M, Mulder H, Wicht O, Luytjes W, et al. Respiratory Syncytial Virus Infects Primary Neonatal and Adult Natural Killer Cells and Affects Their Antiviral Effector Function. J Infect Dis. 2019;219:723-733 pubmed publisher
  104. Dam E, Maier A, Hocking A, Carlin J, Buckner J. Increased Binding of Specificity Protein 1 to the IL21R Promoter in B Cells Results in Enhanced B Cell Responses in Rheumatoid Arthritis. Front Immunol. 2018;9:1978 pubmed publisher
  105. Atkins C, Miao J, Kalveram B, Juelich T, Smith J, Perez D, et al. Natural History and Pathogenesis of Wild-Type Marburg Virus Infection in STAT2 Knockout Hamsters. J Infect Dis. 2018;218:S438-S447 pubmed publisher
  106. Young M, Mitchell T, Vieira Braga F, Tran M, Stewart B, Ferdinand J, et al. Single-cell transcriptomes from human kidneys reveal the cellular identity of renal tumors. Science. 2018;361:594-599 pubmed publisher
  107. Arnold I, Artola Borán M, Tallón de Lara P, Kyburz A, Taube C, OTTEMANN K, et al. Eosinophils suppress Th1 responses and restrict bacterially induced gastrointestinal inflammation. J Exp Med. 2018;215:2055-2072 pubmed publisher
  108. Pulikkan J, Hegde M, Ahmad H, Belaghzal H, Illendula A, Yu J, et al. CBFβ-SMMHC Inhibition Triggers Apoptosis by Disrupting MYC Chromatin Dynamics in Acute Myeloid Leukemia. Cell. 2018;174:172-186.e21 pubmed publisher
  109. Manresa Arraut A, Johansen F, Brakebusch C, Issazadeh Navikas S, Hasseldam H. RhoA Drives T-Cell Activation and Encephalitogenic Potential in an Animal Model of Multiple Sclerosis. Front Immunol. 2018;9:1235 pubmed publisher
  110. Galperin M, Farenc C, Mukhopadhyay M, Jayasinghe D, Decroos A, Benati D, et al. CD4+ T cell-mediated HLA class II cross-restriction in HIV controllers. Sci Immunol. 2018;3: pubmed publisher
  111. Honeycutt J, Liao B, Nixon C, Cleary R, Thayer W, Birath S, et al. T cells establish and maintain CNS viral infection in HIV-infected humanized mice. J Clin Invest. 2018;128:2862-2876 pubmed publisher
  112. Borlido J, Sakuma S, Raices M, Carrette F, Tinoco R, Bradley L, et al. Nuclear pore complex-mediated modulation of TCR signaling is required for naïve CD4+ T cell homeostasis. Nat Immunol. 2018;19:594-605 pubmed publisher
  113. Ondigo B, Ndombi E, Nicholson S, Oguso J, Carter J, Kittur N, et al. Functional Studies of T Regulatory Lymphocytes in Human Schistosomiasis in Western Kenya. Am J Trop Med Hyg. 2018;98:1770-1781 pubmed publisher
  114. Wang E, Pjechova M, Nightingale K, Vlahava V, Patel M, Růcková E, et al. Suppression of costimulation by human cytomegalovirus promotes evasion of cellular immune defenses. Proc Natl Acad Sci U S A. 2018;115:4998-5003 pubmed publisher
  115. Ferrando Martinez S, Moysi E, Pegu A, Andrews S, Nganou Makamdop K, Ambrozak D, et al. Accumulation of follicular CD8+ T cells in pathogenic SIV infection. J Clin Invest. 2018;128:2089-2103 pubmed publisher
  116. Flores Villanueva P, Ganachari M, Guio H, Mejia J, Granados J. An Isolated TCR αβ Restricted by HLA-A*02:01/CT37 Peptide Redirecting CD8+ T Cells To Kill and Secrete IFN-γ in Response to Lung Adenocarcinoma Cell Lines. J Immunol. 2018;200:2965-2977 pubmed publisher
  117. Zukor K, Wang H, Siddharthan V, Julander J, Morrey J. Zika virus-induced acute myelitis and motor deficits in adult interferon ??/? receptor knockout mice. J Neurovirol. 2018;24:273-290 pubmed publisher
  118. Sokhi U, Liber M, Frye L, Park S, Kang K, Pannellini T, et al. Dissection and function of autoimmunity-associated TNFAIP3 (A20) gene enhancers in humanized mouse models. Nat Commun. 2018;9:658 pubmed publisher
  119. Lin H, Wei S, Hurt E, Green M, Zhao L, Vatan L, et al. Host expression of PD-L1 determines efficacy of PD-L1 pathway blockade-mediated tumor regression. J Clin Invest. 2018;128:805-815 pubmed publisher
  120. Pizzolla A, Nguyen T, Sant S, Jaffar J, Loudovaris T, Mannering S, et al. Influenza-specific lung-resident memory T cells are proliferative and polyfunctional and maintain diverse TCR profiles. J Clin Invest. 2018;128:721-733 pubmed publisher
  121. Krishnan B, Massilamany C, Basavalingappa R, Gangaplara A, Rajasekaran R, Afzal M, et al. Epitope Mapping of SERCA2a Identifies an Antigenic Determinant That Induces Mainly Atrial Myocarditis in A/J Mice. J Immunol. 2018;200:523-537 pubmed publisher
  122. Kortlever R, Sodir N, Wilson C, Burkhart D, Pellegrinet L, Brown Swigart L, et al. Myc Cooperates with Ras by Programming Inflammation and Immune Suppression. Cell. 2017;171:1301-1315.e14 pubmed publisher
  123. Meng Y, Zhou W, Jin L, Liu L, Chang K, Mei J, et al. RANKL-mediated harmonious dialogue between fetus and mother guarantees smooth gestation by inducing decidual M2 macrophage polarization. Cell Death Dis. 2017;8:e3105 pubmed publisher
  124. Tothova Z, Krill Burger J, Popova K, Landers C, Sievers Q, Yudovich D, et al. Multiplex CRISPR/Cas9-Based Genome Editing in Human Hematopoietic Stem Cells Models Clonal Hematopoiesis and Myeloid Neoplasia. Cell Stem Cell. 2017;21:547-555.e8 pubmed publisher
  125. Chan Y, Zuo J, Inman C, Croft W, Begum J, Croudace J, et al. NK cells produce high levels of IL-10 early after allogeneic stem cell transplantation and suppress development of acute GVHD. Eur J Immunol. 2018;48:316-329 pubmed publisher
  126. Molnar C, Scherer A, Baraliakos X, de Hooge M, Micheroli R, Exer P, et al. TNF blockers inhibit spinal radiographic progression in ankylosing spondylitis by reducing disease activity: results from the Swiss Clinical Quality Management cohort. Ann Rheum Dis. 2018;77:63-69 pubmed publisher
  127. Zhang Y, Liu Y, Chen H, Zheng X, Xie S, Chen W, et al. TIM-1 attenuates the protection of ischemic preconditioning for ischemia reperfusion injury in liver transplantation. Am J Transl Res. 2017;9:3665-3675 pubmed
  128. Pinaud L, Samassa F, Porat Z, Ferrari M, Belotserkovsky I, Parsot C, et al. Injection of T3SS effectors not resulting in invasion is the main targeting mechanism of Shigella toward human lymphocytes. Proc Natl Acad Sci U S A. 2017;114:9954-9959 pubmed publisher
  129. Kruglova N, Meshkova T, Kopylov A, Mazurov D, Filatov A. Constitutive and activation-dependent phosphorylation of lymphocyte phosphatase-associated phosphoprotein (LPAP). PLoS ONE. 2017;12:e0182468 pubmed publisher
  130. Patel S, Sanjana N, Kishton R, Eidizadeh A, Vodnala S, Cam M, et al. Identification of essential genes for cancer immunotherapy. Nature. 2017;548:537-542 pubmed publisher
  131. Jiang X, Björkström N, Melum E. Intact CD100-CD72 Interaction Necessary for TCR-Induced T Cell Proliferation. Front Immunol. 2017;8:765 pubmed publisher
  132. Hensel M, Peng T, Cheng A, De Rosa S, Wald A, Laing K, et al. Selective Expression of CCR10 and CXCR3 by Circulating Human Herpes Simplex Virus-Specific CD8 T Cells. J Virol. 2017;91: pubmed publisher
  133. Ott P, Hu Z, Keskin D, Shukla S, Sun J, Bozym D, et al. An immunogenic personal neoantigen vaccine for patients with melanoma. Nature. 2017;547:217-221 pubmed publisher
  134. Chang A, Dao T, Gejman R, Jarvis C, Scott A, Dubrovsky L, et al. A therapeutic T cell receptor mimic antibody targets tumor-associated PRAME peptide/HLA-I antigens. J Clin Invest. 2017;127:2705-2718 pubmed publisher
  135. Zheng C, Zheng L, Yoo J, Guo H, Zhang Y, Guo X, et al. Landscape of Infiltrating T Cells in Liver Cancer Revealed by Single-Cell Sequencing. Cell. 2017;169:1342-1356.e16 pubmed publisher
  136. Ridings Figueroa R, Stewart E, Nesterova T, Coker H, Pintacuda G, Godwin J, et al. The nuclear matrix protein CIZ1 facilitates localization of Xist RNA to the inactive X-chromosome territory. Genes Dev. 2017;31:876-888 pubmed publisher
  137. Domae E, Hirai Y, Ikeo T, Goda S, Shimizu Y. Cytokine-mediated activation of human ex vivo-expanded V?9V?2 T cells. Oncotarget. 2017;8:45928-45942 pubmed publisher
  138. Lepore M, Kalinichenko A, Calogero S, Kumar P, Paleja B, Schmaler M, et al. Functionally diverse human T cells recognize non-microbial antigens presented by MR1. elife. 2017;6: pubmed publisher
  139. Djaoud Z, Guethlein L, Horowitz A, Azzi T, Nemat Gorgani N, Olive D, et al. Two alternate strategies for innate immunity to Epstein-Barr virus: One using NK cells and the other NK cells and ?? T cells. J Exp Med. 2017;214:1827-1841 pubmed publisher
  140. Chen C, Sun W, Chen J, Huang J. Dynamic variations of the peripheral blood immune cell subpopulation in patients with critical H7N9 swine-origin influenza A virus infection: A retrospective small-scale study. Exp Ther Med. 2017;13:1490-1494 pubmed publisher
  141. Van Caeneghem Y, De Munter S, Tieppo P, Goetgeluk G, Weening K, Verstichel G, et al. Antigen receptor-redirected T cells derived from hematopoietic precursor cells lack expression of the endogenous TCR/CD3 receptor and exhibit specific antitumor capacities. Oncoimmunology. 2017;6:e1283460 pubmed publisher
  142. Khodadoust M, Olsson N, Wagar L, Haabeth O, Chen B, Swaminathan K, et al. Antigen presentation profiling reveals recognition of lymphoma immunoglobulin neoantigens. Nature. 2017;543:723-727 pubmed publisher
  143. Su S, Liao J, Liu J, Huang D, He C, Chen F, et al. Blocking the recruitment of naive CD4+ T cells reverses immunosuppression in breast cancer. Cell Res. 2017;27:461-482 pubmed publisher
  144. Lopes F, Bálint Å, Valvo S, Felce J, Hessel E, Dustin M, et al. Membrane nanoclusters of FcγRI segregate from inhibitory SIRPα upon activation of human macrophages. J Cell Biol. 2017;216:1123-1141 pubmed publisher
  145. Lim A, Li Y, Lopez Lastra S, Stadhouders R, Paul F, Casrouge A, et al. Systemic Human ILC Precursors Provide a Substrate for Tissue ILC Differentiation. Cell. 2017;168:1086-1100.e10 pubmed publisher
  146. Szabo P, Goswami A, Mazzuca D, Kim K, O Gorman D, Hess D, et al. Rapid and Rigorous IL-17A Production by a Distinct Subpopulation of Effector Memory T Lymphocytes Constitutes a Novel Mechanism of Toxic Shock Syndrome Immunopathology. J Immunol. 2017;198:2805-2818 pubmed publisher
  147. Su S, Zou Z, Chen F, Ding N, Du J, Shao J, et al. CRISPR-Cas9-mediated disruption of PD-1 on human T cells for adoptive cellular therapies of EBV positive gastric cancer. Oncoimmunology. 2017;6:e1249558 pubmed publisher
  148. Furukawa S, Nagaike M, Ozaki K. Databases for technical aspects of immunohistochemistry. J Toxicol Pathol. 2017;30:79-107 pubmed publisher
  149. Watanabe N, Bajgain P, Sukumaran S, Ansari S, Heslop H, Rooney C, et al. Fine-tuning the CAR spacer improves T-cell potency. Oncoimmunology. 2016;5:e1253656 pubmed publisher
  150. Ramjee V, Li D, Manderfield L, Liu F, Engleka K, Aghajanian H, et al. Epicardial YAP/TAZ orchestrate an immunosuppressive response following myocardial infarction. J Clin Invest. 2017;127:899-911 pubmed publisher
  151. Mylvaganam G, Rios D, Abdelaal H, Iyer S, Tharp G, Mavigner M, et al. Dynamics of SIV-specific CXCR5+ CD8 T cells during chronic SIV infection. Proc Natl Acad Sci U S A. 2017;114:1976-1981 pubmed publisher
  152. Rao D, Gurish M, Marshall J, Slowikowski K, Fonseka C, Liu Y, et al. Pathologically expanded peripheral T helper cell subset drives B cells in rheumatoid arthritis. Nature. 2017;542:110-114 pubmed publisher
  153. Raposo R, de Mulder Rougvie M, Paquin Proulx D, Brailey P, Cabido V, Zdinak P, et al. IFITM1 targets HIV-1 latently infected cells for antibody-dependent cytolysis. JCI Insight. 2017;2:e85811 pubmed publisher
  154. Kim J, Kwon C, Joh J, Sinn D, Choi G, Park J, et al. Differences in Peripheral Blood Lymphocytes between Brand-Name and Generic Tacrolimus Used in Stable Liver Transplant Recipients. Med Princ Pract. 2017;26:221-228 pubmed publisher
  155. Lundell A, Nordström I, Andersson K, Lundqvist C, Telemo E, Nava S, et al. IFN type I and II induce BAFF secretion from human decidual stromal cells. Sci Rep. 2017;7:39904 pubmed publisher
  156. Malek Mohammadi M, Kattih B, Grund A, Froese N, Korf Klingebiel M, Gigina A, et al. The transcription factor GATA4 promotes myocardial regeneration in neonatal mice. EMBO Mol Med. 2017;9:265-279 pubmed publisher
  157. Tang J, Shen D, Caranasos T, Wang Z, Vandergriff A, Allen T, et al. Therapeutic microparticles functionalized with biomimetic cardiac stem cell membranes and secretome. Nat Commun. 2017;8:13724 pubmed publisher
  158. Guan X, Lapak K, Hennessey R, Yu C, Shakya R, Zhang J, et al. Stromal Senescence By Prolonged CDK4/6 Inhibition Potentiates Tumor Growth. Mol Cancer Res. 2017;15:237-249 pubmed publisher
  159. Zhang Y, Yu J, Grachtchouk V, Qin T, Lumeng C, Sartor M, et al. Genomic binding of PAX8-PPARG fusion protein regulates cancer-related pathways and alters the immune landscape of thyroid cancer. Oncotarget. 2017;8:5761-5773 pubmed publisher
  160. Cheng L, Ma J, Li J, Li D, Li G, Li F, et al. Blocking type I interferon signaling enhances T cell recovery and reduces HIV-1 reservoirs. J Clin Invest. 2017;127:269-279 pubmed publisher
  161. Zhen A, Rezek V, Youn C, Lam B, Chang N, Rick J, et al. Targeting type I interferon-mediated activation restores immune function in chronic HIV infection. J Clin Invest. 2017;127:260-268 pubmed publisher
  162. Matsuoka Y, Takahashi M, Sumide K, Kawamura H, Nakatsuka R, Fujioka T, et al. CD34 Antigen and the MPL Receptor Expression Defines a Novel Class of Human Cord Blood-Derived Primitive Hematopoietic Stem Cells. Cell Transplant. 2017;26:1043-1058 pubmed publisher
  163. Weyandt J, Carney J, Pavlisko E, Xu M, Counter C. Isoform-Specific Effects of Wild-Type Ras Genes on Carcinogen-Induced Lung Tumorigenesis in Mice. PLoS ONE. 2016;11:e0167205 pubmed publisher
  164. Ryan P, Sumaria N, Holland C, Bradford C, Izotova N, Grandjean C, et al. Heterogeneous yet stable Vδ2(+) T-cell profiles define distinct cytotoxic effector potentials in healthy human individuals. Proc Natl Acad Sci U S A. 2016;113:14378-14383 pubmed
  165. Villanueva Cabello T, Martinez Duncker I. Preparation of CD4+ T Cells for Analysis of GD3 and GD2 Ganglioside Membrane Expression by Microscopy. J Vis Exp. 2016;: pubmed publisher
  166. Tomic A, Varanasi P, Golemac M, Malic S, Riese P, Borst E, et al. Activation of Innate and Adaptive Immunity by a Recombinant Human Cytomegalovirus Strain Expressing an NKG2D Ligand. PLoS Pathog. 2016;12:e1006015 pubmed publisher
  167. Ribeiro S, Tesio M, Ribot J, Macintyre E, Barata J, Silva Santos B. Casein kinase 2 controls the survival of normal thymic and leukemic ?? T cells via promotion of AKT signaling. Leukemia. 2017;31:1603-1610 pubmed publisher
  168. Senbabaoglu Y, Gejman R, Winer A, Liu M, Van Allen E, de Velasco G, et al. Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures. Genome Biol. 2016;17:231 pubmed
  169. Cuff A, Robertson F, Stegmann K, Pallett L, Maini M, Davidson B, et al. Eomeshi NK Cells in Human Liver Are Long-Lived and Do Not Recirculate but Can Be Replenished from the Circulation. J Immunol. 2016;197:4283-4291 pubmed
  170. Michailidou I, Naessens D, Hametner S, Guldenaar W, Kooi E, Geurts J, et al. Complement C3 on microglial clusters in multiple sclerosis occur in chronic but not acute disease: Implication for disease pathogenesis. Glia. 2017;65:264-277 pubmed publisher
  171. Omiya S, Omori Y, Taneike M, Protti A, Yamaguchi O, Akira S, et al. Toll-like receptor 9 prevents cardiac rupture after myocardial infarction in mice independently of inflammation. Am J Physiol Heart Circ Physiol. 2016;311:H1485-H1497 pubmed publisher
  172. Arumughan A, Roske Y, Barth C, Forero L, Bravo Rodriguez K, Redel A, et al. Quantitative interaction mapping reveals an extended UBX domain in ASPL that disrupts functional p97 hexamers. Nat Commun. 2016;7:13047 pubmed publisher
  173. Zukor K, Wang H, Hurst B, Siddharthan V, van Wettere A, Pilowsky P, et al. Phrenic nerve deficits and neurological immunopathology associated with acute West Nile virus infection in mice and hamsters. J Neurovirol. 2017;23:186-204 pubmed publisher
  174. Holzlechner M, Strasser K, Zareva E, Steinhäuser L, Birnleitner H, Beer A, et al. In Situ Characterization of Tissue-Resident Immune Cells by MALDI Mass Spectrometry Imaging. J Proteome Res. 2017;16:65-76 pubmed publisher
  175. Li Y, Shen Y, Hohensinner P, Ju J, Wen Z, Goodman S, et al. Deficient Activity of the Nuclease MRE11A Induces T Cell Aging and Promotes Arthritogenic Effector Functions in Patients with Rheumatoid Arthritis. Immunity. 2016;45:903-916 pubmed publisher
  176. Mascarell L, Airouche S, Berjont N, Gary C, Gueguen C, Fourcade G, et al. The regulatory dendritic cell marker C1q is a potent inhibitor of allergic inflammation. Mucosal Immunol. 2017;10:695-704 pubmed publisher
  177. Milanovic M, Heise N, De Silva N, Anderson M, Silva K, Carette A, et al. Differential requirements for the canonical NF-?B transcription factors c-REL and RELA during the generation and activation of mature B cells. Immunol Cell Biol. 2017;95:261-271 pubmed publisher
  178. Wang Y, Ma C, Ling Y, Bousfiha A, Camcioglu Y, Jacquot S, et al. Dual T cell- and B cell-intrinsic deficiency in humans with biallelic RLTPR mutations. J Exp Med. 2016;213:2413-2435 pubmed
  179. Rudemiller N, Patel M, Zhang J, Jeffs A, Karlovich N, Griffiths R, et al. C-C Motif Chemokine 5 Attenuates Angiotensin II-Dependent Kidney Injury by Limiting Renal Macrophage Infiltration. Am J Pathol. 2016;186:2846-2856 pubmed publisher
  180. George J, Saito M, Tsuta K, Iwakawa R, Shiraishi K, Scheel A, et al. Genomic Amplification of CD274 (PD-L1) in Small-Cell Lung Cancer. Clin Cancer Res. 2017;23:1220-1226 pubmed publisher
  181. Keefer M, Zheng B, Rosenberg A, Kobie J. Increased Steady-State Memory B Cell Subsets Among High-Risk Participants in an HIV Vaccine Trial. AIDS Res Hum Retroviruses. 2016;32:1143-1148 pubmed
  182. Guillou L, Babataheri A, Saitakis M, Bohineust A, Dogniaux S, Hivroz C, et al. T-lymphocyte passive deformation is controlled by unfolding of membrane surface reservoirs. Mol Biol Cell. 2016;27:3574-3582 pubmed
  183. Gallo M, Cacheux V, Vincent L, Bret C, Tempier A, Guittard C, et al. Leukemic non-nodal mantle cell lymphomas have a distinct phenotype and are associated with deletion of PARP1 and 13q14. Virchows Arch. 2016;469:697-706 pubmed
  184. Pageon S, Nicovich P, Mollazade M, Tabarin T, Gaus K. Clus-DoC: a combined cluster detection and colocalization analysis for single-molecule localization microscopy data. Mol Biol Cell. 2016;27:3627-3636 pubmed
  185. Vasilopoulou E, Kolatsi Joannou M, Lindenmeyer M, White K, Robson M, Cohen C, et al. Loss of endogenous thymosin β4 accelerates glomerular disease. Kidney Int. 2016;90:1056-1070 pubmed publisher
  186. Pageon S, Tabarin T, Yamamoto Y, Ma Y, Nicovich P, Bridgeman J, et al. Functional role of T-cell receptor nanoclusters in signal initiation and antigen discrimination. Proc Natl Acad Sci U S A. 2016;113:E5454-63 pubmed publisher
  187. Bentzen A, Marquard A, Lyngaa R, Saini S, Ramskov S, Donia M, et al. Large-scale detection of antigen-specific T cells using peptide-MHC-I multimers labeled with DNA barcodes. Nat Biotechnol. 2016;34:1037-1045 pubmed publisher
  188. Hervier B, Perez M, Allenbach Y, Devilliers H, Cohen F, Uzunhan Y, et al. Involvement of NK Cells and NKp30 Pathway in Antisynthetase Syndrome. J Immunol. 2016;197:1621-30 pubmed publisher
  189. You Y, Tan J, Dai H, Chen H, Xu X, Yang A, et al. MiRNA-22 inhibits oncogene galectin-1 in hepatocellular carcinoma. Oncotarget. 2016;7:57099-57116 pubmed publisher
  190. Zhao Y, Chu X, Chen J, Wang Y, Gao S, Jiang Y, et al. Dectin-1-activated dendritic cells trigger potent antitumour immunity through the induction of Th9 cells. Nat Commun. 2016;7:12368 pubmed publisher
  191. Xing Y, Cao R, Hu H. TLR and NLRP3 inflammasome-dependent innate immune responses to tumor-derived autophagosomes (DRibbles). Cell Death Dis. 2016;7:e2322 pubmed publisher
  192. Demers K, Makedonas G, Buggert M, Eller M, Ratcliffe S, Goonetilleke N, et al. Temporal Dynamics of CD8+ T Cell Effector Responses during Primary HIV Infection. PLoS Pathog. 2016;12:e1005805 pubmed publisher
  193. Sullivan K, Lewis H, Hill A, Pandey A, Jackson L, Cabral J, et al. Trisomy 21 consistently activates the interferon response. elife. 2016;5: pubmed publisher
  194. Dorand R, Nthale J, Myers J, Barkauskas D, Avril S, Chirieleison S, et al. Cdk5 disruption attenuates tumor PD-L1 expression and promotes antitumor immunity. Science. 2016;353:399-403 pubmed publisher
  195. Schweiger T, Berghoff A, Glogner C, Glueck O, Rajky O, Traxler D, et al. Tumor-infiltrating lymphocyte subsets and tertiary lymphoid structures in pulmonary metastases from colorectal cancer. Clin Exp Metastasis. 2016;33:727-39 pubmed publisher
  196. Sadallah S, Schmied L, Eken C, Charoudeh H, Amicarella F, Schifferli J. Platelet-Derived Ectosomes Reduce NK Cell Function. J Immunol. 2016;197:1663-71 pubmed publisher
  197. Kang J, Park S, Jeong S, Han M, Lee C, Lee K, et al. Epigenetic regulation of Kcna3-encoding Kv1.3 potassium channel by cereblon contributes to regulation of CD4+ T-cell activation. Proc Natl Acad Sci U S A. 2016;113:8771-6 pubmed publisher
  198. Suliman S, Geldenhuys H, Johnson J, Hughes J, Smit E, Murphy M, et al. Bacillus Calmette-Guérin (BCG) Revaccination of Adults with Latent Mycobacterium tuberculosis Infection Induces Long-Lived BCG-Reactive NK Cell Responses. J Immunol. 2016;197:1100-1110 pubmed publisher
  199. Keil M, Sonner J, Lanz T, Oezen I, Bunse T, Bittner S, et al. General control non-derepressible 2 (GCN2) in T cells controls disease progression of autoimmune neuroinflammation. J Neuroimmunol. 2016;297:117-26 pubmed publisher
  200. Piepenbrink M, Samuel M, Zheng B, Carter B, Fucile C, Bunce C, et al. Humoral Dysregulation Associated with Increased Systemic Inflammation among Injection Heroin Users. PLoS ONE. 2016;11:e0158641 pubmed publisher
  201. Konkalmatt P, Asico L, Zhang Y, Yang Y, Drachenberg C, Zheng X, et al. Renal rescue of dopamine D2 receptor function reverses renal injury and high blood pressure. JCI Insight. 2016;1: pubmed
  202. Mo A, Jackson S, Varma K, Carpino A, Giardina C, Devers T, et al. Distinct Transcriptional Changes and Epithelial-Stromal Interactions Are Altered in Early-Stage Colon Cancer Development. Mol Cancer Res. 2016;14:795-804 pubmed publisher
  203. Eichner R, Heider M, Fernández Sáiz V, van Bebber F, Garz A, Lemeer S, et al. Immunomodulatory drugs disrupt the cereblon-CD147-MCT1 axis to exert antitumor activity and teratogenicity. Nat Med. 2016;22:735-43 pubmed publisher
  204. Domingues R, de Carvalho G, Aoki V, da Silva Duarte A, Sato M. Activation of myeloid dendritic cells, effector cells and regulatory T cells in lichen planus. J Transl Med. 2016;14:171 pubmed publisher
  205. Salvi V, Vermi W, Gianello V, Lonardi S, Gagliostro V, Naldini A, et al. Dendritic cell-derived VEGF-A plays a role in inflammatory angiogenesis of human secondary lymphoid organs and is driven by the coordinated activation of multiple transcription factors. Oncotarget. 2016;7:39256-39269 pubmed publisher
  206. Hahn S, Neuhoff A, Landsberg J, Schupp J, Eberts D, Leukel P, et al. A key role of GARP in the immune suppressive tumor microenvironment. Oncotarget. 2016;7:42996-43009 pubmed publisher
  207. Wang H, Schuetz C, Arima A, Chihaya Y, Weinbauer G, Habermann G, et al. Assessment of placental transfer and the effect on embryo-fetal development of a humanized monoclonal antibody targeting lymphotoxin-alpha in non-human primates. Reprod Toxicol. 2016;63:82-95 pubmed publisher
  208. Akashi K, Saegusa J, Sendo S, Nishimura K, Okano T, Yagi K, et al. Knockout of endothelin type B receptor signaling attenuates bleomycin-induced skin sclerosis in mice. Arthritis Res Ther. 2016;18:113 pubmed publisher
  209. Yin W, Tong S, Zhang Q, Shao J, Liu Q, Peng H, et al. Functional dichotomy of Vδ2 γδ T cells in chronic hepatitis C virus infections: role in cytotoxicity but not for IFN-γ production. Sci Rep. 2016;6:26296 pubmed publisher
  210. Kay A, Strauss Albee D, Blish C. Application of Mass Cytometry (CyTOF) for Functional and Phenotypic Analysis of Natural Killer Cells. Methods Mol Biol. 2016;1441:13-26 pubmed publisher
  211. Chikh G, Luu R, Patel S, Davis H, Weeratna R. Effects of KLK Peptide on Adjuvanticity of Different ODN Sequences. Vaccines (Basel). 2016;4: pubmed publisher
  212. Stikvoort A, Sundin M, Uzunel M, Gertow J, Sundberg B, Schaffer M, et al. Long-Term Stable Mixed Chimerism after Hematopoietic Stem Cell Transplantation in Patients with Non-Malignant Disease, Shall We Be Tolerant?. PLoS ONE. 2016;11:e0154737 pubmed publisher
  213. Amarilla S, Gómez Laguna J, Carrasco L, Rodríguez Gómez I, Caridad Y Ocerín J, Graham S, et al. Thymic depletion of lymphocytes is associated with the virulence of PRRSV-1 strains. Vet Microbiol. 2016;188:47-58 pubmed publisher
  214. Qualai J, Li L, Cantero J, Tarrats A, Fernández M, Sumoy L, et al. Expression of CD11c Is Associated with Unconventional Activated T Cell Subsets with High Migratory Potential. PLoS ONE. 2016;11:e0154253 pubmed publisher
  215. Siddiqui I, Erreni M, van Brakel M, Debets R, Allavena P. Enhanced recruitment of genetically modified CX3CR1-positive human T cells into Fractalkine/CX3CL1 expressing tumors: importance of the chemokine gradient. J Immunother Cancer. 2016;4:21 pubmed publisher
  216. Graves S, Kouriba B, Diarra I, Daou M, Niangaly A, Coulibaly D, et al. Strain-specific Plasmodium falciparum multifunctional CD4(+) T cell cytokine expression in Malian children immunized with the FMP2.1/AS02A vaccine candidate. Vaccine. 2016;34:2546-55 pubmed publisher
  217. Chang C, Petrie T, Clark A, Lin X, Sondergaard C, Griffiths L. Mesenchymal Stem Cell Seeding of Porcine Small Intestinal Submucosal Extracellular Matrix for Cardiovascular Applications. PLoS ONE. 2016;11:e0153412 pubmed publisher
  218. Osterloh A, Papp S, Moderzynski K, Kuehl S, Richardt U, Fleischer B. Persisting Rickettsia typhi Causes Fatal Central Nervous System Inflammation. Infect Immun. 2016;84:1615-1632 pubmed publisher
  219. Flint S, Gibson A, Lucas G, Nandigam R, Taylor L, Provan D, et al. A distinct plasmablast and naïve B-cell phenotype in primary immune thrombocytopenia. Haematologica. 2016;101:698-706 pubmed publisher
  220. Gossmann J, Stolte M, Lohoff M, Yu P, Moll R, Finkernagel F, et al. A Gain-Of-Function Mutation in the Plcg2 Gene Protects Mice from Helicobacter felis-Induced Gastric MALT Lymphoma. PLoS ONE. 2016;11:e0150411 pubmed publisher
  221. Simon S, Vignard V, Florenceau L, Dreno B, Khammari A, Lang F, et al. PD-1 expression conditions T cell avidity within an antigen-specific repertoire. Oncoimmunology. 2016;5:e1104448 pubmed
  222. Gao J, Duan Z, Zhang L, Huang X, Long L, Tu J, et al. Failure recovery of circulating NKG2D+CD56dimNK cells in HBV-associated hepatocellular carcinoma after hepatectomy predicts early recurrence. Oncoimmunology. 2016;5:e1048061 pubmed
  223. Frodermann V, Van Duijn J, van Puijvelde G, van Santbrink P, Lagraauw H, de Vries M, et al. Heat-killed Staphylococcus aureus reduces atherosclerosis by inducing anti-inflammatory macrophages. J Intern Med. 2016;279:592-605 pubmed publisher
  224. Hu H, Wang H, Xiao Y, Jin J, Chang J, Zou Q, et al. Otud7b facilitates T cell activation and inflammatory responses by regulating Zap70 ubiquitination. J Exp Med. 2016;213:399-414 pubmed publisher
  225. Singhal G, Fisher F, Chee M, Tan T, El Ouaamari A, Adams A, et al. Fibroblast Growth Factor 21 (FGF21) Protects against High Fat Diet Induced Inflammation and Islet Hyperplasia in Pancreas. PLoS ONE. 2016;11:e0148252 pubmed publisher
  226. Gupta S, Itagaki R, Zheng X, Batkai S, Thum S, Ahmad F, et al. miR-21 promotes fibrosis in an acute cardiac allograft transplantation model. Cardiovasc Res. 2016;110:215-26 pubmed publisher
  227. Kanazawa H, Tseliou E, Dawkins J, de Couto G, Gallet R, Malliaras K, et al. Durable Benefits of Cellular Postconditioning: Long-Term Effects of Allogeneic Cardiosphere-Derived Cells Infused After Reperfusion in Pigs with Acute Myocardial Infarction. J Am Heart Assoc. 2016;5: pubmed publisher
  228. Gibson Corley K, Boyden A, Leidinger M, Lambertz A, Ofori Amanfo G, Naumann P, et al. A method for histopathological study of the multifocal nature of spinal cord lesions in murine experimental autoimmune encephalomyelitis. Peerj. 2016;4:e1600 pubmed publisher
  229. Vallera D, Felices M, McElmurry R, McCullar V, Zhou X, Schmohl J, et al. IL15 Trispecific Killer Engagers (TriKE) Make Natural Killer Cells Specific to CD33+ Targets While Also Inducing Persistence, In Vivo Expansion, and Enhanced Function. Clin Cancer Res. 2016;22:3440-50 pubmed publisher
  230. Freeman B, Ogle B. Viral-mediated fusion of mesenchymal stem cells with cells of the infarcted heart hinders healing via decreased vascularization and immune modulation. Sci Rep. 2016;6:20283 pubmed publisher
  231. Azpilikueta A, Agorreta J, Labiano S, Pérez Gracia J, Sánchez Paulete A, Aznar M, et al. Successful Immunotherapy against a Transplantable Mouse Squamous Lung Carcinoma with Anti-PD-1 and Anti-CD137 Monoclonal Antibodies. J Thorac Oncol. 2016;11:524-36 pubmed publisher
  232. Llibre A, López Macías C, Marafioti T, Mehta H, Partridge A, Kanzig C, et al. LLT1 and CD161 Expression in Human Germinal Centers Promotes B Cell Activation and CXCR4 Downregulation. J Immunol. 2016;196:2085-94 pubmed publisher
  233. Su S, Hu B, Shao J, Shen B, Du J, Du Y, et al. CRISPR-Cas9 mediated efficient PD-1 disruption on human primary T cells from cancer patients. Sci Rep. 2016;6:20070 pubmed publisher
  234. Hu X, Liu C, An J, Shen Y, Hu Y, Jiang J, et al. Development of a Novel Functional Monoclonal Antibody to Human CD275: Characterization and Biological Activity. Monoclon Antib Immunodiagn Immunother. 2016;35:18-24 pubmed publisher
  235. Catarinella M, Monestiroli A, Escobar G, Fiocchi A, Tran N, Aiolfi R, et al. IFNα gene/cell therapy curbs colorectal cancer colonization of the liver by acting on the hepatic microenvironment. EMBO Mol Med. 2016;8:155-70 pubmed publisher
  236. Tsianakas A, Brunner P, Ghoreschi K, Berger C, Loser K, Röcken M, et al. The single-chain anti-TNF-α antibody DLX105 induces clinical and biomarker responses upon local administration in patients with chronic plaque-type psoriasis. Exp Dermatol. 2016;25:428-33 pubmed publisher
  237. Zhang T, Zhang Y, Cui M, Jin L, Wang Y, Lv F, et al. CaMKII is a RIP3 substrate mediating ischemia- and oxidative stress-induced myocardial necroptosis. Nat Med. 2016;22:175-82 pubmed publisher
  238. Gonzalez S, Taborda N, Correa L, Castro G, Hernandez J, Montoya C, et al. Particular activation phenotype of T cells expressing HLA-DR but not CD38 in GALT from HIV-controllers is associated with immune regulation and delayed progression to AIDS. Immunol Res. 2016;64:765-74 pubmed publisher
  239. Vivar O, Masi G, Carpier J, Magalhaes J, Galgano D, Pazour G, et al. IFT20 controls LAT recruitment to the immune synapse and T-cell activation in vivo. Proc Natl Acad Sci U S A. 2016;113:386-91 pubmed publisher
  240. Liu T, Weng S, Wang M, Huang W. Nontuberculous mycobacterial infection with concurrent IgG4-related lymphadenopathy. APMIS. 2016;124:216-20 pubmed publisher
  241. Westman J, Papareddy P, Dahlgren M, Chakrakodi B, Norrby Teglund A, Smeds E, et al. Extracellular Histones Induce Chemokine Production in Whole Blood Ex Vivo and Leukocyte Recruitment In Vivo. PLoS Pathog. 2015;11:e1005319 pubmed publisher
  242. Höftberger R, Leisser M, Bauer J, Lassmann H. Autoimmune encephalitis in humans: how closely does it reflect multiple sclerosis ?. Acta Neuropathol Commun. 2015;3:80 pubmed publisher
  243. Qian B, Ji M, Qiu Y, Pan T, Wang B, Mao S, et al. Is There any Correlation Between Pathological Profile of Facet Joints and Clinical Feature in Patients With Thoracolumbar Kyphosis Secondary to Ankylosing Spondylitis?: An Immunohistochemical Investigation. Spine (Phila Pa 1976). 2016;41:E512-8 pubmed publisher
  244. Kobayashi S, Watanabe T, Suzuki R, Furu M, Ito H, Ito J, et al. TGF-β induces the differentiation of human CXCL13-producing CD4(+) T cells. Eur J Immunol. 2016;46:360-71 pubmed publisher
  245. Skovdahl H, Granlund A, Østvik A, Bruland T, Bakke I, Torp S, et al. Expression of CCL20 and Its Corresponding Receptor CCR6 Is Enhanced in Active Inflammatory Bowel Disease, and TLR3 Mediates CCL20 Expression in Colonic Epithelial Cells. PLoS ONE. 2015;10:e0141710 pubmed publisher
  246. Arvey A, van der Veeken J, Plitas G, Rich S, Concannon P, Rudensky A. Genetic and epigenetic variation in the lineage specification of regulatory T cells. elife. 2015;4:e07571 pubmed publisher
  247. Li L, Xu L, Yan J, Zhen Z, Ji Y, Liu C, et al. CXCR2-CXCL1 axis is correlated with neutrophil infiltration and predicts a poor prognosis in hepatocellular carcinoma. J Exp Clin Cancer Res. 2015;34:129 pubmed publisher
  248. Miles B, Miller S, Folkvord J, Kimball A, Chamanian M, Meditz A, et al. Follicular regulatory T cells impair follicular T helper cells in HIV and SIV infection. Nat Commun. 2015;6:8608 pubmed publisher
  249. Alam M, Gaida M, Bergmann F, Lasitschka F, Giese T, Giese N, et al. Selective inhibition of the p38 alternative activation pathway in infiltrating T cells inhibits pancreatic cancer progression. Nat Med. 2015;21:1337-43 pubmed publisher
  250. Venkatasubramanian S, Tripathi D, Tucker T, Paidipally P, Cheekatla S, Welch E, et al. Tissue factor expression by myeloid cells contributes to protective immune response against Mycobacterium tuberculosis infection. Eur J Immunol. 2016;46:464-79 pubmed publisher
  251. Spiesberger K, Paulfranz F, Egger A, Reiser J, Vogl C, Rudolf Scholik J, et al. Large-Scale Purification of r28M: A Bispecific scFv Antibody Targeting Human Melanoma Produced in Transgenic Cattle. PLoS ONE. 2015;10:e0140471 pubmed publisher
  252. Schulz A, Mälzer J, Domingo C, Jürchott K, Grützkau A, Babel N, et al. Low Thymic Activity and Dendritic Cell Numbers Are Associated with the Immune Response to Primary Viral Infection in Elderly Humans. J Immunol. 2015;195:4699-711 pubmed publisher
  253. Okoye Okafor U, Bartholdy B, Cartier J, Gao E, Pietrak B, Rendina A, et al. New IDH1 mutant inhibitors for treatment of acute myeloid leukemia. Nat Chem Biol. 2015;11:878-86 pubmed publisher
  254. Mitson Salazar A, Yin Y, Wansley D, Young M, Bolan H, Arceo S, et al. Hematopoietic prostaglandin D synthase defines a proeosinophilic pathogenic effector human T(H)2 cell subpopulation with enhanced function. J Allergy Clin Immunol. 2016;137:907-18.e9 pubmed publisher
  255. Liu K, Yang K, Wu B, Chen H, Chen X, Chen X, et al. Tumor-Infiltrating Immune Cells Are Associated With Prognosis of Gastric Cancer. Medicine (Baltimore). 2015;94:e1631 pubmed publisher
  256. Rosario M, Liu B, Kong L, Collins L, Schneider S, Chen X, et al. The IL-15-Based ALT-803 Complex Enhances FcγRIIIa-Triggered NK Cell Responses and In Vivo Clearance of B Cell Lymphomas. Clin Cancer Res. 2016;22:596-608 pubmed publisher
  257. Cichocki F, Cooley S, Davis Z, DeFor T, Schlums H, Zhang B, et al. CD56dimCD57+NKG2C+ NK cell expansion is associated with reduced leukemia relapse after reduced intensity HCT. Leukemia. 2016;30:456-63 pubmed publisher
  258. Banat G, Tretyn A, Pullamsetti S, Wilhelm J, Weigert A, Olesch C, et al. Immune and Inflammatory Cell Composition of Human Lung Cancer Stroma. PLoS ONE. 2015;10:e0139073 pubmed publisher
  259. Silacci M, Lembke W, Woods R, Attinger Toller I, Baenziger Tobler N, Batey S, et al. Discovery and characterization of COVA322, a clinical-stage bispecific TNF/IL-17A inhibitor for the treatment of inflammatory diseases. MAbs. 2016;8:141-9 pubmed publisher
  260. Broos C, van Nimwegen M, Kleinjan A, Ten Berge B, Muskens F, In t Veen J, et al. Impaired survival of regulatory T cells in pulmonary sarcoidosis. Respir Res. 2015;16:108 pubmed publisher
  261. Masek Hammerman K, Peeva E, Ahmad A, Menon S, Afsharvand M, Peng Qu R, et al. Monoclonal antibody against macrophage colony-stimulating factor suppresses circulating monocytes and tissue macrophage function but does not alter cell infiltration/activation in cutaneous lesions or clinical outcomes in patients with cutaneous lupu. Clin Exp Immunol. 2016;183:258-70 pubmed publisher
  262. Campi Azevedo A, Costa Pereira C, Antonelli L, Fonseca C, Teixeira Carvalho A, Villela Rezende G, et al. Booster dose after 10 years is recommended following 17DD-YF primary vaccination. Hum Vaccin Immunother. 2016;12:491-502 pubmed publisher
  263. Nakatsukasa H, Zhang D, Maruyama T, Chen H, Cui K, Ishikawa M, et al. The DNA-binding inhibitor Id3 regulates IL-9 production in CD4(+) T cells. Nat Immunol. 2015;16:1077-84 pubmed publisher
  264. Oliver R, Lovric V, Yu Y, Christou C, Aiken S, Cooper J, et al. Development of a Novel Model for the Assessment of Dead-Space Management in Soft Tissue. PLoS ONE. 2015;10:e0136514 pubmed publisher
  265. Lee Y, Liu C, Liao M, Sukhova G, Shirakawa J, Abdennour M, et al. Deficiency of FcϵR1 Increases Body Weight Gain but Improves Glucose Tolerance in Diet-Induced Obese Mice. Endocrinology. 2015;156:4047-58 pubmed publisher
  266. Japp A, Kursunel M, Meier S, Mälzer J, Li X, Rahman N, et al. Dysfunction of PSA-specific CD8+ T cells in prostate cancer patients correlates with CD38 and Tim-3 expression. Cancer Immunol Immunother. 2015;64:1487-94 pubmed publisher
  267. Klammt C, Novotná L, Li D, Wolf M, Blount A, Zhang K, et al. T cell receptor dwell times control the kinase activity of Zap70. Nat Immunol. 2015;16:961-9 pubmed publisher
  268. Weist B, Wehler P, El Ahmad L, Schmueck Henneresse M, Millward J, Nienen M, et al. A revised strategy for monitoring BKV-specific cellular immunity in kidney transplant patients. Kidney Int. 2015;88:1293-1303 pubmed publisher
  269. Owens G, Erickson K, Malone C, Pan C, Huynh M, Chang J, et al. Evidence for the involvement of gamma delta T cells in the immune response in Rasmussen encephalitis. J Neuroinflammation. 2015;12:134 pubmed publisher
  270. Patyka M, Malamud D, Weissman D, Abrams W, Kurago Z. Periluminal Distribution of HIV-Binding Target Cells and Gp340 in the Oral, Cervical and Sigmoid/Rectal Mucosae: A Mapping Study. PLoS ONE. 2015;10:e0132942 pubmed publisher
  271. Jasinski Bergner S, Stoehr C, Bukur J, Massa C, Braun J, Hüttelmaier S, et al. Clinical relevance of miR-mediated HLA-G regulation and the associated immune cell infiltration in renal cell carcinoma. Oncoimmunology. 2015;4:e1008805 pubmed
  272. Wang Y, Zhong H, Xie X, Chen C, Huang D, Shen L, et al. Long noncoding RNA derived from CD244 signaling epigenetically controls CD8+ T-cell immune responses in tuberculosis infection. Proc Natl Acad Sci U S A. 2015;112:E3883-92 pubmed publisher
  273. Mende N, Kuchen E, Lesche M, Grinenko T, Kokkaliaris K, Hanenberg H, et al. CCND1-CDK4-mediated cell cycle progression provides a competitive advantage for human hematopoietic stem cells in vivo. J Exp Med. 2015;212:1171-83 pubmed publisher
  274. Marshall M, Pattu V, Halimani M, Maier Peuschel M, Müller M, Becherer U, et al. VAMP8-dependent fusion of recycling endosomes with the plasma membrane facilitates T lymphocyte cytotoxicity. J Cell Biol. 2015;210:135-51 pubmed publisher
  275. Mikucki M, Fisher D, Matsuzaki J, Skitzki J, Gaulin N, Muhitch J, et al. Non-redundant requirement for CXCR3 signalling during tumoricidal T-cell trafficking across tumour vascular checkpoints. Nat Commun. 2015;6:7458 pubmed publisher
  276. Fahlbusch F, Ruebner M, Huebner H, Volkert G, Bartunik H, Winterfeld I, et al. Trophoblast expression dynamics of the tumor suppressor gene gastrokine 2. Histochem Cell Biol. 2015;144:281-91 pubmed publisher
  277. Punt S, Thijssen V, Vrolijk J, de Kroon C, Gorter A, Jordanova E. Galectin-1, -3 and -9 Expression and Clinical Significance in Squamous Cervical Cancer. PLoS ONE. 2015;10:e0129119 pubmed publisher
  278. Shields E, Lam C, Cox A, Rankin M, Van Winkle T, Hess R, et al. Extreme Beta-Cell Deficiency in Pancreata of Dogs with Canine Diabetes. PLoS ONE. 2015;10:e0129809 pubmed publisher
  279. Horn T, Laus J, Seitz A, Maurer T, Schmid S, Wolf P, et al. The prognostic effect of tumour-infiltrating lymphocytic subpopulations in bladder cancer. World J Urol. 2016;34:181-7 pubmed publisher
  280. Kim S, Theunissen J, Balibalos J, Liao Chan S, Babcock M, Wong T, et al. A novel antibody-drug conjugate targeting SAIL for the treatment of hematologic malignancies. Blood Cancer J. 2015;5:e316 pubmed publisher
  281. Tsai P, Chang Y, Lee Y, Ko Y, Yang Y, Lin C, et al. Differentiation of blood T cells: Reprogramming human induced pluripotent stem cells into neuronal cells. J Chin Med Assoc. 2015;78:353-9 pubmed publisher
  282. Tipton C, Fucile C, DARCE J, Chida A, Ichikawa T, Gregoretti I, et al. Diversity, cellular origin and autoreactivity of antibody-secreting cell population expansions in acute systemic lupus erythematosus. Nat Immunol. 2015;16:755-65 pubmed publisher
  283. Li Y, Kang G, Duan L, Lu W, Katze M, Lewis M, et al. SIV Infection of Lung Macrophages. PLoS ONE. 2015;10:e0125500 pubmed publisher
  284. Schmueck Henneresse M, Sharaf R, Vogt K, Weist B, Landwehr Kenzel S, Fuehrer H, et al. Peripheral blood-derived virus-specific memory stem T cells mature to functional effector memory subsets with self-renewal potency. J Immunol. 2015;194:5559-67 pubmed publisher
  285. Anandasabapathy N, Breton G, Hurley A, Caskey M, Trumpfheller C, Sarma P, et al. Efficacy and safety of CDX-301, recombinant human Flt3L, at expanding dendritic cells and hematopoietic stem cells in healthy human volunteers. Bone Marrow Transplant. 2015;50:924-30 pubmed publisher
  286. Jeon Y, Kim J, Sung J, Han J, Ko Y. Epstein-Barr virus-positive nodal T/NK-cell lymphoma: an analysis of 15 cases with distinct clinicopathological features. Hum Pathol. 2015;46:981-90 pubmed publisher
  287. Rogers R, Eastham Anderson J, DeVoss J, Lesch J, Yan D, Xu M, et al. Image Analysis-Based Approaches for Scoring Mouse Models of Colitis. Vet Pathol. 2016;53:200-10 pubmed publisher
  288. Kreiter S, Vormehr M, van de Roemer N, Diken M, Löwer M, Diekmann J, et al. Mutant MHC class II epitopes drive therapeutic immune responses to cancer. Nature. 2015;520:692-6 pubmed publisher
  289. Maiwald S, Motazacker M, van Capelleveen J, Sivapalaratnam S, van der Wal A, van der Loos C, et al. A rare variant in MCF2L identified using exclusion linkage in a pedigree with premature atherosclerosis. Eur J Hum Genet. 2016;24:86-91 pubmed publisher
  290. Heinzmann D, Bangert A, Müller A, von Ungern Sternberg S, Emschermann F, Schönberger T, et al. The Novel Extracellular Cyclophilin A (CyPA) - Inhibitor MM284 Reduces Myocardial Inflammation and Remodeling in a Mouse Model of Troponin I -Induced Myocarditis. PLoS ONE. 2015;10:e0124606 pubmed publisher
  291. Tabariès S, Ouellet V, Hsu B, Annis M, Rose A, Meunier L, et al. Granulocytic immune infiltrates are essential for the efficient formation of breast cancer liver metastases. Breast Cancer Res. 2015;17:45 pubmed publisher
  292. Førsvoll J, Janssen E, Møller I, Wathne N, Skaland I, Klos J, et al. Reduced Number of CD8+ Cells in Tonsillar Germinal Centres in Children with the Periodic Fever, Aphthous Stomatitis, Pharyngitis and Cervical Adenitis Syndrome. Scand J Immunol. 2015;82:76-83 pubmed publisher
  293. Wan W, Liu Q, Lionakis M, Marino A, Anderson S, Swamydas M, et al. Atypical chemokine receptor 1 deficiency reduces atherogenesis in ApoE-knockout mice. Cardiovasc Res. 2015;106:478-87 pubmed publisher
  294. Katz S, Burga R, McCormack E, Wang L, Mooring W, Point G, et al. Phase I Hepatic Immunotherapy for Metastases Study of Intra-Arterial Chimeric Antigen Receptor-Modified T-cell Therapy for CEA+ Liver Metastases. Clin Cancer Res. 2015;21:3149-59 pubmed publisher
  295. Vassena L, Giuliani E, Koppensteiner H, Bolduan S, Schindler M, Doria M. HIV-1 Nef and Vpu Interfere with L-Selectin (CD62L) Cell Surface Expression To Inhibit Adhesion and Signaling in Infected CD4+ T Lymphocytes. J Virol. 2015;89:5687-700 pubmed publisher
  296. Lougaris V, Ravelli A, Villanacci V, Salemme M, Soresina A, Fuoti M, et al. Gastrointestinal Pathologic Abnormalities in Pediatric- and Adult-Onset Common Variable Immunodeficiency. Dig Dis Sci. 2015;60:2384-9 pubmed publisher
  297. Yukl S, Shergill A, Girling V, Li Q, Killian M, Epling L, et al. Site-specific differences in T cell frequencies and phenotypes in the blood and gut of HIV-uninfected and ART-treated HIV+ adults. PLoS ONE. 2015;10:e0121290 pubmed publisher
  298. Axelsson Robertson R, Rao M, Loxton A, Walzl G, Bates M, Zumla A, et al. Frequency of Mycobacterium tuberculosis-specific CD8+ T-cells in the course of anti-tuberculosis treatment. Int J Infect Dis. 2015;32:23-9 pubmed publisher
  299. Komori M, Blake A, Greenwood M, Lin Y, Kosa P, Ghazali D, et al. Cerebrospinal fluid markers reveal intrathecal inflammation in progressive multiple sclerosis. Ann Neurol. 2015;78:3-20 pubmed publisher
  300. McClintock S, Warner R, Ali S, Chekuri A, Dame M, Attili D, et al. Monoclonal antibodies specific for oncofetal antigen--immature laminin receptor protein: Effects on tumor growth and spread in two murine models. Cancer Biol Ther. 2015;16:724-32 pubmed publisher
  301. Laing K, Russell R, Dong L, Schmid D, Stern M, Magaret A, et al. Zoster Vaccination Increases the Breadth of CD4+ T Cells Responsive to Varicella Zoster Virus. J Infect Dis. 2015;212:1022-31 pubmed publisher
  302. Dudek Perić A, Ferreira G, Muchowicz A, Wouters J, Prada N, Martin S, et al. Antitumor immunity triggered by melphalan is potentiated by melanoma cell surface-associated calreticulin. Cancer Res. 2015;75:1603-14 pubmed publisher
  303. Chung T, Christopher Stine L, Paik J, Corse A, MAMMEN A. The composition of cellular infiltrates in anti-HMG-CoA reductase-associated myopathy. Muscle Nerve. 2015;52:189-95 pubmed publisher
  304. Grabner B, Schramek D, Mueller K, Moll H, Svinka J, Hoffmann T, et al. Disruption of STAT3 signalling promotes KRAS-induced lung tumorigenesis. Nat Commun. 2015;6:6285 pubmed publisher
  305. Tsai C, Liong K, Gunalan M, Li N, Lim D, Fisher D, et al. Type I IFNs and IL-18 regulate the antiviral response of primary human γδ T cells against dendritic cells infected with Dengue virus. J Immunol. 2015;194:3890-900 pubmed publisher
  306. Claiborne D, Prince J, Scully E, Macharia G, Micci L, Lawson B, et al. Replicative fitness of transmitted HIV-1 drives acute immune activation, proviral load in memory CD4+ T cells, and disease progression. Proc Natl Acad Sci U S A. 2015;112:E1480-9 pubmed publisher
  307. Otsuki S, Sawada H, Yodoya N, Shinohara T, Kato T, Ohashi H, et al. Potential contribution of phenotypically modulated smooth muscle cells and related inflammation in the development of experimental obstructive pulmonary vasculopathy in rats. PLoS ONE. 2015;10:e0118655 pubmed publisher
  308. Severson J, Serracino H, Mateescu V, Raeburn C, McIntyre R, Sams S, et al. PD-1+Tim-3+ CD8+ T Lymphocytes Display Varied Degrees of Functional Exhaustion in Patients with Regionally Metastatic Differentiated Thyroid Cancer. Cancer Immunol Res. 2015;3:620-30 pubmed publisher
  309. Elliott G, Hong C, Xing X, Zhou X, Li D, Coarfa C, et al. Intermediate DNA methylation is a conserved signature of genome regulation. Nat Commun. 2015;6:6363 pubmed publisher
  310. Comrie W, Babich A, Burkhardt J. F-actin flow drives affinity maturation and spatial organization of LFA-1 at the immunological synapse. J Cell Biol. 2015;208:475-91 pubmed publisher
  311. Hladik F, Burgener A, Ballweber L, Gottardo R, Vojtech L, Fourati S, et al. Mucosal effects of tenofovir 1% gel. elife. 2015;4: pubmed publisher
  312. Crncec I, Pathria P, Svinka J, Eferl R. Induction of colorectal cancer in mice and histomorphometric evaluation of tumors. Methods Mol Biol. 2015;1267:145-64 pubmed publisher
  313. Watson M, Hedley D. Whole blood measurement of histone modifications linked to the epigenetic regulation of gene expression. Curr Protoc Cytom. 2015;71:6.36.1-9 pubmed publisher
  314. Chauhan A, Chen C, Moore T, DiPaolo R. Induced expression of FcγRIIIa (CD16a) on CD4+ T cells triggers generation of IFN-γhigh subset. J Biol Chem. 2015;290:5127-40 pubmed publisher
  315. Bende R, Slot L, Hoogeboom R, Wormhoudt T, Adeoye A, Guikema J, et al. Stereotypic rheumatoid factors that are frequently expressed in mucosa-associated lymphoid tissue-type lymphomas are rare in the labial salivary glands of patients with Sjögren's syndrome. Arthritis Rheumatol. 2015;67:1074-83 pubmed publisher
  316. Ito S, Barrett A, Dutra A, Pak E, Miner S, Keyvanfar K, et al. Long term maintenance of myeloid leukemic stem cells cultured with unrelated human mesenchymal stromal cells. Stem Cell Res. 2015;14:95-104 pubmed publisher
  317. Caramalho I, Nunes Silva V, Pires A, Mota C, Pinto A, Nunes Cabaço H, et al. Human regulatory T-cell development is dictated by Interleukin-2 and -15 expressed in a non-overlapping pattern in the thymus. J Autoimmun. 2015;56:98-110 pubmed publisher
  318. Van Eyck L, Hershfield M, Pombal D, Kelly S, Ganson N, Moens L, et al. Hematopoietic stem cell transplantation rescues the immunologic phenotype and prevents vasculopathy in patients with adenosine deaminase 2 deficiency. J Allergy Clin Immunol. 2015;135:283-7.e5 pubmed publisher
  319. Peroni A, Colato C, Schena D, Rongioletti F, Girolomoni G. Histiocytoid Sweet syndrome is infiltrated predominantly by M2-like macrophages. J Am Acad Dermatol. 2015;72:131-9 pubmed publisher
  320. Chovancová J, Bernard T, Stehlíková O, Sálek D, Janíková A, Mayer J, et al. Detection of Minimal Residual Disease in Mantle Cell Lymphoma. Establishment of Novel 8-Color Flow Cytometry Approach. Cytometry B Clin Cytom. 2014;: pubmed publisher
  321. Wang L, Wang G, Gao T. Acneiform primary cutaneous CD4-positive small/medium pleomorphic T-cell lymphoma with prominent necrosis. J Cutan Pathol. 2015;42:265-70 pubmed publisher
  322. Willmann K, Klaver S, DoÄŸu F, Santos Valente E, Garncarz W, Bilic I, et al. Biallelic loss-of-function mutation in NIK causes a primary immunodeficiency with multifaceted aberrant lymphoid immunity. Nat Commun. 2014;5:5360 pubmed publisher
  323. Kamburova E, Koenen H, van den Hoogen M, Baas M, Joosten I, Hilbrands L. Longitudinal analysis of T and B cell phenotype and function in renal transplant recipients with or without rituximab induction therapy. PLoS ONE. 2014;9:e112658 pubmed publisher
  324. Freeman A, Bridge J, Maruthayanar P, Overgaard N, Jung J, Simpson F, et al. Comparative immune phenotypic analysis of cutaneous Squamous Cell Carcinoma and Intraepidermal Carcinoma in immune-competent individuals: proportional representation of CD8+ T-cells but not FoxP3+ Regulatory T-cells is associated with disease stage. PLoS ONE. 2014;9:e110928 pubmed publisher
  325. Lim D, Yawata N, Selva K, Li N, Tsai C, Yeong L, et al. The combination of type I IFN, TNF-α, and cell surface receptor engagement with dendritic cells enables NK cells to overcome immune evasion by dengue virus. J Immunol. 2014;193:5065-75 pubmed publisher
  326. Gerna G, Lilleri D, Fornara C, Bruno F, Gabanti E, Cane I, et al. Differential kinetics of human cytomegalovirus load and antibody responses in primary infection of the immunocompetent and immunocompromised host. J Gen Virol. 2015;96:360-9 pubmed publisher
  327. Stinson S, Amrani Y, Brightling C. D prostanoid receptor 2 (chemoattractant receptor-homologous molecule expressed on TH2 cells) protein expression in asthmatic patients and its effects on bronchial epithelial cells. J Allergy Clin Immunol. 2015;135:395-406 pubmed publisher
  328. Spaan M, Kreefft K, de Graav G, Brouwer W, de Knegt R, ten Kate F, et al. CD4+ CXCR5+ T cells in chronic HCV infection produce less IL-21, yet are efficient at supporting B cell responses. J Hepatol. 2015;62:303-10 pubmed publisher
  329. Clement M, Fornasa G, Loyau S, Morvan M, Andreata F, Guedj K, et al. Upholding the T cell immune-regulatory function of CD31 inhibits the formation of T/B immunological synapses in vitro and attenuates the development of experimental autoimmune arthritis in vivo. J Autoimmun. 2015;56:23-33 pubmed publisher
  330. O Regan N, Steinfelder S, Venugopal G, Rao G, Lucius R, Srikantam A, et al. Brugia malayi microfilariae induce a regulatory monocyte/macrophage phenotype that suppresses innate and adaptive immune responses. PLoS Negl Trop Dis. 2014;8:e3206 pubmed publisher
  331. Lu H, Clauser K, Tam W, Fröse J, Ye X, Eaton E, et al. A breast cancer stem cell niche supported by juxtacrine signalling from monocytes and macrophages. Nat Cell Biol. 2014;16:1105-17 pubmed publisher
  332. Novinger L, Ashikaga T, Krag D. Identification of tumor-binding scFv derived from clonally related B cells in tumor and lymph node of a patient with breast cancer. Cancer Immunol Immunother. 2015;64:29-39 pubmed publisher
  333. Cucak H, Vistisen D, Witte D, Philipsen A, Rosendahl A. Reduction of specific circulating lymphocyte populations with metabolic risk factors in patients at risk to develop type 2 diabetes. PLoS ONE. 2014;9:e107140 pubmed publisher
  334. Cérbulo Vázquez A, Figueroa Damián R, Arriaga Pizano L, Hernández Andrade E, Mancilla Herrera I, Flores Mejía L, et al. Pregnant women infected with pandemic H1N1pdm2009 influenza virus displayed overproduction of peripheral blood CD69+ lymphocytes and increased levels of serum cytokines. PLoS ONE. 2014;9:e107900 pubmed publisher
  335. Perino G, Ricciardi B, Jerabek S, Martignoni G, Wilner G, Maass D, et al. Implant based differences in adverse local tissue reaction in failed total hip arthroplasties: a morphological and immunohistochemical study. BMC Clin Pathol. 2014;14:39 pubmed publisher
  336. Perreau M, Vigano S, Bellanger F, Pellaton C, Buss G, Comte D, et al. Exhaustion of bacteria-specific CD4 T cells and microbial translocation in common variable immunodeficiency disorders. J Exp Med. 2014;211:2033-45 pubmed publisher
  337. Naik E, Webster J, DeVoss J, Liu J, Suriben R, Dixit V. Regulation of proximal T cell receptor signaling and tolerance induction by deubiquitinase Usp9X. J Exp Med. 2014;211:1947-55 pubmed publisher
  338. Abramowski P, Ogrodowczyk C, Martin R, Pongs O. A truncation variant of the cation channel P2RX5 is upregulated during T cell activation. PLoS ONE. 2014;9:e104692 pubmed publisher
  339. Parker K, Sinha P, Horn L, Clements V, Yang H, Li J, et al. HMGB1 enhances immune suppression by facilitating the differentiation and suppressive activity of myeloid-derived suppressor cells. Cancer Res. 2014;74:5723-33 pubmed publisher
  340. Ramirez L, Arango T, Thompson E, Naji M, Tebas P, Boyer J. High IP-10 levels decrease T cell function in HIV-1-infected individuals on ART. J Leukoc Biol. 2014;96:1055-63 pubmed publisher
  341. Kreiser S, Eckhardt J, Kuhnt C, Stein M, Krzyzak L, Seitz C, et al. Murine CD83-positive T cells mediate suppressor functions in vitro and in vivo. Immunobiology. 2015;220:270-9 pubmed publisher
  342. Schneider Hohendorf T, Rossaint J, Mohan H, Böning D, Breuer J, Kuhlmann T, et al. VLA-4 blockade promotes differential routes into human CNS involving PSGL-1 rolling of T cells and MCAM-adhesion of TH17 cells. J Exp Med. 2014;211:1833-46 pubmed publisher
  343. Ohue Y, Kurose K, Mizote Y, Matsumoto H, Nishio Y, Isobe M, et al. Prolongation of overall survival in advanced lung adenocarcinoma patients with the XAGE1 (GAGED2a) antibody. Clin Cancer Res. 2014;20:5052-63 pubmed publisher
  344. Menon M, Sawada A, Chaturvedi A, Mishra P, Schuster Gossler K, Galla M, et al. Genetic deletion of SEPT7 reveals a cell type-specific role of septins in microtubule destabilization for the completion of cytokinesis. PLoS Genet. 2014;10:e1004558 pubmed publisher
  345. Weist B, Schmueck M, Fuehrer H, Sattler A, Reinke P, Babel N. The role of CD4(+) T cells in BKV-specific T cell immunity. Med Microbiol Immunol. 2014;203:395-408 pubmed publisher
  346. Longman R, Diehl G, Victorio D, Huh J, Galan C, Miraldi E, et al. CX?CR1? mononuclear phagocytes support colitis-associated innate lymphoid cell production of IL-22. J Exp Med. 2014;211:1571-83 pubmed publisher
  347. Stenfeldt C, Pacheco J, Borca M, Rodriguez L, Arzt J. Morphologic and phenotypic characteristics of myocarditis in two pigs infected by foot-and mouth disease virus strains of serotypes O or A. Acta Vet Scand. 2014;56:42 pubmed publisher
  348. Butcher L, Garcia M, Arnold M, Ueno H, Goel A, Boland C. Immune response to JC virus T antigen in patients with and without colorectal neoplasia. Gut Microbes. 2014;5:468-75 pubmed publisher
  349. Ikeshita S, Miyatake Y, Otsuka N, Kasahara M. MICA/B expression in macrophage foam cells infiltrating atherosclerotic plaques. Exp Mol Pathol. 2014;97:171-5 pubmed publisher
  350. Haider L, Simeonidou C, Steinberger G, Hametner S, Grigoriadis N, Deretzi G, et al. Multiple sclerosis deep grey matter: the relation between demyelination, neurodegeneration, inflammation and iron. J Neurol Neurosurg Psychiatry. 2014;85:1386-95 pubmed publisher
  351. Nandi B, Pai C, Huang Q, Prabhala R, Munshi N, Gold J. CCR6, the sole receptor for the chemokine CCL20, promotes spontaneous intestinal tumorigenesis. PLoS ONE. 2014;9:e97566 pubmed publisher
  352. Adamski M, Li Y, Wagner E, Yu H, Seales Bailey C, Durkin H, et al. Pre-existing hypertension dominates ??T cell reduction in human ischemic stroke. PLoS ONE. 2014;9:e97755 pubmed publisher
  353. Wilson E, Singh A, Hullsiek K, Gibson D, Henry W, Lichtenstein K, et al. Monocyte-activation phenotypes are associated with biomarkers of inflammation and coagulation in chronic HIV infection. J Infect Dis. 2014;210:1396-406 pubmed publisher
  354. Barbosa R, Silva S, Silva S, Melo A, Pereira Santos M, Barata J, et al. Reduced BAFF-R and increased TACI expression in common variable immunodeficiency. J Clin Immunol. 2014;34:573-83 pubmed publisher
  355. Jakobsson T, Vedin L, Hassan T, Venteclef N, Greco D, D AMATO M, et al. The oxysterol receptor LXR? protects against DSS- and TNBS-induced colitis in mice. Mucosal Immunol. 2014;7:1416-28 pubmed publisher
  356. Helm O, Mennrich R, Petrick D, Goebel L, Freitag Wolf S, Roder C, et al. Comparative characterization of stroma cells and ductal epithelium in chronic pancreatitis and pancreatic ductal adenocarcinoma. PLoS ONE. 2014;9:e94357 pubmed publisher
  357. Deng N, Weaver J, Mosmann T. Cytokine diversity in the Th1-dominated human anti-influenza response caused by variable cytokine expression by Th1 cells, and a minor population of uncommitted IL-2+IFN?- Thpp cells. PLoS ONE. 2014;9:e95986 pubmed publisher
  358. Tarbox J, Keppel M, Topcagic N, Mackin C, Ben Abdallah M, Baszis K, et al. Elevated double negative T cells in pediatric autoimmunity. J Clin Immunol. 2014;34:594-9 pubmed publisher
  359. Mao C, Mou X, Zhou Y, Yuan G, Xu C, Liu H, et al. Tumor-activated TCR??? T cells from gastric cancer patients induce the antitumor immune response of TCR??? T cells via their antigen-presenting cell-like effects. J Immunol Res. 2014;2014:593562 pubmed publisher
  360. Ye W, Xing Y, Paustian C, van de Ven R, Moudgil T, Hilton T, et al. Cross-presentation of viral antigens in dribbles leads to efficient activation of virus-specific human memory T cells. J Transl Med. 2014;12:100 pubmed publisher
  361. Okimura K, Maeta K, Kobayashi N, Goto M, Kano N, Ishihara T, et al. Characterization of ASKP1240, a fully human antibody targeting human CD40 with potent immunosuppressive effects. Am J Transplant. 2014;14:1290-9 pubmed publisher
  362. Cartellieri M, Koristka S, Arndt C, Feldmann A, Stamova S, von Bonin M, et al. A novel ex vivo isolation and expansion procedure for chimeric antigen receptor engrafted human T cells. PLoS ONE. 2014;9:e93745 pubmed publisher
  363. Abramowski P, Otto B, Martin R. The orally available, synthetic ether lipid edelfosine inhibits T cell proliferation and induces a type I interferon response. PLoS ONE. 2014;9:e91970 pubmed publisher
  364. Loh L, Ivarsson M, Michaelsson J, Sandberg J, Nixon D. Invariant natural killer T cells developing in the human fetus accumulate and mature in the small intestine. Mucosal Immunol. 2014;7:1233-43 pubmed publisher
  365. Lanteri M, Diamond M, Law J, Chew G, Wu S, Inglis H, et al. Increased frequency of Tim-3 expressing T cells is associated with symptomatic West Nile virus infection. PLoS ONE. 2014;9:e92134 pubmed publisher
  366. Le Saout C, Hasley R, Imamichi H, Tcheung L, Hu Z, Luckey M, et al. Chronic exposure to type-I IFN under lymphopenic conditions alters CD4 T cell homeostasis. PLoS Pathog. 2014;10:e1003976 pubmed publisher
  367. Magri G, Miyajima M, Bascones S, Mortha A, Puga I, Cassis L, et al. Innate lymphoid cells integrate stromal and immunological signals to enhance antibody production by splenic marginal zone B cells. Nat Immunol. 2014;15:354-364 pubmed publisher
  368. Peguillet I, Milder M, Louis D, Vincent Salomon A, Dorval T, Piperno Neumann S, et al. High numbers of differentiated effector CD4 T cells are found in patients with cancer and correlate with clinical response after neoadjuvant therapy of breast cancer. Cancer Res. 2014;74:2204-16 pubmed publisher
  369. Rizzo S, Basso C, Troost D, Aronica E, Frigo A, Driessen A, et al. T-cell-mediated inflammatory activity in the stellate ganglia of patients with ion-channel disease and severe ventricular arrhythmias. Circ Arrhythm Electrophysiol. 2014;7:224-9 pubmed publisher
  370. Lyngaa R, Pedersen N, Schrama D, Thrue C, Ibrani D, Met O, et al. T-cell responses to oncogenic merkel cell polyomavirus proteins distinguish patients with merkel cell carcinoma from healthy donors. Clin Cancer Res. 2014;20:1768-78 pubmed publisher
  371. Sereti I, Estes J, Thompson W, Morcock D, Fischl M, Croughs T, et al. Decreases in colonic and systemic inflammation in chronic HIV infection after IL-7 administration. PLoS Pathog. 2014;10:e1003890 pubmed publisher
  372. Chang S, Kohrt H, Maecker H. Monitoring the immune competence of cancer patients to predict outcome. Cancer Immunol Immunother. 2014;63:713-9 pubmed publisher
  373. Naviglio S, Arrigo S, Martelossi S, Villanacci V, Tommasini A, Loganes C, et al. Severe inflammatory bowel disease associated with congenital alteration of transforming growth factor beta signaling. J Crohns Colitis. 2014;8:770-4 pubmed publisher
  374. Shikhagaie M, Andersson C, Mori M, Kortekaas Krohn I, Bergqvist A, Dahl R, et al. Mapping of TLR5 and TLR7 in central and distal human airways and identification of reduced TLR expression in severe asthma. Clin Exp Allergy. 2014;44:184-96 pubmed publisher
  375. Bodi I, Curran O, Selway R, Elwes R, Burrone J, Laxton R, et al. Two cases of multinodular and vacuolating neuronal tumour. Acta Neuropathol Commun. 2014;2:7 pubmed publisher
  376. Salerno Goncalves R, Rezwan T, Sztein M. B cells modulate mucosal associated invariant T cell immune responses. Front Immunol. 2014;4:511 pubmed publisher
  377. Yang C, Li J, Chiu L, Lan J, Chen D, Chuang H, et al. Dual-specificity phosphatase 14 (DUSP14/MKP6) negatively regulates TCR signaling by inhibiting TAB1 activation. J Immunol. 2014;192:1547-57 pubmed publisher
  378. Kesdangsakonwut S, Sunden Y, Aoshima K, Iwaki Y, Okumura M, Sawa H, et al. Survival of rabid rabbits after intrathecal immunization. Neuropathology. 2014;34:277-83 pubmed publisher
  379. Wong E, Akilimali N, Govender P, Sullivan Z, Cosgrove C, Pillay M, et al. Low levels of peripheral CD161++CD8+ mucosal associated invariant T (MAIT) cells are found in HIV and HIV/TB co-infection. PLoS ONE. 2013;8:e83474 pubmed publisher
  380. Koppensteiner H, H hne K, Gondim M, Gobert F, Widder M, Gundlach S, et al. Lentiviral Nef suppresses iron uptake in a strain specific manner through inhibition of Transferrin endocytosis. Retrovirology. 2014;11:1 pubmed publisher
  381. Engel R, Morris M, Henning T, Ritter J, Jones T, Dietz S, et al. Evaluation of pigtail macaques as a model for the effects of copper intrauterine devices on HIV infection. J Med Primatol. 2014;43:349-59 pubmed publisher
  382. Kim H, Lee H, Chang Y, Pichavant M, Shore S, Fitzgerald K, et al. Interleukin-17-producing innate lymphoid cells and the NLRP3 inflammasome facilitate obesity-associated airway hyperreactivity. Nat Med. 2014;20:54-61 pubmed publisher
  383. Rodriguez M, Loyd C, Ding X, Karim A, MCDONALD D, Canaday D, et al. Mycobacterial phosphatidylinositol mannoside 6 (PIM6) up-regulates TCR-triggered HIV-1 replication in CD4+ T cells. PLoS ONE. 2013;8:e80938 pubmed publisher
  384. Rapetti L, Chavele K, Evans C, Ehrenstein M. B cell resistance to Fas-mediated apoptosis contributes to their ineffective control by regulatory T cells in rheumatoid arthritis. Ann Rheum Dis. 2015;74:294-302 pubmed publisher
  385. Zouk H, d Hennezel E, Du X, Ounissi Benkalha H, Piccirillo C, Polychronakos C. Functional evaluation of the role of C-type lectin domain family 16A at the chromosome 16p13 locus. Clin Exp Immunol. 2014;175:485-97 pubmed publisher
  386. Yaiw K, Ovchinnikova O, Taher C, Mohammad A, Davoudi B, Shlyakhto E, et al. High prevalence of human cytomegalovirus in carotid atherosclerotic plaques obtained from Russian patients undergoing carotid endarterectomy. Herpesviridae. 2013;4:3 pubmed publisher
  387. Turcotte S, Gros A, Tran E, Lee C, Wunderlich J, Robbins P, et al. Tumor-reactive CD8+ T cells in metastatic gastrointestinal cancer refractory to chemotherapy. Clin Cancer Res. 2014;20:331-43 pubmed publisher
  388. Krishnan S, Wilson E, Sheikh V, Rupert A, Mendoza D, Yang J, et al. Evidence for innate immune system activation in HIV type 1-infected elite controllers. J Infect Dis. 2014;209:931-9 pubmed publisher
  389. Didigu C, Wilen C, Wang J, Duong J, Secreto A, Danet Desnoyers G, et al. Simultaneous zinc-finger nuclease editing of the HIV coreceptors ccr5 and cxcr4 protects CD4+ T cells from HIV-1 infection. Blood. 2014;123:61-9 pubmed publisher
  390. Luan G, Gao Q, Guan Y, Zhai F, Zhou J, Liu C, et al. Upregulation of adenosine kinase in Rasmussen encephalitis. J Neuropathol Exp Neurol. 2013;72:1000-8 pubmed publisher
  391. Lin G, Field J, Yu J, Ken R, Neuberg D, Nathan D, et al. NF-?B is activated in CD4+ iNKT cells by sickle cell disease and mediates rapid induction of adenosine A2A receptors. PLoS ONE. 2013;8:e74664 pubmed publisher
  392. Miyashita T, Kimura K, Fukami T, Nakajima M, Yokoi T. Evaluation and mechanistic analysis of the cytotoxicity of the acyl glucuronide of nonsteroidal anti-inflammatory drugs. Drug Metab Dispos. 2014;42:1-8 pubmed publisher
  393. Saghafian Hedengren S, Sohlberg E, Theorell J, Carvalho Queiroz C, Nagy N, Persson J, et al. Epstein-Barr virus coinfection in children boosts cytomegalovirus-induced differentiation of natural killer cells. J Virol. 2013;87:13446-55 pubmed publisher
  394. Tan A, Hoang L, Chin D, Rasmussen E, Lopatin U, Hart S, et al. Reduction of HBV replication prolongs the early immunological response to IFN? therapy. J Hepatol. 2014;60:54-61 pubmed publisher
  395. Aresu L, Martini V, Rossi F, Vignoli M, Sampaolo M, Aricò A, et al. Canine indolent and aggressive lymphoma: clinical spectrum with histologic correlation. Vet Comp Oncol. 2015;13:348-62 pubmed publisher
  396. Melis L, Van Praet L, Pircher H, Venken K, Elewaut D. Senescence marker killer cell lectin-like receptor G1 (KLRG1) contributes to TNF-? production by interaction with its soluble E-cadherin ligand in chronically inflamed joints. Ann Rheum Dis. 2014;73:1223-31 pubmed publisher
  397. Dintwe O, Day C, Smit E, Nemes E, Gray C, Tameris M, et al. Heterologous vaccination against human tuberculosis modulates antigen-specific CD4+ T-cell function. Eur J Immunol. 2013;43:2409-20 pubmed publisher
  398. Wiernik A, Foley B, Zhang B, Verneris M, Warlick E, Gleason M, et al. Targeting natural killer cells to acute myeloid leukemia in vitro with a CD16 x 33 bispecific killer cell engager and ADAM17 inhibition. Clin Cancer Res. 2013;19:3844-55 pubmed publisher
  399. Fischer M, Wimmer I, Hoftberger R, Gerlach S, Haider L, Zrzavy T, et al. Disease-specific molecular events in cortical multiple sclerosis lesions. Brain. 2013;136:1799-815 pubmed publisher
  400. Kvarnung M, Nilsson D, Lindstrand A, Korenke G, Chiang S, Blennow E, et al. A novel intellectual disability syndrome caused by GPI anchor deficiency due to homozygous mutations in PIGT. J Med Genet. 2013;50:521-8 pubmed publisher
  401. Sharma S, Roumanes D, Almudevar A, Mosmann T, Pichichero M. CD4+ T-cell responses among adults and young children in response to Streptococcus pneumoniae and Haemophilus influenzae vaccine candidate protein antigens. Vaccine. 2013;31:3090-7 pubmed publisher
  402. Introini A, Vanpouille C, Lisco A, Grivel J, Margolis L. Interleukin-7 facilitates HIV-1 transmission to cervico-vaginal tissue ex vivo. PLoS Pathog. 2013;9:e1003148 pubmed publisher
  403. Palin A, Ramachandran V, Acharya S, Lewis D. Human neonatal naive CD4+ T cells have enhanced activation-dependent signaling regulated by the microRNA miR-181a. J Immunol. 2013;190:2682-91 pubmed publisher
  404. Yan R, Zhong W, Zhu Y, Zhang X. Trichosanthin-stimulated dendritic cells induce a type 2 helper T lymphocyte response through the OX40 ligand. J Investig Allergol Clin Immunol. 2012;22:491-500 pubmed
  405. Field J, Lin G, Okam M, Majerus E, Keefer J, Onyekwere O, et al. Sickle cell vaso-occlusion causes activation of iNKT cells that is decreased by the adenosine A2A receptor agonist regadenoson. Blood. 2013;121:3329-34 pubmed publisher
  406. Muñoz Ruiz M, Pérez Flores V, Garcillán B, Guardo A, Mazariegos M, Takada H, et al. Human CD3?, but not CD3?, haploinsufficiency differentially impairs ?? versus ?? surface TCR expression. BMC Immunol. 2013;14:3 pubmed publisher
  407. Nichele I, Zamo A, Bertolaso A, Bifari F, Tinelli M, Franchini M, et al. VR09 cell line: an EBV-positive lymphoblastoid cell line with in vivo characteristics of diffuse large B cell lymphoma of activated B-cell type. PLoS ONE. 2012;7:e52811 pubmed publisher
  408. Wong W, Sigvardsson M, Astrand Grundström I, Hogge D, Larsson J, Qian H, et al. Expression of integrin ?2 receptor in human cord blood CD34+CD38-CD90+ stem cells engrafting long-term in NOD/SCID-IL2R?(c) null mice. Stem Cells. 2013;31:360-71 pubmed publisher
  409. He Y, He X, Guo P, Du M, Shao J, Li M, et al. The decidual stromal cells-secreted CCL2 induces and maintains decidual leukocytes into Th2 bias in human early pregnancy. Clin Immunol. 2012;145:161-73 pubmed publisher
  410. O CONNOR T, Frei N, Sponarova J, Schwarz P, Heikenwalder M, Aguzzi A. Lymphotoxin, but not TNF, is required for prion invasion of lymph nodes. PLoS Pathog. 2012;8:e1002867 pubmed publisher
  411. Sharma S, Pichichero M. Functional deficits of pertussis-specific CD4+ T cells in infants compared to adults following DTaP vaccination. Clin Exp Immunol. 2012;169:281-91 pubmed publisher
  412. Prabowo A, Anink J, Lammens M, Nellist M, van den Ouweland A, Adle Biassette H, et al. Fetal brain lesions in tuberous sclerosis complex: TORC1 activation and inflammation. Brain Pathol. 2013;23:45-59 pubmed publisher
  413. Takahashi A, Torigoe T, Tamura Y, Kanaseki T, Tsukahara T, Sasaki Y, et al. Heat shock enhances the expression of cytotoxic granule proteins and augments the activities of tumor-associated antigen-specific cytotoxic T lymphocytes. Cell Stress Chaperones. 2012;17:757-63 pubmed publisher
  414. Qi Y, Operario D, Georas S, Mosmann T. The acute environment, rather than T cell subset pre-commitment, regulates expression of the human T cell cytokine amphiregulin. PLoS ONE. 2012;7:e39072 pubmed publisher
  415. Li X, Miao H, Henn A, Topham D, Wu H, Zand M, et al. Ki-67 expression reveals strong, transient influenza specific CD4 T cell responses after adult vaccination. Vaccine. 2012;30:4581-4 pubmed publisher
  416. Fong B, JIN R, Wang X, Safaee M, Lisiero D, Yang I, et al. Monitoring of regulatory T cell frequencies and expression of CTLA-4 on T cells, before and after DC vaccination, can predict survival in GBM patients. PLoS ONE. 2012;7:e32614 pubmed publisher
  417. Frahm M, Picking R, Kuruc J, McGee K, Gay C, Eron J, et al. CD4+CD8+ T cells represent a significant portion of the anti-HIV T cell response to acute HIV infection. J Immunol. 2012;188:4289-96 pubmed publisher
  418. Zeng M, Southern P, Reilly C, Beilman G, Chipman J, Schacker T, et al. Lymphoid tissue damage in HIV-1 infection depletes naïve T cells and limits T cell reconstitution after antiretroviral therapy. PLoS Pathog. 2012;8:e1002437 pubmed publisher
  419. Schneckenleithner C, Bago Horvath Z, Dolznig H, Neugebauer N, Kollmann K, Kolbe T, et al. Putting the brakes on mammary tumorigenesis: loss of STAT1 predisposes to intraepithelial neoplasias. Oncotarget. 2011;2:1043-54 pubmed
  420. West N, Milne K, Truong P, MacPherson N, Nelson B, Watson P. Tumor-infiltrating lymphocytes predict response to anthracycline-based chemotherapy in estrogen receptor-negative breast cancer. Breast Cancer Res. 2011;13:R126 pubmed publisher
  421. Meeths M, Chiang S, Wood S, Entesarian M, Schlums H, Bang B, et al. Familial hemophagocytic lymphohistiocytosis type 3 (FHL3) caused by deep intronic mutation and inversion in UNC13D. Blood. 2011;118:5783-93 pubmed publisher
  422. Magrini E, Szabo I, Doni A, Cibella J, Viola A. Serotonin-mediated tuning of human helper T cell responsiveness to the chemokine CXCL12. PLoS ONE. 2011;6:e22482 pubmed publisher
  423. Lorenzi L, Lonardi S, Petrilli G, Tanda F, Bella M, Laurino L, et al. Folliculocentric B-cell-rich follicular dendritic cells sarcoma: a hitherto unreported morphological variant mimicking lymphoproliferative disorders. Hum Pathol. 2012;43:209-15 pubmed publisher
  424. Ruffell B, Au A, Rugo H, Esserman L, Hwang E, Coussens L. Leukocyte composition of human breast cancer. Proc Natl Acad Sci U S A. 2012;109:2796-801 pubmed publisher
  425. Gall A, Horowitz A, Joof H, Natividad A, Tetteh K, Riley E, et al. Systemic effector and regulatory immune responses to chlamydial antigens in trachomatous trichiasis. Front Microbiol. 2011;2:10 pubmed publisher
  426. West N, Panet Raymond V, Truong P, Alexander C, Babinszky S, Milne K, et al. Intratumoral Immune Responses Can Distinguish New Primary and True Recurrence Types of Ipsilateral Breast Tumor Recurrences (IBTR). Breast Cancer (Auckl). 2011;5:105-15 pubmed publisher
  427. Petrilli G, Lorenzi L, Paracchini R, Ubiali A, Schumacher R, Cabassa P, et al. Epstein-Barr virus-associated adrenal smooth muscle tumors and disseminated diffuse large B-cell lymphoma in a child with common variable immunodeficiency: a case report and review of the literature. Int J Surg Pathol. 2014;22:712-21 pubmed publisher
  428. Mamedov I, Britanova O, Bolotin D, Chkalina A, Staroverov D, Zvyagin I, et al. Quantitative tracking of T cell clones after haematopoietic stem cell transplantation. EMBO Mol Med. 2011;3:201-7 pubmed publisher
  429. Kuzin I, Sun H, Moshkani S, Feng C, Mantalaris A, Wu J, et al. Long-term immunologically competent human peripheral lymphoid tissue cultures in a 3D bioreactor. Biotechnol Bioeng. 2011;108:1430-40 pubmed publisher
  430. Catalfamo M, Wilhelm C, Tcheung L, Proschan M, Friesen T, Park J, et al. CD4 and CD8 T cell immune activation during chronic HIV infection: roles of homeostasis, HIV, type I IFN, and IL-7. J Immunol. 2011;186:2106-16 pubmed publisher
  431. de Almeida C, de Lima T, Castro D, Torres K, da Silva Braga W, Peruhype Magalhães V, et al. Immunological/virological peripheral blood biomarkers and distinct patterns of sleeping quality in chronic hepatitis C patients. Scand J Immunol. 2011;73:486-95 pubmed publisher
  432. Scheible K, Zhang G, Baer J, Azadniv M, Lambert K, Pryhuber G, et al. CD8+ T cell immunity to 2009 pandemic and seasonal H1N1 influenza viruses. Vaccine. 2011;29:2159-68 pubmed publisher
  433. Reuwer A, van Eijk M, Houttuijn Bloemendaal F, van der Loos C, Claessen N, Teeling P, et al. The prolactin receptor is expressed in macrophages within human carotid atherosclerotic plaques: a role for prolactin in atherogenesis?. J Endocrinol. 2011;208:107-17 pubmed publisher
  434. Correia M, Costa A, Uhrberg M, Cardoso E, Arosa F. IL-15 induces CD8+ T cells to acquire functional NK receptors capable of modulating cytotoxicity and cytokine secretion. Immunobiology. 2011;216:604-12 pubmed publisher
  435. Horowitz A, Behrens R, Okell L, Fooks A, Riley E. NK cells as effectors of acquired immune responses: effector CD4+ T cell-dependent activation of NK cells following vaccination. J Immunol. 2010;185:2808-18 pubmed publisher
  436. Markley J, Sadelain M. IL-7 and IL-21 are superior to IL-2 and IL-15 in promoting human T cell-mediated rejection of systemic lymphoma in immunodeficient mice. Blood. 2010;115:3508-19 pubmed publisher
  437. Oo Y, Weston C, Lalor P, Curbishley S, Withers D, Reynolds G, et al. Distinct roles for CCR4 and CXCR3 in the recruitment and positioning of regulatory T cells in the inflamed human liver. J Immunol. 2010;184:2886-98 pubmed publisher
  438. Zhou J, Belov L, Huang P, Shin J, Solomon M, Chapuis P, et al. Surface antigen profiling of colorectal cancer using antibody microarrays with fluorescence multiplexing. J Immunol Methods. 2010;355:40-51 pubmed publisher
  439. Hunter P, Nistala K, Jina N, Eddaoudi A, Thomson W, Hubank M, et al. Biologic predictors of extension of oligoarticular juvenile idiopathic arthritis as determined from synovial fluid cellular composition and gene expression. Arthritis Rheum. 2010;62:896-907 pubmed publisher
  440. Marino J, Tan C, Taylor A, Bentley C, Van De Wiele C, Ranne R, et al. Differential IL-7 responses in developing human thymocytes. Hum Immunol. 2010;71:329-33 pubmed publisher
  441. Carrion F, Nova E, Ruiz C, Diaz F, Inostroza C, Rojo D, et al. Autologous mesenchymal stem cell treatment increased T regulatory cells with no effect on disease activity in two systemic lupus erythematosus patients. Lupus. 2010;19:317-22 pubmed publisher
  442. Strickland L, Ross J, Williams S, Ross S, Romero M, Spencer S, et al. Preclinical evaluation of carcinoembryonic cell adhesion molecule (CEACAM) 6 as potential therapy target for pancreatic adenocarcinoma. J Pathol. 2009;218:380-90 pubmed publisher
  443. Kapoor V, Hakim F, Rehman N, Gress R, Telford W. Quantum dots thermal stability improves simultaneous phenotype-specific telomere length measurement by FISH-flow cytometry. J Immunol Methods. 2009;344:6-14 pubmed publisher
  444. Park C, Majeti R, Weissman I. In vivo evaluation of human hematopoiesis through xenotransplantation of purified hematopoietic stem cells from umbilical cord blood. Nat Protoc. 2008;3:1932-40 pubmed publisher
  445. Karagoz B, Bilgi O, Gumus M, Erikci A, Sayan O, Turken O, et al. CD8+CD28- cells and CD4+CD25+ regulatory T cells in the peripheral blood of advanced stage lung cancer patients. Med Oncol. 2010;27:29-33 pubmed publisher
  446. Milne K, Barnes R, Girardin A, Mawer M, Nesslinger N, Ng A, et al. Tumor-infiltrating T cells correlate with NY-ESO-1-specific autoantibodies in ovarian cancer. PLoS ONE. 2008;3:e3409 pubmed publisher
  447. Richardson M, Carroll R, Stremlau M, Korokhov N, Humeau L, Silvestri G, et al. Mode of transmission affects the sensitivity of human immunodeficiency virus type 1 to restriction by rhesus TRIM5alpha. J Virol. 2008;82:11117-28 pubmed publisher
  448. Sodsai P, Hirankarn N, Avihingsanon Y, Palaga T. Defects in Notch1 upregulation upon activation of T Cells from patients with systemic lupus erythematosus are related to lupus disease activity. Lupus. 2008;17:645-53 pubmed publisher
  449. Lunemann J, Frey O, Eidner T, Baier M, Roberts S, Sashihara J, et al. Increased frequency of EBV-specific effector memory CD8+ T cells correlates with higher viral load in rheumatoid arthritis. J Immunol. 2008;181:991-1000 pubmed
  450. Giannelli S, Taddeo A, Presicce P, Villa M, Della Bella S. A six-color flow cytometric assay for the analysis of peripheral blood dendritic cells. Cytometry B Clin Cytom. 2008;74:349-55 pubmed publisher
  451. Gurer C, Strowig T, Brilot F, Pack M, Trumpfheller C, Arrey F, et al. Targeting the nuclear antigen 1 of Epstein-Barr virus to the human endocytic receptor DEC-205 stimulates protective T-cell responses. Blood. 2008;112:1231-9 pubmed publisher
  452. Grahmann P, Braun R. A new protocol for multiple inhalation of IFN-gamma successfully treats MDR-TB: a case study. Int J Tuberc Lung Dis. 2008;12:636-44 pubmed
  453. Muniz J, McCauley L, Scherer J, Lasarev M, Koshy M, Kow Y, et al. Biomarkers of oxidative stress and DNA damage in agricultural workers: a pilot study. Toxicol Appl Pharmacol. 2008;227:97-107 pubmed
  454. Sangiolo D, Lesnikova M, Nash R, Jensen M, Nikitine A, Kiem H, et al. Lentiviral vector conferring resistance to mycophenolate mofetil and sensitivity to ganciclovir for in vivo T-cell selection. Gene Ther. 2007;14:1549-54 pubmed
  455. Wilson N, Boniface K, Chan J, McKenzie B, Blumenschein W, Mattson J, et al. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat Immunol. 2007;8:950-7 pubmed
  456. Kueng H, Leb V, Haiderer D, Raposo G, Thery C, Derdak S, et al. General strategy for decoration of enveloped viruses with functionally active lipid-modified cytokines. J Virol. 2007;81:8666-76 pubmed
  457. Estefanía E, Flores R, Gómez Lozano N, Aguilar H, Lopez Botet M, Vilches C. Human KIR2DL5 is an inhibitory receptor expressed on the surface of NK and T lymphocyte subsets. J Immunol. 2007;178:4402-10 pubmed
  458. Diaz Blanco E, Bruns I, Neumann F, Fischer J, Graef T, Rosskopf M, et al. Molecular signature of CD34(+) hematopoietic stem and progenitor cells of patients with CML in chronic phase. Leukemia. 2007;21:494-504 pubmed
  459. De Fanis U, Mori F, Kurnat R, Lee W, Bova M, Adkinson N, et al. GATA3 up-regulation associated with surface expression of CD294/CRTH2: a unique feature of human Th cells. Blood. 2007;109:4343-50 pubmed
  460. Clarke S, Betts G, Plant A, Wright K, El Shanawany T, Harrop R, et al. CD4+CD25+FOXP3+ regulatory T cells suppress anti-tumor immune responses in patients with colorectal cancer. PLoS ONE. 2006;1:e129 pubmed
  461. Xin K, Mizukami H, Urabe M, Toda Y, Shinoda K, Yoshida A, et al. Induction of robust immune responses against human immunodeficiency virus is supported by the inherent tropism of adeno-associated virus type 5 for dendritic cells. J Virol. 2006;80:11899-910 pubmed
  462. Hoves S, Krause S, Schutz C, Halbritter D, Scholmerich J, Herfarth H, et al. Monocyte-derived human macrophages mediate anergy in allogeneic T cells and induce regulatory T cells. J Immunol. 2006;177:2691-8 pubmed
  463. Quiroga M, Pasquinelli V, Martinez G, Jurado J, Zorrilla L, Musella R, et al. Inducible costimulator: a modulator of IFN-gamma production in human tuberculosis. J Immunol. 2006;176:5965-74 pubmed
  464. Jamieson C, Gotlib J, Durocher J, Chao M, Mariappan M, Lay M, et al. The JAK2 V617F mutation occurs in hematopoietic stem cells in polycythemia vera and predisposes toward erythroid differentiation. Proc Natl Acad Sci U S A. 2006;103:6224-9 pubmed
  465. Barsov E, Andersen H, Coalter V, Carrington M, Lifson J, Ott D. Capture of antigen-specific T lymphocytes from human blood by selective immortalization to establish long-term T-cell lines maintaining primary cell characteristics. Immunol Lett. 2006;105:26-37 pubmed
  466. Olivier A, Lauret E, Gonin P, Galy A. The Notch ligand delta-1 is a hematopoietic development cofactor for plasmacytoid dendritic cells. Blood. 2006;107:2694-701 pubmed
  467. Schaap A, Fortin J, Sommer M, Zerboni L, Stamatis S, Ku C, et al. T-cell tropism and the role of ORF66 protein in pathogenesis of varicella-zoster virus infection. J Virol. 2005;79:12921-33 pubmed
  468. Bratke K, Kuepper M, Bade B, Virchow J, Luttmann W. Differential expression of human granzymes A, B, and K in natural killer cells and during CD8+ T cell differentiation in peripheral blood. Eur J Immunol. 2005;35:2608-16 pubmed
  469. Tas S, Quartier P, Botto M, Fossati Jimack L. Macrophages from patients with SLE and rheumatoid arthritis have defective adhesion in vitro, while only SLE macrophages have impaired uptake of apoptotic cells. Ann Rheum Dis. 2006;65:216-21 pubmed
  470. Yamada H, Shimada S, Morikawa M, Iwabuchi K, Kishi R, Onoe K, et al. Divergence of natural killer cell receptor and related molecule in the decidua from sporadic miscarriage with normal chromosome karyotype. Mol Hum Reprod. 2005;11:451-7 pubmed
  471. Mittag A, Lenz D, Gerstner A, Sack U, Steinbrecher M, Koksch M, et al. Polychromatic (eight-color) slide-based cytometry for the phenotyping of leukocyte, NK, and NKT subsets. Cytometry A. 2005;65:103-15 pubmed
  472. Contamin H, Loizon S, Bourreau E, Michel J, Garraud O, Mercereau Puijalon O, et al. Flow cytometry identification and characterization of mononuclear cell subsets in the neotropical primate Saimiri sciureus (squirrel monkey). J Immunol Methods. 2005;297:61-71 pubmed
  473. Stütz A, Graf P, Beinhauer B, Hammerschmid F, Neumann C, Woisetschläger M, et al. CD45 isoform expression is associated with different susceptibilities of human naive and effector CD4+ T cells to respond to IL-4. Eur J Immunol. 2005;35:575-83 pubmed
  474. Canonico B, Zamai L, Burattini S, Granger V, Mannello F, Gobbi P, et al. Evaluation of leukocyte stabilisation in TransFix-treated blood samples by flow cytometry and transmission electron microscopy. J Immunol Methods. 2004;295:67-78 pubmed
  475. Pfistershammer K, Majdic O, Stockl J, Zlabinger G, Kirchberger S, Steinberger P, et al. CD63 as an activation-linked T cell costimulatory element. J Immunol. 2004;173:6000-8 pubmed
  476. Ku C, Zerboni L, Ito H, Graham B, Wallace M, Arvin A. Varicella-zoster virus transfer to skin by T Cells and modulation of viral replication by epidermal cell interferon-alpha. J Exp Med. 2004;200:917-25 pubmed
  477. Bonanno G, Perillo A, Rutella S, De Ritis D, Mariotti A, Marone M, et al. Clinical isolation and functional characterization of cord blood CD133+ hematopoietic progenitor cells. Transfusion. 2004;44:1087-97 pubmed
  478. Asin S, Fanger M, Wildt Perinic D, Ware P, Wira C, Howell A. Transmission of HIV-1 by primary human uterine epithelial cells and stromal fibroblasts. J Infect Dis. 2004;190:236-45 pubmed
  479. Yamada H, Shimada S, Kato E, Morikawa M, Iwabuchi K, Kishi R, et al. Decrease in a specific killer cell immunoglobulin-like receptor on peripheral natural killer cells in women with recurrent spontaneous abortion of unexplained etiology. Am J Reprod Immunol. 2004;51:241-7 pubmed
  480. Beinhauer B, McBride J, Graf P, Pursch E, Bongers M, Rogy M, et al. Interleukin 10 regulates cell surface and soluble LIR-2 (CD85d) expression on dendritic cells resulting in T cell hyporesponsiveness in vitro. Eur J Immunol. 2004;34:74-80 pubmed
  481. Braun R, Foerster M, Grahmann P, Haefner D, Workalemahu G, Kroegel C. Phenotypic and molecular characterization of CD103+ CD4+ T cells in bronchoalveolar lavage from patients with interstitial lung diseases. Cytometry B Clin Cytom. 2003;54:19-27 pubmed
  482. Stacchini A, Demurtas A, Godio L, Martini G, Antinoro V, Palestro G. Flow cytometry in the bone marrow staging of mature B-cell neoplasms. Cytometry B Clin Cytom. 2003;54:10-8 pubmed
  483. Tjernlund A, Fleener Z, Behbahani H, Connick E, Sonnerborg A, Broström C, et al. Suppression of leukemia inhibitor factor in lymphoid tissue in primary HIV infection: absence of HIV replication in gp130-positive cells. AIDS. 2003;17:1303-10 pubmed
  484. Rahimi K, Maerz H, Zotz R, Tarnok A. Pre-procedural expression of Mac-1 and LFA-1 on leukocytes for prediction of late restenosis and their possible correlation with advanced coronary artery disease. Cytometry B Clin Cytom. 2003;53:63-9 pubmed
  485. Rouard H, Leon A, De Reys S, Taylor L, Logan J, Marquet J, et al. A closed and single-use system for monocyte enrichment: potential for dendritic cell generation for clinical applications. Transfusion. 2003;43:481-7 pubmed
  486. Grimbacher B, Hutloff A, Schlesier M, Glocker E, Warnatz K, Dräger R, et al. Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency. Nat Immunol. 2003;4:261-8 pubmed
  487. Dekel B, Burakova T, Arditti F, Reich Zeliger S, Milstein O, Aviel Ronen S, et al. Human and porcine early kidney precursors as a new source for transplantation. Nat Med. 2003;9:53-60 pubmed
  488. Loza M, Perussia B. Peripheral immature CD2-/low T cell development from type 2 to type 1 cytokine production. J Immunol. 2002;169:3061-8 pubmed
  489. Manz M, Miyamoto T, Akashi K, Weissman I. Prospective isolation of human clonogenic common myeloid progenitors. Proc Natl Acad Sci U S A. 2002;99:11872-7 pubmed
  490. McIlroy D, Troadec C, Grassi F, Samri A, Barrou B, Autran B, et al. Investigation of human spleen dendritic cell phenotype and distribution reveals evidence of in vivo activation in a subset of organ donors. Blood. 2001;97:3470-7 pubmed
  491. Thompson S, Luyrink L, Graham T, Tsoras M, Ryan M, Passo M, et al. Chemokine receptor CCR4 on CD4+ T cells in juvenile rheumatoid arthritis synovial fluid defines a subset of cells with increased IL-4:IFN-gamma mRNA ratios. J Immunol. 2001;166:6899-906 pubmed
  492. Telford W, Moss M, Morseman J, Allnutt F. Cryptomonad algal phycobiliproteins as fluorochromes for extracellular and intracellular antigen detection by flow cytometry. Cytometry. 2001;44:16-23 pubmed
  493. Agrawal S, Marquet J, Plumas J, Rouard H, Delfau Larue M, Gaulard P, et al. Multiple co-stimulatory signals are required for triggering proliferation of T cells from human secondary lymphoid tissue. Int Immunol. 2001;13:441-50 pubmed
  494. Miller A, Kraiem Z, Sobel E, Lider O, Lahat N. Modulation of human leukocyte antigen and intracellular adhesion molecule-1 surface expression in malignant and nonmalignant human thyroid cells by cytokines in the context of extracellular matrix. Thyroid. 2000;10:945-50 pubmed
  495. Lafont B, Gloeckler L, D Hautcourt J, Gut J, Aubertin A. One-round determination of seven leukocyte subsets in rhesus macaque blood by flow cytometry. Cytometry. 2000;41:193-202 pubmed
  496. Kappelmayer J, Gratama J, Karászi E, Menendez P, Ciudad J, Rivas R, et al. Flow cytometric detection of intracellular myeloperoxidase, CD3 and CD79a. Interaction between monoclonal antibody clones, fluorochromes and sample preparation protocols. J Immunol Methods. 2000;242:53-65 pubmed
  497. Graziani Bowering G, Filion L. Down regulation of CD4 expression following isolation and culture of human monocytes. Clin Diagn Lab Immunol. 2000;7:182-91 pubmed
  498. Martín Henao G, Picon M, Amill B, Querol S, Gonzalez J, Martinez C, et al. Isolation of CD34+ progenitor cells from peripheral blood by use of an automated immunomagnetic selection system: factors affecting the results. Transfusion. 2000;40:35-43 pubmed
  499. Le Cleach L, Delaire S, Boumsell L, Bagot M, Bourgault Villada I, Bensussan A, et al. Blister fluid T lymphocytes during toxic epidermal necrolysis are functional cytotoxic cells which express human natural killer (NK) inhibitory receptors. Clin Exp Immunol. 2000;119:225-30 pubmed
  500. Gopinath R, Hanna L, Kumaraswami V, Perumal V, Kavitha V, Vijayasekaran V, et al. Perturbations in eosinophil homeostasis following treatment of lymphatic filariasis. Infect Immun. 2000;68:93-9 pubmed
  501. Paz Miguel J, Flores R, Sanchez Velasco P, Ocejo Vinyals G, Escribano de Diego J, López de Rego J, et al. Reactive oxygen intermediates during programmed cell death induced in the thymus of the Ts(1716)65Dn mouse, a murine model for human Down's syndrome. J Immunol. 1999;163:5399-410 pubmed
  502. Cron R, Bort S, Wang Y, Brunvand M, Lewis D. T cell priming enhances IL-4 gene expression by increasing nuclear factor of activated T cells. J Immunol. 1999;162:860-70 pubmed
  503. Kim C, Pelus L, White J, Applebaum E, Johanson K, Broxmeyer H. CK beta-11/macrophage inflammatory protein-3 beta/EBI1-ligand chemokine is an efficacious chemoattractant for T and B cells. J Immunol. 1998;160:2418-24 pubmed
  504. Verhasselt B, De Smedt M, Verhelst R, Naessens E, Plum J. Retrovirally transduced CD34++ human cord blood cells generate T cells expressing high levels of the retroviral encoded green fluorescent protein marker in vitro. Blood. 1998;91:431-40 pubmed
  505. Basch R, Quito F, Beh J, Hirst J. Growth of human hematopoietic cells in immunodeficient mice conditioned with cyclophosphamide and busulfan. Stem Cells. 1997;15:314-23 pubmed
  506. Yeaman G, Guyre P, Fanger M, Collins J, White H, Rathbun W, et al. Unique CD8+ T cell-rich lymphoid aggregates in human uterine endometrium. J Leukoc Biol. 1997;61:427-35 pubmed
  507. Borst J, Alexander S, Elder J, Terhorst C. The T3 complex on human T lymphocytes involves four structurally distinct glycoproteins. J Biol Chem. 1983;258:5135-41 pubmed
  508. Furley A, Mizutani S, Weilbaecher K, Dhaliwal H, Ford A, Chan L, et al. Developmentally regulated rearrangement and expression of genes encoding the T cell receptor-T3 complex. Cell. 1986;46:75-87 pubmed
  509. Gold D, Puck J, Pettey C, Cho M, Coligan J, Woody J, et al. Isolation of cDNA clones encoding the 20K non-glycosylated polypeptide chain of the human T-cell receptor/T3 complex. Nature. 1986;321:431-4 pubmed